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ABSTRACT

Perceived Health Status, Adherence to Disease Modifying Therapy and Religious Coping
in Adults with Multiple Sclerosis
by
Marcia Jones George

Adviser: Dr. Eileen Gigliotti
Purpose: People living with MS need to employ both problem and emotion-focused coping
strategies to maintain optimal health. Specifically, with one’s Perceived Health Status as an
indicator of optimal health, treatment adherence and religious coping are indicators of problem
and emotion-focused coping, respectively. This study aimed to examine the relations between
Perceived Health Status, the dependent variable, and the independent variables Adherence to
DMT and Religious Coping. Based on the Neuman Systems Model (Neuman & Fawcett, 2011)
and Pargament's Theory of Religious Coping (1997), it was proposed that Adherence to DMT
and Religious Coping are respectively one's physiological and spiritual lines of resistance that
would affect reconstitution to the Normal Lines of Defense, Perceived Health Status.
Method: This was a cross-sectional randomized sample (N = 266), response rate 46%, of adults
from a national MS registry (NARCOMS) who completed the RAND Short Form-36 (SF-36)
questionnaire, the Multiple Sclerosis Treatment Adherence Questionnaire (MS-TAQ) Barriers
Subscale, the Brief Religious Cope (Brief RCOPE) Questionnaire, and demographic data to
explore the relations among the variables. An alpha of 0.05, power at .80 with an anticipated
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effect size of .065, determined statistical significance. Data were analyzed using regression,
correlations, ANOVA, chi-square, and t-tests.
Findings: Together, Adherence to DMT nor Religious Coping (R2 = .02, p = .159) did not
influence Perceived Health Status in this study. However, ancillary analyses revealed the best
predictor of Perceived Health Status was employment status (β = 6.29, p < .001) with significant
variations noted among the employment groups (F (4,250) = 19.07, p < .001). People who report
being unable to work had significantly lower mean Perceived Health (M = 40.09, SD = 14.79)
scores than all other employment groups.
Conclusions: There is some support for the conceptual and theoretical link between Neuman's
Systems Model (Neuman & Fawcett, 2011) and Pargament's Theory of Religious Coping (1997).
The spiritual variable worked to weakly influence Reconstitution via Negative Religious Coping.
Participants who used less Negative Religious Coping reported better Mental Health. Future
studies should focus on employment status and its role as a stressor influencing the Lines of
Resistance. Research with people with MS should include measuring appraisal methods they use
to arrive at Perceived Health Status.

Keywords: multiple sclerosis, perceived health status, adherence, religious coping,
Neuman Systems Model, employment status
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Chapter 1
The Research Objective
Perception of one’s current health status, especially in patients with chronic disease,
indicates how well one is coping with the disease and its effects (McCabe & McKern, 2002).
Thus, one’s Perceived Health Status is the outcome of coping. If coping is effective, Perceived
Health Status should be high, and ineffective coping should result in low Perceived Health
Status. However, because health perception is a continual process of reappraisal (Phillips et al.,
2009), then the reverse must also hold: coping can be seen as the outcome of health perception.
That is, one’s Perceived Health Status can be the stimulus that evokes coping behaviors.
Therefore, knowledge of health perception and coping mechanisms is vital to health care
professionals as they seek to assist patients in this coping process.
This knowledge is especially crucial to Multiple Sclerosis (MS) health care providers
because MS, a neurological disease that affects over 1million people in the United States
(Walton et al., 2020), is characterized by onset in early adulthood and an unpredictable but
progressive decline in all body systems. People with MS face a lifetime of coping with the limits
and consequences of progressive neurological disease and rely on treatments that offer no cure.
(Bonsaksen, Lerdal, & Fagermoen, 2015; Ghafari, Khoshknab, Nourozi, & Mohammadi, 2015).
Coping with MS requires a continuous reappraisal of the disease's effects and work to solve or
manage perceived problems to return to optimum health. Patients use problem and emotionfocused coping strategies to preserve optimal health and continuously redefine personal goals
(Büssing, Osterman, Neugebauer, & Heusser, 2010).
Problem-focused coping concerns the physiological management of MS and is centered
on treatment recommendations. Early and sustained treatment with disease-modifying therapies
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(DMT) can reduce clinical symptoms, slow disability progression, and decrease central nervous
system lesions (Steinberg, Faris, Chang, Chan, & Tankersley, 2010). Clinical outcomes and cost
to the individual and society are directly related to DMT adherence (Lizán et al., 2014).
However, adherence is not easy and requires emotion-focused coping. Emotion-focused
coping involves ongoing cognitive reappraisal to self-reflect and make choices to adapt
to stressors (Baldacchino, Borg, Muscat, & Sturgeon, 2012; Folkman & Moskowitz, 2000).
Though there are many emotion-focused coping strategies, Rosmarin, Wachholtz, and Ai (2011)
note that religion is commonly used and may positively impact health indices, especially
in people with chronic disease. When faced with stress, people often turn to religion to
restore order to their lives, and religious coping plays a crucial role throughout the
illness (Exline et al., 2014).
People living with MS need to employ both problem and emotion-focused coping
strategies to maintain optimal health. Specifically, with one’s Perceived Health Status as an
indicator of optimal health, treatment adherence and religious coping are indicators of problem
and emotion-focused coping, respectively. This study will investigate the relations between
Perceived Health Status, DMT Treatment Adherence, and Religious Coping in people with MS.
The Problem
What are the relations among Perceived Health Status, Adherence to DMT, and Religious
Coping in adults with MS?
Definitions
Perceived Health Status
Perceived Health Status is conceptually defined as health concepts relevant to the patient
from the patient’s perspective. The two concepts are physical and mental health (Ware, 2000).
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Perceived Health Status is operationally defined as scores on the RAND SF-36 physical and
mental health components (Ware & Sherbourne, 1992).
Adherence DMT
Adherence to DMT is conceptually defined as the extent to which a patient acts in
accordance with the prescribed interval and dose of DMT within the past four weeks (Cramer et
al., 2008). Adherence to DMT is operationally defined as Missed Dose Ratio (MDR) scores
from the Multiple Sclerosis Treatment Adherence Questionnaire (MS-TAQ) Barriers subscale
(Wicks et al., 2011).
Religious Coping
Religious Coping is conceptually defined as efforts by people to understand and come to
terms with personal stressors in ways related to the sacred (Pargament, 1997). Religious Coping
is operationally defined as scores on the Brief-RCOPE (Pargament, Feuille, & Burdzy, 2011)
which measures Positive and Negative Religious Coping. People using Positive Religious
Coping view stressors as a chance to transform for the better and have a collaborative
relationship with the sacred. People using Negative Religious Coping are self-directing or view
stressors as punishment from the sacred and may have spiritual and religious struggles.
Delimitations
The proposed sample were males and females, 18 years of age and older in the United
States (US) with a clinically definite MS diagnosis. All were currently taking a US Food and
Drug Administration (FDA) approved DMT prescribed by a health care provider and will have
been taking this DMT for at least six months at study enrollment. The stipulation that DMT use
must be current and have lasted at least six months is due to Coyle et al. (2014) and Devonshire
et al. (2011), who report that time to discontinue DMT ranges from 6 months to over 11 years.
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Participants were recruited from a US national database of over 38,000 adults with MS to
provide a randomized sample and strengthen the study's external validity. Thus, participation
was limited to only those on an FDA-approved DMT.
Differences in adherence to DMT were similar regardless of the type of MS or treatment
duration (Devonshire et al., 2011a; Tan et al., 2011). Therefore, all patients on any prescribed
DMT were eligible to participate. Regarding the effects of marital status on the study variables,
there are conflicting findings. Ren (1997) found that marital or cohabitating status influences
Perceived Health Status. However, McCabe and McKern (2002) found no statistically significant
relation between relationship status and perceived health. The participants' marital status data
were analyzed to determine if there were statistically significant differences between the groups
on study variables.
Research on Religious Coping included participants of all religious denominations:
Christianity, Judaism, Muslims, other religions, and people who identify as atheists, agnostics, or
without a designated religious faith (Pargament, 1997; Pargament, Koenig, & Perez, 2000;
Pedersen, Pedersen, Pargament, & Zachariae, 2013; Trevino et al., 2010). The study included
people with MS of all religious faiths/lack of faith. Adults who are not capable of selfadministration were excluded from the study because, in an extensive observational study, 32%
of participants were not adherent due to not having someone administer the DMT (Turner,
Kivlahan, Sloan, & Haselkorn, 2007). Also excluded are those who are non-English speaking
because all study instruments are in English.
Theoretical Rationale
The Neuman System Model (NSM) (Neuman & Fawcett, 2011) and the Pargament
Theory of Religious Coping (Pargament, 1997) explained how Religious Coping and Adherence
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to DMT come together to influence Perceived Health Status in adults with MS. Both
frameworks describe possible adaptational outcomes when individuals try to cope and adjust to
situational demands that affect health and well-being. The NSM and Pargament’s Theory of
Religious Coping incorporate stress and coping elements from the seminal work of Lazarus and
Folkman (1984).
According to Lazarus and Folkman (1984), the coping process is continually changing to
enable people to manage environmental stressors that are cognitively appraised as exceeding
personal resources. They describe two forms of coping: problem-focused and emotion-focused.
Folkman (2010) posits that problem-focused coping involves planful problem solving, and
emotion-focused coping involves regulating negative emotions.
In the NSM (Neuman & Fawcett, 2011), environmental stressors lead to system
instability, which sets in motion attempts to return to well-being by activating coping
mechanisms. The NSM views the client as an open and multidimensional system. The
environment is external and internal and depicted by a series of concentric circles called the
flexible line of defense, normal line of defense, and lines of resistance that protect the client’s
basic structure or central core from environmental stressors (see Appendix A). To understand the
model wholistically, one must consider the individual’s five-person variables: physiological,
psychological, sociocultural, developmental, and spiritual, which are inherent in all lines of
defense and resistance and therefore affect the degree of protection against stressors.
Stressors can cause system instability disrupting the normal line of defense, which is the
person’s typical state of wellness. The lines of resistance are then activated to protect the core
from instability and help the person return to a state of wellness. If the lines of resistance are not
effective, then the person does not return to a state of wellness, and a core response occurs.
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Stressors that strain the client system can affect any or all of the five-person variables in the lines
of resistance.
When stressors invade the normal line of defense or normal state of wellness, the
individual uses the lines of resistance to cope and optimally adjust to the new circumstances.
Neuman refers to this process as Reconstitution, a dynamic state where the client system
adjusts to the new normal (Gehrling, 2011). The reconstitution process helps rebuild the
normal line of defense and regain a, sometimes redefined, state of wellness
(Gehrling & Memmott, 2008; Gehrling, 2011). Reconstitution is an ongoing process that
requires continuous psychological processes to manage the change (Gigliotti, 2012).
Pargament’s Theory of Religious Coping (1997) provides greater specificity to one aspect
of the reconstitution process described by Neuman (Neuman and Fawcett, 2011) and
Gehrling (2011). Specifically, Pargament (1997) describes coping behaviors related to Neuman’s
spiritual variable in the lines of resistance. According to Pargament (1997), coping behaviors are
dynamic processes between people’s life situations and spiritual and religious dimensions.
Individuals, therefore, take an active role in responding to and acting on life stressors by
exhibiting coping behaviors in ways related to the sacred.
The Religious Coping methods involve active, passive, and interactive methods and are
used explicitly to cope with stressful events that threaten a person’s fundamental beliefs
(Folkman & Moskowitz, 2000; Pargament, 1997). Religious Coping can be both positive and
negative (Pargament, Smith, Koenig, & Perez, 1998) and includes appraisal and reappraisal of
God’s power. Positive Religious Coping is associated with better Perceived Health Status
(Hebert, Zdaniuk, Schulz, & Scheier, 2009; Lee, Nezu, & Nezu, 2014; Pargament et al., 1998).
Negative Religious Coping has been linked to worse health outcomes, psychological distress,
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and hopelessness, possibly due to the belief that illness is God’s punishment for disobedience
(Cummings & Pargament, 2010; Park & Dornelas, 2012).
Positive Religious Coping involves a collaborative give and take relationship with the
higher power. Collaborative people have high self-esteem and exhibited the best sense of
personal control over what happens in their lives. Alternatively, Negative Religious Coping
involves self-directing and deferring behaviors. Self-directed people rely only on themselves to
cope with stressors with minimal reliance on a higher power for help to cope. Deferring people
typically have lower self-esteem, lower personal control, and rely on chance to explain how
things happen in their lives (Pargament, 2013).
Both theorists' propositions and assumptions can be used to describe the relations among
Perceived Health Status, Religious Coping, and Adherence to DMT in adults with MS. The MS
diagnosis constitutes a stressor that invades the normal defense line, thereby disrupting the
steady-state of dynamic equilibrium. To return to a steady state of optimal functioning, defined
as high Perceived Health Status, a person with MS must cope and adjust to changes brought on
by a chronic illness. The person’s lines of resistance help the person with choices and
possibilities to manage the stress of MS. The physiological and spiritual lines of resistance are
activated to cope with the stressor. In a patient with MS, the normal line of defense is a
participant’s Perceived Health Status, DMT’s and Religious Coping are the physiological and
spiritual variables in the lines of resistance. These lines of resistance help a person to adapt to the
changes and find meaning in the encounter by reorienting and revising definitions of health.
Good Adherence to DMT’s and positive Religious Coping would result in high Perceived Health
Status: Reconstitution. If the person cannot use these coping mechanisms, then Reconstitution
will be impaired, and the Perceived Health Status score will be low.
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In summary, positive perceived health results when people with MS can appraise MS's
challenges and effectively use DMT and religious coping to reconstitute to a new normal line of
defense. It is proposed that Adherence to DMT and Religious Coping work together to predict
Perceived Health Status in adults with MS.
Research Question
Considered together, does Adherence to DMT and Religious Coping explain a
statistically significant portion of the explained variance in Perceived Health Status in patients
diagnosed with MS?
Need For The Study
People with MS must cope with the devastating effects of a chronic illness that leads to
varying levels of disability (Chen et al., 2011). This disability can adversely affect their
perceived health. Adherence to DMT, a problem-focused means of coping, is crucial to
mitigating the disease's effects. McCabe and McKern (2002) note that problem and emotionfocused coping strategies predict adjustment to MS. Also, Dehghani, Keshavarzi, Jahromi,
Shahsavari isfahani, and Keshavarzi (2018) note that behavioral and cognitive coping strategies
influence adjustment and provide an avenue to improve perceived health in people with MS. To
date, little attention has been given to the role of religious coping as an emotion-focused coping
strategy in MS.
Clark, Drain, and Malone (2003), commissioned by the Joint Commission, a US
healthcare accrediting organization, reviewed satisfaction data from US hospitals and found
strong relationships between patient satisfaction and staff’s involvement in the patient's
emotional and spiritual needs. Therefore, the Joint Commission requires a spiritual assessment
for all patients that includes a question about whether their religious faith has a role in their
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coping with illness (Joint Commission, n.d.). This study investigated the importance of Religious
Coping when used in conjunction with Adherence to DMT to predict Perceived Health Status in
people with MS.
Theoretically, this study can add information about the NSM concept of Reconstitution.
Gehrling (2011) noted that the investigations of the NSM concept of Reconstitution are lacking.
Also, though Gigliotti (2012) called for a focus on the reconstitution effects of the lines of
resistance, to date, no reported studies have examined these effects empirically. Finally, this
study's results could better inform health care providers about when and how to intervene with
people with MS who are at risk for adverse outcomes. Healthcare professionals may take more
seriously those who draw upon religious coping methods to cope with their illness and initiate a
timely referral and psycho-spiritual interventions to support positive religious coping, improving
perceived health status (Freitas et al., 2015).

10
Chapter II
Review of the Literature
This chapter includes a literature review of the study variables, Perceived Health Status,
Adherence to DMT and Religious Coping. Perceived Health Status is presented first as it
pertains to stress and appraisal in people with MS. Adherence to DMT is then discussed,
including factors influencing Adherence to DMT and Adherence to DMT in people with MS.
Finally, Religious Coping is presented, including a discussion of the relations between stress,
coping, and health outcomes.
Perceived Health Status
MS is the most common neurological disease that affects young and middle-aged adults
contributing to physical, emotional, and cognitive problems that may significantly decrease a
person’s overall quality of life and, therefore, their Perceived Health Status (Benedict et al.,
2005). Perceived Health Status is affected because MS affects both physical disability (Thong et
al., 2009) and physical functioning (Pugliatti et al., 2008) and psychosocial factors such as
anxiety (Pontone et al., 2011), social support, depression (Krokavcova et al., 2008) and, stress
(Senn et al., 2014). Within the NSM, MS is an intrapersonal stressor that taxes the system
resulting in disruption to the normal lines of defense, producing physical and psychological
coping responses to return to a stable state (Gehrling & Memmott, 2008).
Stressors can also be classified as the interpersonal and extrapersonal dimensions of an
individual, and the reactions to the stressors are influenced by cognitive appraisal and coping
(Lazarus, 1999). The NSM (Neuman, & Fawcett, 2011) posits that the outcome of appraisal and
coping is Reconstitution. Reconstitution represents a return to and maintenance of system
stability at a level of wellness present before the stressor or can return to a lower level of
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wellness – a new normal. So knowing how people appraise, cope, and adhere to treatment
recommendations should be an essential MS management objective (Benito-León, Morales, &
Rivera‐Navarro, 2002; Heiskanen, Meriläinen, & Pietilä, 2007). The use of strategies that help
people cope and adjust to MS may allow Reconstitution and improve Perceived Health Status in
people with MS.
Perceived Health Status Defined
Perceived Health Status is the subjective experience of illness on an individual’s physical
and psychological well-being and is predictive of morbidity and mortality (Charmaz, 1995; Xiao
& Barber, 2008). Lazarus and Folkman (1984) postulate that cognitive appraisal's subjective
process may differ with context, over time and inter and intra-personally helping patients cope
with stressors relevant to health status.
Therefore, how an individual appraises and views the effects of disease stressors on their
lives informs decision making and influences the degree of acceptance and adjustment to
physical changes. Acceptance and adjustment to disease stressors may result in planful problemsolving and positive reappraisal of the problem to help patients manage and work towards a
perceived favorable outcome. Alternatively, such acceptance and adjustment may be negatively
influenced by depression and emotional distress leading to inaction and unfavorable outcomes.
Ultimately, the person’s perspective and experiences can help healthcare providers identify
patient goals, priorities, and concerns for healthcare resulting in a collaborative care approach to
disease management (Ahmed et al., 2012).
Perceived Health Status In MS
Rapkin and Schwartz (2016) suggest that, in patients with MS, cognitive appraisal
reflects fundamental ways in which people understand and interpret the disease experience to
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arrive at Perceived Health Status. In their mixed-method longitudinal analysis of secondary
patient-reported outcomes obtained from the North American Research Committee on Multiple
Sclerosis (NARCOMS), the RAND SF-12 (Hays et al., 1995) was used to measure the physical
(PCS) and mental (MCS) health components of Perceived Health Status. The RAND SF-12
Health Survey has just 12 questions and is a shorter version of the SF-36 (Ware & Sherbourne,
1992) Health Survey used in the present study. Cognitive appraisal processes were assessed
using the QOL appraisal profile (Morganstern et al., 2011). The sample (N = 859) had a mean
age of 55 years, and 74% of the participants were female, which is in line with MS gender
prevalence distribution (Chao et al., 2011).
Rapkin and Schwartz (2016) identified four cognitive appraisal processes that people use
to rate their Perceived Health Status. These key appraisal processes describe the person’s
personal goals or frame of reference, how the individual recalls previous experiences to make
decisions, the individual’s standard of comparisons used to appraise experiences, and a person’s
subjective algorithm used to arrive at Perceived Health Status (Rapkin & Schwartz, 2004).
In contrast, a healthcare provider’s perception of an individual’s health status is based only
on clinical signs and may not be congruent with the person’s own Perceived Health Status.
The authors suggest that the four appraisal processes, personal goals/frame of reference,
experience recall, standards of comparison, and the personal combinatory algorithm may
allow an individual to rate their Perceived Health Status the same, lower or higher than the
healthcare provider ratings.
They found that patients with self-rated PCS higher than the provider’s rating appraised
personal goals, recalled recent experiences, and compared themselves to a time before MS.
Additionally, people with higher self-rated PCS used problem-focused strategies to think about
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the difficulties they may face with MS and manage those difficulties. These patients also used
sampling experiences that emphasized the positives, sought a balance between positive and
negative problems and used emotion-focused strategies to work towards religiousness or
spirituality goals.
Interestingly, though Rapkin and Schwartz (2016) found that problem-focused coping
improved PCS, Pakenham (1999) deduced that problem-focused coping might be related to PCS
and MCS because people with MS must solve practical problems associated with a disability.
In a crossectional analysis, Pakenham proposed that problem-focused coping will be more
evident at stressful events leading to better adjustment, therefore better overall Perceived Health
Status and coping.
In a sample (N = 96) of people with relapsing and progressive MS, Perceived Health
Status was assessed using a five-point scale developed by the researcher, rated from 1= excellent
to 5 = extremely poor. Regression analyses of the effects of stress and coping on Perceived
Health Status indicate that people who used more problem-focused coping strategies
(R2 = .37, p < .01) had a better adjustment and Perceived Health Status over time. In contrast,
higher levels of emotion-focused coping were associated with more distress (r = .69, p < .01) and
depression (r = .55, p < .01). Though adjustment to MS requires both problem and emotionfocused strategies over time, emotion-focused coping strategies such as avoidance and wishing
for a better life are associated with high-stress levels.
Wilski and Tasiemski (2016) reported that cognitive appraisal and reappraisal by people
with MS are essential correlates of Perceived Health Status. One hundred and seventy-two
women and 85 men (N = 257), with relapsing-remitting MS (RRMS, 37%), primary progressive
MS (PPMS, 29.5%), secondary progressive MS (SPMS 23%), and progressive-relapsing MS
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(PRMS, 8%) were recruited to investigate the relationship between cognitive appraisal and
Perceived Health Status. The 29-item Multiple Sclerosis Impact Scale was used to measure
Perceived Health Status (Hobart et al., 2001).
Wilski and Tasiemski (2016) demonstrated that patients with troublesome symptoms and
more disability had increased self-identity with MS resulting in worse PCS
(R2 = 0.45, p  0.001). This finding is similar to Rapkin and Schwartz’s (2016) discussion on
cognitive appraisal, indicating that participants with poor PCS had a negative frame of reference
about MS. Regarding MCS, Wilski and Tasiemski found that self-esteem ( = - 0.41, p  0.001)
was the best predictor. It is reasonable that better self-esteem results in better confidence to
manage MS and its consequences. Thus, if an individual with MS thinks positively of themselves
and their ability to achieve personal health goals that may lead to better physical and
psychological outcomes, it influences Perceived Health Status.
Interestingly in Wilski and Tasiemski’s (2016) study, the type of MS, relapsing or
progressive, or how long the person had the disease did not significantly influence Perceived
Health Status. Both Rapkin and Schwartz (2016) and Wilski and Tasiemski (2016) demonstrated
that psychological influences such as feeling good about themselves and being married led to
better Perceived Health Status. Perhaps being married gave the person more social and
emotional support to manage the consequences of the disease. However, predictably, in both
studies, there was an association between more disability (β = 0.34, p  0.001) and lower scores
on overall Perceived Health Status. So we know people with MS face many physical challenges
which negatively impact Perceived Health Status, but how do people with MS compare to the
general population psychologically?
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Pittock et al.'s (2004) study on self-reported Perceived Health Status for patients with MS
compared to normative data for the general US population noted that, for people with MS,
Perceived Health Status remained stable over time despite increasing physical disability. They
used the Multiple Sclerosis Quality of Life Health Survey (MSQoL-54) (Vickrey, 1995) to
measure Perceived Health Status. The MSQol is a combined version of the SF-36
(Ware & Sherbourne, 1992) with 18 additional items pertinent to MS. In the cohort (N = 185),
participants were diagnosed with relapsing, secondary or primary progressive MS with a median
age of onset of 31 years and a median disease duration of 19.3 years. As expected, longer disease
duration with resulting physical disability led to significantly worse Perceived Health Status in
the people with MS (r = - 0.37; p < .001). Additionally, mean scores in Perceived Health Status
were lower (M = 39.2, SD = 12.7) in the people with MS compared to normative mean (M = 50
± 10) scores for the general US population.
Because MS can cause profound physical deterioration, it was expected that physical
domains of Perceived Health Status for those with MS, particularly physical functioning
(M= 36.8, SD =17.4), would be worse than the normative mean score (M = 50 ± 10) for the
general US population. As expected, regardless of age, people with more disability
(whether with MS or not) had worse PCS than people with minimal or no physical disability
(M = 39.2, SD = 12.7). Regarding MCS however, the overall MCS of the people with MS were
not lower than the general population (M = 50 ± 10) studied but notably were better (M = 54.2,
SD = 8.6, p < .001). Notably, there were no significant relationships in some subset of MCS and
physical disability particularly role emotional and disease duration (r = - 0.05, p = .46) or mental
health (r = -0.05, p = .50) for the MS patients.
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These findings are similar to those of Rapkin and Schwartz (2016), who also found that
psychological health was not statistically significantly affected by disability. In general, 77%
(n = 142) of the patients in Pittock et al.’s (2004) study were mostly satisfied or delighted about
their lives. Why physical disability does not significantly influence psychological health status
may be influenced by coping mechanisms that help patients adjust to health situations allowing
them to compensate psychologically. The cross-sectional analysis suggests that psychological
status demonstrates little change in MS patients, but how is it impacted over time in people
with MS?
Tepavcevic et al. (2014) noted that in a cohort of patients (N= 93) followed for three and
six years, both the PCS and MCS deteriorated over time. Tepavcevic et al.’s results contrast with
other longitudinal cohort studies (Hopman, Coo, Brunet, Edgar, & Singer, 2000), showing the
mental component scores' stability over time. The MSQoL-54 (Vickrey, 1995) was used to assess
Perceived Health Status in Tepavcevic et al.’s(2014) study. Participants were 18 - 60 years of age
and diagnosed with relapsing, secondary progressive, and primary progressive MS with a gender
distribution of males (n = 27) and females (n = 66).
Tepavcevic et al.'s. (2014) analyses of changes in Perceived Health Status's magnitude
over the first three years showed a medium effect size for Perceived Health Status (−0.54).
Additionally, by six years, there was further deterioration in Perceived Health Status, resulting
in a large ES (≥ 0.80) (p < 0.01). Changes in the MCS (r = −0.474, p < 0.01) and
PCS (r = −0.727, p < 0.01) were negatively correlated with the changes in the disability scores
during the entire study period. Therefore, as physical disability worsened, patients reported
worsening of Perceived Health Status's physical and mental components.
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In Tepavcevic et al.’s. (2014) study, all aspects of Perceived Health Status changed over
time from baseline and at 3-years and 6-years, most notably in patients with lower disability at
baseline. Explanations may be that people who have little physical effects of MS initially may
not have developed adequate modes of adaptation in coping with disability. Therefore, as levels
of disability rise, people with MS face significant adverse effects on basic self-care and
functioning, becoming more dependent on others leading to worse Perceived Health Status.
The aim of measuring health status in people with MS is to help tailor clinical
interventions and assess their effectiveness in routine care. Knowing a patient’s Perceived Health
Status may indicate patients’ priorities for treatment. For instance, if a person is more concerned
about and rated MCS low, psychological interventions may be prioritized. Additionally, shared
decision-making to help specify patients’ preferences and priorities for treatment may help
patients cope and adhere to DMTs over time (Solari, 2005). Collaborative care requires patients
to be involved in all aspects of treatment and consider their choices (LeBlanc et al., 2009) when
recommending DMT use. Furthermore, collaborative care depends on how patients and
healthcare providers share information relevant to clinical outcomes that foster shared decisionmaking. Perhaps then patients may be more apt to adhere to recommendations for DMT.
Adherence To DMT
Due to variable disease progression, the uncertainty of relapses, and side effects of DMT,
adherence is hard for MS patients (Bruce et al., 2016). In people with MS, adherence to DMT
has been estimated to be between 18% to 45% (Portaccio & Amato, 2009; Río et al., 2005).
Even with good adherence, MS patients may still experience relapses and not have
confidence in the treatment regimen (Caon et al., 2010). However, there is growing
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evidence that when DMT is started early and patients are persistent with therapy, treatment
efficacy is improved (Bruce & Lynch, 2011).
Additionally, people with MS must cope effectively with the stress of adhering to
medications that offer no immediate benefits but have implications for good long-term outcomes
(Beatty et al., 1998). Unlike an infection that goes away with treatment, MS symptoms may
not go away, and patients often have a residual disability. Thus, healthcare providers'
challenge is working with patients to help them see the benefits of long-term DMT use in
lessening disease progression.
Adherence Defined
The World Health Organization (WHO, 2003) defines adherence as: “the extent to which
a person’s behavior – taking medication, following a diet and executing lifestyle changes
corresponds with an agreed recommendation from a healthcare provider.” (p. 17). In the context
of research trials in MS, assessing adherence is varied. Operationally adherence is defined as
follows: not missing any prescribed dose (Devonshire et al., 2011; Treadaway et al., 2009)
medication possession ratio (MPR) (≥ 80% is considered adherent) (Kozma et al., 2013; Tan et
al., 2011) and diary self-report on a scale of poor to good based on the number of missed doses
(Hupperts et al., 2014) that the researcher defines. Because the definitions of adherence are
varied, cross-study comparisons often pose a challenge (McKay et al., 2017).
Importantly, subjective measures of adherence, which are standard practice, may
overestimate the degree to which patients are adherent. However, there is no single measurement
of adherence that is optimal (WHO, 2003). Subsequently, clinicians often use multimethod
approaches that are reliable and valid with a combination of patient self-reporting and objective
measures. The Multiple Sclerosis Coalition (DMT Consensus MS Coalition, 2017) lists DMT
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adherence as essential to treatment efficacy. Therefore early identification and timely
interventions of factors that affect adherence are necessary to help patients. As MS progresses,
there is evidence that Perceived Health Status deteriorates. Clinicians may help to mitigate the
effects of MS by focusing on Adherence to DMT. There is evidence that Adherence to DMT over
the long term can help slow disease progression, thereby improving the physiological and
psychological domains of Perceived Health Status in people with MS.
Factors Influencing Adherence
Social support, hope, self-efficacy, perceived treatment benefit, and injection anxiety
contributes to DMT adherence in MS (Bruce, Hancock, Arnett, & Lynch, 2010; Siegel, Turner, &
Haselkorn, 2008; Turner, Sloan, Kivlahan, & Haselkom, 2014). Devonshire et al., (2011)
reported the greater odds of having better adherence include being female ((OR) 1.25; 95% (CI):
0.99 –1.56; p = 0.0572), being satisfied with DMT therapy ((OR) 1.54; 95% (CI): 1.20 –1.98; p =
0.0007) and having family support ((OR) 1.33; 95% (CI): 1.06 –1.67; p = 0.0157).
Treadaway et al. (2009) explored adherent and non-adherent drug-taking behavior in
patients with MS in a multicenter observational study. The researchers aimed to understand from
the patient’s perspective why medications were omitted and determine if missing doses impacted
future adherence. The MSQoL (Vickrey, 1995), a combined version of the SF-36 (Ware &
Sherbourne, 1992) with 18 additional items pertinent to MS, was used to measure Perceived
Health Status. Adherence was defined as a medication possession ratio (MPR) > 80 %. MPR is
the total number of a drug available to the patient during any period to meet prescribed doses.
The drug data was obtained from pharmacy refill records and noted as a percentage of time
patients have the medication available for use (Kozma et al., 2013). Participants were eligible for
the study if they had relapsing MS, were 18 years of age or older, were on an FDA-approved
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injectable disease-modifying agent for at least six months, and had access to the internet. The
survey instruments were all administered via the internet.
The participants were recruited mostly (66%) from academic medical centers to complete
the study. The majority of participants were female (77%), with an average age of 43 years.
Patients who were older (M = 37.0 ± 9.16)) at disease onset had significantly
(t = 2.17, p = .0002) better adherence than younger patients (M = 34.6 ± 8.69). It may be
difficult for someone newly diagnosed, younger, and symptom-free to accept an MS diagnosis
and start treatment with DMT with side effects. It is also possible that older people with MS who
may have the longer medication-taking experience had better insight and knowledge into how
DMT may affect disease course.
As expected, adherent patients had higher scores on both the PCS (M = 59.7 ± 20.7,
p = 0.0020) and MCS (M = 69.5 ± 20.5), p < 0.0001) of Perceived Health Status compared to
patients who reported nonadherent behaviors in PCS (M = 55.2.± 19.7) and MCS (M = 63.1 ±
21.6) (t statistics not reported). So patients who cognitively appraise changes in health and take
steps to cope with the changes by being adherent to DMT have better Perceived Health Status
than those who are not adherent and may be unable to cope with MS's challenges.
Munsell, Frean, Menzin and Phillips (2016) found, in a cohort (N = 8382) of people with
MS, that age range older than 18 – 34 years was significantly associated with a higher likelihood
of adherence: 45 to 54 years ((OR) 1.33; 95% [CI]: 1.178 - 1.505, p < 0.0001) and 55 - 64 years
((OR) 1.321; 95% [CI]: 1.318 1.533, p = 0.0003). However, the odds of being more adherent
with oral versus injectable DMT were not significant
((OR) 1.062; 95% [CI]: 0.937–1.202; p = 0.3473) in any age group. One would expect that
patients would be more apt to take a pill than inject. However, the number of days to inject
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was at most three times weekly, and an oral DMT is prescribed to be taken one to two times
daily. Thus it would be expected that patients may forget to take all oral doses as
prescribed — the more complex the medication regimens, the more likely that adherence
decreases (Kalogianni, 2011).
Males (95% [CI]: 1.085–1.335; p = 0.0005) were 1.2 times more apt to be adherent than
females which is in contrast to another study (Devonshire et al., 2011) reporting females with
1.25 (95% [CI]: 99–1.56; p = 0.05) better adherence than males. Notably, the male-to-female
adherence rate has been inconsistent across studies (Turner, Kivlahan, Sloan, & Haselkorn, 2007;
Zhornitsky et al., 2015). It may be possible that males are more adherent because of the social
stigma of disability and the idea that better adherence may lead to better physical outcomes.
Depression at baseline ((OR) 0.618; 95% [CI]: 0.511–0.747; p < 0.0001) was also predictive of a
lower likelihood of adherence. People who are depressed may not have the drive to do what is
necessary to adhere to treatment. Therefore, lower rates of adherence may be possible in
depressed people.
Of 89 patients with MS who were on a DMT, those who perceived benefits of therapy at
four months and six months reported better adherence (80% or better) than those who did not
perceive a benefit of therapy (Turner et al., 2007). The sample population was representative of
the population of army veterans with MS in the US. Adherence was measured with selected
items from the Adherence Determinants Questionnaire (ADQ) (DiMatteo et al., 1993). All
participants were on an FDA-approved injectable DMT. The MS diagnosis length was
11.79 (SD + 7.95) years and taking the current DMT for 3.43 (SD = 3.29) years. There was
significantly better adherence in the group that believed there was a benefit in taking DMT that
did not change when assessed in four months ((OR) 4.07 (95% [CI]:1.23–13.44, p < 05) and
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six months, ((OR) 2.49; [CI]: 1.01–6.17, p < .05). These results are supported by
Treadway et al.’s. (2009) study on factors that influence adherence to DMT where 80% of
adherent patients cited slowing MS progression and decreasing neurological attacks as the most
crucial benefit of adherence. The longer the patients were on DMT, the better the adherence,
perhaps because as the disease progresses and symptoms become more evident, patients cope by
adhering to try and mitigate MS's disabling effects. In Turner’s (2007) study, 80% adherence
was achieved by over 80% of the participants, which is higher than and is in contrast to
adherence estimates in MS (Heesen et al., 2014).
Zhornitsky et al. (2015) reported that, over 12 years, 50% (N = 1471) of patients who
started DMT discontinued the drug. Patients who were > 18 years old with relapsing MS on an
injectable DMT at an MS clinic participated in the study. Mean age was 38.4 (SD = 9.3) years,
75% were women, and mean MS duration was 6.0 years (SD = 6.7). Patients who were younger
18 - 30 years were 7.8 times more likely to stop DMT sooner (95% [CI] (6.0 - 9.9) p < 0.0001)
than patients who were 31 - 73 years. Across the study, demographic variables such as route of
administration and type of DMT did not significantly impact adherence rates.
A common thread in all the reported adherence study outcomes was that younger patients
were more apt to have less adherence than older people with MS. It has been reported that
treatment failure is more easily detected in younger patients with less disability because relapses
are more common before the disease reaches the progressive phase (Mowry et al., 2009). If the
frequency of relapses does not decrease, patients may have no confidence in the DMT and are
more likely to have low adherence.
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Adherence To DMT And Perceived Health Status In MS
Devonshire et al. (2011) found that overall adherence to DMT was 75% in a multicenter
observational international study that included the US (N = 2566). Participants were ≥ 18 years
of age at the time of enrollment, had a documented diagnosis of relapsing-remitting MS,
and were on monotherapy with their current DMT for at least six months before enrollment.
The MusiQoL ((Vickrey, 1995) was used to measure Perceived Health Status. The MusiQoL
is another name for the MSQoL-54 (Vickrey, 1995). The study's adherence was defined
as not missing a single dose of DMT within four weeks before the study began based on
patient self-report.
Most patients (70%; N = 1923) in Devonshire et al.’s (2011) study with a mean exposure
to DMT for 31 months took their DMT as prescribed. Adherent patients on all injectable DMT
had better Perceived Health Status in all dimensions, particularly physical well-being
(p < 0.0001, t not reported) than non-adherent patients. Patients who were adherent to DMT
had less neuropsychological impairment with a significantly lower score of 18 (better)
on an MS neuropsychological impairment questionnaire than non-adherent patients (n = 175:
median = 22.0; p < 0.0001). In this large cohort, a significant 75% of patients who had better
adherence to DMT rated their Perceived Health Status better. The results indicate that adherence
to DMT can significantly affect the PCS and MCS of Perceived Health Status regardless of the
type of DMT. There were fewer neuropsychological impairments in adherent people, showing
that perhaps starting and staying on therapy does mitigate some of the damage from MS.
Therefore studies that can find approaches to improve adherence to DMT over the long term may
help preserve function longer in people with MS.
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In a prospective observational study on DMT adherence, Coyle et al. (2014) established
that MS participants (N =2966) with increasing levels of medication possession ratio (MPR)
remained relapse-free over a 24 month study period. Inclusion criteria were people ≥ 18 years
old, diagnosed with MS, and taking an FDA-approved DMT. Study measure for Perceived
Health Status was the Short Form Health Survey 12 items (SF - 12v2©) (Hays et al., 1995),
which is a shorter version of the SF-36 Health Survey (Ware & Sherbourne, 1992) that uses just
12 questions to measure Perceived Health Status. The participants' mean age was 49 years
(SD = 10.3) and was 80% female.
Coyle et al.’s (2014) objective was to determine how adherence to DMT was associated
with health outcomes. In the study, time since diagnosis ranged from less than one year to 47
years, and 75% of the participants had relapsing MS. Overall, the lowest mean scores and worst
quality of life assessments were found on PCS (M = 40.9 ± 13.2) and role physical (M = 41.2 ±
11.9) subscales, while one of the highest scores was in the MCS (M = 47.4 ± 10.7).
The findings of Coyle et al. (2014) were consistent with Steinberg, Faris, Chang, Chan,
and Tankersley (2010), who found that, over three years, an MPR ≥ 85% was associated with
a decreased risk of relapse compared to an MPR ≤ 50%. Steinberg et al.’s. (2010)
non-experimental retrospective analysis of (N = 1606) of participant’s prescription claims data
assessed relapse rates and healthcare utilization based on MPR. The study population was ≥ 18
years old, and 76% were female. The data showed an increasing adherence trend over three
years, from 72% to 76%. However, as adherence decreased, mainly in 5% decrements, there was
an increased risk for relapse. Additionally, there was a significantly higher risk
((OR) = 1.12; 95% [CI]: 1.03 - 1.23, p < 0.05) of relapse at MPR adherence levels below 70%.
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Steinberg et al. (2010) also found significantly decreased healthcare resource utilization
for inpatient admissions (RR 0.79; 95% CI 0.65 - 0.98), p < 0.05) and fewer emergency room
(ER) visits (RR 0.78; 95% CI 0.61 - 0.9), p < 0.05) for adherent patients. Across studies, the
least number of relapses were observed in groups with an MPR ≥ 85%
(Cohen et al., 2015; Coyle et al., 2014; Steinberg et al., 2010), showing that better adherence not
only resulted in better Perceived Health Status but also in better clinical outcomes. Furthermore,
economic savings and increased productivity may be realized because of less time spent in the
ER and on hospital inpatient stays.
Treadaway et al. (2009) reported, in a cohort of MS patients (N = 708), adherent patients
(> 75% - 100% adherent) scored significantly higher than non-adherent patients in Perceived
Health Status in both the PCS (t not reported, p = 0.0020) and MCS (t not reported, p < 0.0001).
The results are similar to Cerghet et al. (2010), who reported positive associations between
increased adherence and select Perceived Health Status dimensions.
Cerghet et al. (2010) used claims data to evaluate the association between adherence to
DMT and patient-reported outcomes over 12 months. Eligible patients were ≥ 18 years old with
MS. The participants (N = 163) with relapsing MS were surveyed to collect information on
Perceived Health Status, disease severity, and MS duration. Medication Adherence was defined
as the percent of the time the patient had the medication available. The MSQLI (Vickrey, 1995),
a combined version of the SF-36 (Ware & Sherbourne, 1992) with 18 additional items pertinent
to MS, measured Perceived Health Status. Better adherence to DMT (n = 111) was associated
with better MCS (β = 1.002, p = .04) although there was no significant association (β = 0.508, p
=.20) with the PCS even with better adherence. The non-significant associations with PCS are
contradictory to others' results, showing adherence to DMT positively affects both the PCS and
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MCS of patients with MS. Because the MCS of patients with MS is generally better and shows
stability in cross-sectional and longitudinal analysis, patients may adjust and learn how to
manage the disease's consequences over time.
The decision to adhere to DMT requires thinking about the disease effects and developing
a plan to cope, adjust, and conform to having MS. Therefore, Adherence to DMT, a
problem-focused coping method, may be a way to help manage the stress of MS and improve
Perceived Health Status (Goretti et al., 2010). Coping mechanisms help patients adjust to health
situations allowing them to also compensate psychologically to the disease. There is evidence
that Religious Coping, a form of emotion-focused coping, is associated with better mental health,
adjustment, and Perceived Health Status among people with chronic illnesses (Naghi et al., 2012)
Religious Coping
Religion is a multidimensional construct and has been used to describe beliefs, rituals,
sacred texts, prayers, religious attendance, and faith in a higher power (Makros & McCabe,
2003). When stressful health events occur, many people turn to religion, which may help them
manage the consequences of chronic disease (Bussing et al., 2013). People often use prayer to
cope with stressors as a source of strength to gain control over the unknown (Gordon et al.,
2002). It is associated with greater well-being, improved coping with stress, and better mental
health (Koenig, 2012).
The spiritual dimensions include religion and spiritual beliefs that are intrinsic and give
purpose and meaning to all life processes (Neuman & Fawcett, 2011). According to Neuman
(2011), the spiritual variable is a source of strength to the person giving stability to the system.
As a result, when a person experiences stress, they find the strength to cope by drawing upon
their religious and spiritual beliefs. Addressing religious and spiritual issues by the healthcare
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team leads to better patient satisfaction reports, influencing communication, collaboration,
coping, and adjustment (Hughes et al., 2017).
Koenig’s (2012) meta-analysis of clinical research on religion and spirituality and
Perceived Health Status found 37 rigorous studies where 57% reported significant positive
relations while only 8% found no significant relationships. Pargament et al. (1998) found,
through exploratory factor analysis, patterns of Positive and Negative Religious Coping in three
cohorts, including hospitalized medically ill elderly. The positive and negative scales were
significantly positively correlated (r = .18, p < .001), indicating that people use a combination of
Positive and Negative Religious Coping methods in their efforts to manage stressors.
Religious Coping Defined
Religious Coping is an effort by individuals to search for significance, understand,
manage, and come to terms with stressors in ways related to the sacred (Pargament 1997).
Religious Coping is a process of discovering, conserving, and sometimes altering specific
goals and values (Pargament, 2002) and is used when personal resources are limited, and religion
is available (Harrison et al., 2001). Therefore, religious, and spiritual concerns must be assessed
to provide collaborative, holistic, and caring perspectives for patients.
Religious Coping is categorized into two patterns: positive and negative
(Pargament, 1997; Pargament et al., 1998). The positive pattern includes collaborative methods
with the sacred. The negative pattern is evident when a person relies solely on oneself for
spiritual guidance or submits all control over one’s life situation to a higher power, deferring
Religious Coping.
Negative Religious Coping is associated with religious tension and struggle, where
people view stressors in their lives as punishment from the sacred, ultimately coping by deferring
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to an outside force to solve their problems. They can also be self-directing by coping
independently without relying on God’s help (Pargament, 1997). Positive Religious Coping
strategies are helpful to people under stress because the person has a secure relationship with the
sacred collaboratively and sees stress as a transformative force in their lives (Pargament, 1997).
People who use Positive Religious Coping have a comprehensive view of the world that
is good-natured. Positive collaborative Religious Coping has been linked to better physical
health (Bjorck & Thurman, 2007; Lee, Nezu, & Nezu, 2014; VandeCreek et al., 2004), which is
in contrast to self-directing and deferring religious coping, which has shown mixed results
(Pargament et al., 1998). How people use religion to cope has implications for clinical outcomes.
Notably, people who utilize Negative Religious Coping see disease and health problems as an act
of the divine that they cannot change or make better, so self-care may be affected. Alternatively,
Positive Religious Coping methods can motivate the person to act, transforming or reconstituting
to a new normal to take care of body and spirit.
Religious Coping And Health Outcomes
Controlling for secular variables, negative Religious Coping was a significant predictor
of poor health outcomes (Sherman et al., 2005; Tsevat et al., 2009). Sherman et al. (2005)
hypothesized that Religious Coping rather than general religious orientation would be
significantly tied to health outcomes in cancer patients.
In Sherman et al.’s. (2005) study participants (N = 213) with multiple myeloma were
predominantly Christian Protestants (approximately 87%), with smaller proportions of Catholics,
Jews, Muslims, nonreligious individuals, and those from other affiliations. Religious Coping was
assessed using the Brief RCOPE (Pargament et al., 2011), and the SF-12 (Ware, 1995) measured
Perceived Health Status. People with worse Perceived Health Status in both the physical
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component score (PCS) (r= -.18, p < .01) and mental component score (MCS) (r = −.29, p
< .0001) used more Negative Religious Coping compared to those who use Positive Religious
Coping. Negative Religious Coping was associated with more pain (β = -.19, p < .01), less
energy (β = -.21, p < .01) and worse health outcomes (β = -.15, p < .05).
Tsevat et al. (2009) measured Perceived Health Status in people with HIV before and
after diagnosis to determine if health status changed over time and whether spirituality/religious
coping affected the outcome. The HIV/AIDS-Targeted Quality of Life (HAT-QoL) (Holmes &
Shea, 1998) measured Perceived Health Status and, the Brief RCOPE (Pargament et al., 2011a)
measured Religious Coping. Participants (N = 347) were interviewed twice, 18-months apart,
and 273 (79%) identiﬁed most commonly as Roman Catholic, Baptist, or Southern Baptist. Use
of Positive Religious Coping methods before diagnosis improved odds (OR 1.07, 95% CI: 1.02–
1.12, p = 0.008) of better Perceived Health Status and health outcomes after diagnosis. Religious
Coping in this sample persisted across time to help the participants cope with improving
Perceived Health Status and adapting to an HIV diagnosis.
Freitas et al. (2015) examined the influence of Religious Coping and quality of life in
people (N = 147) with inflammatory bowel disease (IBD). Religious Coping was measured with
the Brief RCOPE (Pargament et al., 2011), and Perceived Health Status was measured with the
World Health Organization Quality of Life Instrument-Abbreviated version (WHO | The World
Health Organization Quality of Life (WHOQOL), n.d.). The participants identified primarily as
Roman Catholics and Protestants.
In the sample, better Perceived Health Status was independently associated with higher
Positive Religious Coping (β = 0.196, p = 0.022). Additionally, more depression was associated
with greater Negative Religious Coping (β = 0.307, p < 0.001). Like people with MS, patients
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with IBD face significant challenges that require coping with chronic disease and adapting to
lifelong changes. Positive Religious Coping in the participants was associated with better
Perceived Health which is consistent with Sherman et al. (2005) and Tsevat et al. (2009).
Understanding the differences in how religiousness and spirituality impact health
outcomes can help shed light on how Religious Coping differs and why Religious Coping may
be a better indicator of coping with chronic disease. McCullough and Laurenceau (2005)
examined religiousness with Perceived Health status over the adult life span. The researchers did
a retrospective analysis of data (N = 1119) from an original sample born in 1910 who have been
contacted over the years for follow-up surveys. Participants were Protestant, Catholic, Jewish,
and 45% indicated no church affiliation. The participants’ data had at least one measure of
Perceived Health Status. They were at least 20 years of age and had been in the original study for
59 years. Perceived Health Status was measured 11 times using a 5-point Likert scale where 1 =
very poor to 5 = very good. Religiousness was measured with a single item using a 5-point scale
(1 = none to 5 = very much). It should be noted that religiousness denotes involvement in
religious activities. There was a significant relationship between religiousness and Perceived
Health Status only in women (r = .71, p < .05). For men, the relationship was weak and
non-significant (r = .08).
Koenig, George, and Titus (2004) examined religiousness and spirituality as correlates of
better psychological and physical health in older patients. The participants (N = 838) aged 50
years and older with a range of medical diagnoses for infectious, heart, pulmonary and
gastrointestinal diseases were religiously affiliated primarily as Baptist, Methodist, Pentecostal,
Catholic, Presbyterian, and Episcopal. Self-rated spirituality and religiousness were measured on
a five-point Likert scale from 1 to 5. Perceived Health Status was measured on a scale from very
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poor = 1 to excellent = 6. Greater intrinsic religiosity was associated with fewer depressive
symptoms (β = 0.16, p < 0.01). Being both spiritual and religious was associated with less
impairment in activities of daily living (β = -0.06, p < .05). Better Perceived Health Status was
associated with being religious, not spiritual (β = .10, p < .01), and being spiritual not religious
(β = .01, p >.05) had no association with better Perceived Health Status. The participants in the
study who were among the most debilitated must cope with significant illness and disability.
Although the relationships of religion and spiritual characteristics with physical outcomes were
weak, there are limitations on the role religion and spirituality have in decreasing disability.
However, Religious Coping can positively influence psychosocial outcomes allowing people to
successfully cope with illness, adjust to changes and decrease depression.
Religiosity and religious/spiritual beliefs are frequently used to cope with illness. People
who identify as religiously motivated have less depression and better Perceived Health Status,
allowing these individuals to adjust and integrate changes into their lives which were also
evident in McCullough and Laurenceau’s (2005) study. Pargament, Koenig, Tarakeshwar, and
Hahn (2004) examined Religious Coping as a predictor of both psychological outcomes (quality
of life, spiritual outcomes, and stress related growth) and physiological outcomes (activities of
daily living (ADL)), depression, and cognitive functioning, over two years. The participants
(N =268) were medically ill, hospitalized elders, and 95% identified their religious affiliation as
Christian. The Brief RCOPE ( Pargament et al., 2011a) measured Religious Coping at follow-up.
Separate hierarchical regressions were run for each dependent variable. Because this was
longitudinal data, demographic variables, baseline health (functional status and depression), and
mortality, and selective attrition was entered on each analysis's first regression step. Positive and
Negative Religious Coping was entered on the second step. The following results indicate an R2
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change on the second step. Higher Positive Religious Coping resulted in better spiritual
outcomes (.32, p < .001) and stress related growth (.32, p < .001) but quality of life (.00)
depressed mood (.02), ADL’s (.04) and cognitive functioning (.05) showed no statistically
significant changes. Higher Negative Religious Coping was related to worse spiritual outcomes
(-.11, p < .05), worse quality of life (- .13, p < .01) and more depression (.15, p < .001) but better
ADL‘s (.20, p < .05). Negative Religious Coping had no statistically significant effect on stress
related growth (-.12) or cognitive function (-.04). Thus, patients using Positive Religious Coping
appear to be somewhat more able to adapt and cope with health changes over time.
Cross-sectionally and longitudinally, Positive Religious Coping is an emotion-focused
coping strategy that may influence Perceived Health Status by changing personal views of
health, allowing people to adapt over time. Therefore, Religious Coping is an essential factor to
consider when attending to medically ill people's health and well-being. People turn to religion
to cope with things they do not understand, and Religious Coping may have implications for
better long-term psychological outcomes.
Religious Coping And MS
Spiritual well-being and health outcomes have been explored in people with MS (Bredle,
Salsman, Debb, Arnold, & Cella, 2011; Ghabaee, Bagheri-Nesami, & Shafaroudi, 2016).
However, the research literature is scant concerning Religious Coping and MS. No studies on
Religious Coping using the Brief RCOPE and Perceived Health Status in people with MS have
been done. Studies outside the US in Iran on people with MS have found an association between
religion and Perceived Health Status (Vizehfar & Jaberi, 2017). Iran is primarily Islamic;
therefore, the results may not be meaningful in the US, where Christians make up 70.6% of the
population and Muslims only 0.9% (Pew Research Center, 2014.). However, the study was the
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only published literature on patients with MS and religious beliefs, but studies on Religious
Coping in other disease states in the US have been done.
Vizehfar & Jaberi (2017) assessed the relationship between religious beliefs and
Perceived Health Status cross-sectionally using the SF-36 (Ware & Sherbourne, 1992) and the
Duke University Religion Index (DUREL) questionnaire (Koenig & Büssing, 2010) with
(N = 145) MS patients. The study participants were primarily female (85.5%), with a mean age
of 30.21 and diagnosed with MS for 2.52 ± 3.76 years.
In the participants, religious variables determined a non significant 5.3% of the changes
in PCS (R² = 0.05, p = 0.66) and 2.1% of the changes in MCS (R² = 0.021, p = 0.58) therefore
religious variables in this population were not predictors of physical or mental component scores
in Perceived Health Status. Additionally, the study only observed religiousness and not Religious
Coping in the context of MS. Although a more homogenous religious society such as Iran may
not reflect the US's sociocultural context, it was worthy of evaluating the results.
In a cohort of individuals who were at least 18 years old and were HIV positive, the
Religious Coping Scale (RCOPE) (Pargament, Koenig, & Perez, 2000) a more extended version
of the Brief Religious Coping Scale (Brief-RCOPE) (Pargament, Feuille, & Burdzy, 2011) was
used to measure Religious Coping. The HIV/AIDS-targeted quality of life (HAT-QoL) (Holmes
& Shea, 1998) was used to measure HIV/AIDS Perceived Health Status (Lee, Nezu & Nezu,
2014). Because HIV can now be classified as a chronic disease (Deeks et al., 2013), crosscomparison to MS may yield noteworthy results.
The participants' mean age was 44.89 years (range 20 - 73), 60.5% were male, and the
average length of diagnosis was 13.31 years. The gender difference in the participants contrasts
with MS, where the most affected people are female. Lee, Nezu, and Nezu (2014) found in the
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cohort with HIV (N = 198), higher Negative Religious Coping scores were negatively correlated
with overall Perceived Health Status (r = -.39, p < .001). Therefore, as Negative Religious
Coping increased, there was a corresponding decrease in Perceived Health Status. As expected,
Negative Religious Coping, where people often focused on the negative aspect of stress leading
to maladaptive coping such as self-blame and God’s will, was associated with poor Perceived
Health Status. People may have felt hopeless and despondent in the face of a devastating illness
that often leads to early death and, as a result, poor Perceived Health Status.
VandeCreek et al. (2004) found that Positive Religious Coping (r = 0.29 p = .01) was
correlated with better management of the stress of rheumatoid arthritis (RA), another chronic
disease that can lead to physical disability and dependence on a caregiver. In the cohort of
people with RA (N=181), the nonreligious coping inventory (COPE) (Carver et al., 1989) and the
RCOPE (Pargament et al., 2000) were used to examine Religious Coping and nonreligious
coping. The participants had a mean age of 59 (SD 1.04) years, and 86% were female. The
gender distribution is similar to people with MS. Roman Catholics were 55%, Protestants 22%,
and 23% reported other religious heritages such as Judaism. The length of time since RA
diagnosis was (M = 18 (SD) ±0.97 years).
Non-religious coping methods are used to find meaning in life situations and have an
emotional or problem-solving focus. Consequently, there was a 70% correlation between the
COPE subscales (Carver et al., 1989) and the RCOPE (Pargament et al., 2000) that describe
emotional or mental coping methods. Positive Religious Coping was associated with religious
helping and focus (β = 0.309; 95% CI 0.107 - 0.512). Indicating that individuals who viewed
religion as positive and essential in their lives used more Positive Religious methods to cope
with stressors.

35
Negative Religious Coping was associated with depressive symptoms (β = 0.111; 95% CI
0.083 - 0.139); however, there was no significant correlation with non-religious coping.
Therefore, depressed individuals used more Negative Religious Coping methods over nonreligious methods to cope with illness and life stress. Negative Religious Coping, mainly passive
reappraisal, demonic reappraisal, marking religious boundaries, and interpersonal discontent, are
more emotion-focused coping strategies. Overall, Religious Coping seems to have an emotional
versus a problem-solving focus, is related to less depressive symptoms, and can help or hinder
coping, facilitate adjustment to chronic disease such as Adherence to DMT and improve overall
health perceptions.
Summary
The stress of MS disrupts the usual defenses of an individual, resulting in lower
physiological (PCS) and mental (MCS) dimensions of Perceived Health Status and disruption to
the system's Lines of Defense. Efforts to appraise the situation, devise a plan of action, and bring
about a new normal; Reconstitution of the system activates problem and emotion-focused coping
strategies to manage the disease's consequences. Adherence to DMT which requires effective
problem-focused coping skills can help patients to mitigate the disability trajectory in MS.
Positive Religious Coping, a form of emotion-focused coping strategy, has shown good results in
helping patients to adjust what normal looks like with an MS diagnosis. Reconstitution allows
individuals to adapt to MS's changes and effectively cope with the consequences of the disease to
have better physiological and psychological outcomes.
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Chapter III
The Method
Design
In this descriptive correlational cross-sectional study, a random sample of adults with MS
was used to gather data to explore the relations between the dependent variable Perceived Health
Status and the independent variables Adherence to DMT and Religious Coping. Participants
were contacted by e-mail and invited to complete the RAND 36-Item Health Survey (Ware,
2000) (see Appendix B), MS-TAQ Barriers subscale (Wicks, Massagli, Kulkarni, & Dastani,
2011) (see Appendix C), The Brief RCOPE (Pargament, Feuille, & Burdzy, 2011) (see Appendix
D), and a personal demographic data sheet (see Appendix E). Relations among variables were
analyzed using multiple regression analysis of variance with alpha set at .05 and power at .80
with an anticipated effect size of .065.
Sample
The calculated sample size for the study was 172 participants ≥ 18 years old in the US
with MS who are currently on an FDA-approved DMT prescribed by a health care provider.
Thus a priori calculation of sample size was done using GPower (Faul, Erdfelder, Lang, &
Buchner, 2007) based on the above stated .05 alpha, .80 power, and an anticipated effect size
of .065. Although Cohen (1992) suggests anticipating a medium effect of .15, an effect size
of .065, which is midway between a small (.02) and medium (.15) effect was chosen based on
reported results in the literature for relations between perceived health status and adherence (.10
- .37 ) and perceived health status and religious coping (.05 - .39) (Pittock et al., 2004; Rapkin &
Schwartz, 2016; VandeCreek et al., 2004; Vizehfar & Jaberi, 2017). To obtain a representative
sample of adults with MS, the North American Research Committee on Multiple Sclerosis
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(NARCOMS) provided access to adult MS participants in the US interested in participating in
the study. The North American Research Committee on Multiple Sclerosis (see Appendix G)
only provided recruitment assistance.
The focus of NARCOMS is creating and maintaining a database of individuals’
experience with MS and making that information available to researchers who can use it to help
people with MS and others and for studies conducted by experts within the NARCOMS
consortium. A confirmation study of 240 randomly selected participants done by Marrie, Cutter,
and Tyry (2007) determined the diagnostic accuracy of MS as reported by registry participants.
Of the 240 participants, only (N = 142) were active participants, and (N = 81) completed the
study. Marrie et al. (2007) determined that 98% of the respondents had a confirmed MS
diagnosis based on medical records review and treating physician diagnosis. Stratified sampling
was used to compare the characteristics of responders to non-responders. There were no
significant differences between responders and non-responders in gender (p = 0.44), race (p
= .84), education (p = .60), and income (p = 0.62). The database supports the validity of an MS
diagnosis as reported by registry participants.
The registry, an active database of over 38,000 persons with MS, provides a way for
participants to supply researchers with information about their MS experience and participate in
research studies. The participants received no compensation from participating. The registry also
maintains a computerized database representing at least 10% of the MS population in the US that
tracks changes in the participants over time with updated semi-annual participant surveys.
The Institutional Review Board at The College of Staten Island, City University of New
York (CUNY) approved the study (see Appendix F). Six hundred randomized participants from
NARCOMS (see Appendix G) who are ≥ 18 years old, reside in the US, have MS, and are

38
prescribed an FDA-approved DMT were invited to participate in the study. The participants were
notified via email by NARCOMS and provided with a link (SurveyMonkey) for taking the
survey online. Each participant completed four self-report web-based questionnaires assessing
Perceived Health Status, Adherence to DMT, Religious Coping, and a demographic information
sheet. Data on internet surveys of MS patients yielded response rates of 49.5% (Hadjimichael,
Vollmer, & Oleen-Burkey, 2008), 40% (Hemmett, Holmes, Barnes, & Russell, 2004),
and 37.5% (Wicks et al., 2011). Of the 600 participants, 277 responded for an overall 46%
response rate. A conservative estimate of a 20% response was planned to allow for a reportedly
relatively low internet response rate (Millar & Dillman, 2011) or respondents who did not meet
the inclusion criteria.
Data Collection
NARCOMS managed all initial and follow-up e-mail correspondences to participants to
maintain participants' anonymity. Potential participants received an e-mail with information
about the study (see Appendix H). Additionally, participants were told the study's aggregate
results would be published with no individual identifying information. Included in the e-mail was
a URL link to SurveyMonkey, a web survey delivery tool. The participants contacted a
NARCOMS designated representative if they did not wish to participate, receive further emails,
or have questions regarding the research study. The NARCOMS representative then
communicated with the researcher.
All survey responses were automatically entered into a CSV data file set up by the
investigator in advance through SurveyMonkey. The investigator then downloaded the file into
(SPSS) version 25.0 (IBM SPSS Statistics for Windows, 2017) and stored them on a computer
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protected by user ID and password. Participation in this survey involved minimal risk to the
participants (see Appendix I).
All responses were anonymous, with no identifying information on the returned response.
Participants were informed that clicking on the link and completing the survey is considered tacit
consent. Participants were allowed to complete the survey only once with no incentives from
participating. Only the researcher and faculty sponsor have access to the data. Data will remain
in an encrypted password-protected file in the researcher’s computer for at least five years and be
kept password locked. Additionally, McAfee, an anti-virus/firewall product, protects the
computer from internet threats.
Instruments
RAND 36-Item Health Survey (SF-36) (Version 1.0)
The SF-36 (Ware, 2000; Ware & Sherbourne, 1992) measures medical and socially
relevant differences in health status and changes in health over time and is an appropriate
instrument for measuring perceived general health, which is not specific for any age, disease, or
treatment group. Of the 40 health concepts studied in the original Medical Outcomes Study
(MOS) (N = 2293), eight concepts that factored into two summary scores were selected for the
SF-36 (Ware, 2000). The chosen concepts represent independent objective and subjective reports
of Perceived Health Status. The two summary scales measure physical (PCS) and mental (MCS)
health.
The PCS measures: physical functioning (PF) (10 items), role-physical (RP) (four items),
body pain (BP) (two items), and general health (GH) (five items). The MCS measures: vitality
(VT) (four items), social functioning (SF) (two items), role-emotional (RE) (three items) and
mental health (MH) (five items). One additional question covers the perceived change in health
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status over the past year. There is a total of 36 items. However, the total score will not include
the one item about change in health status. The SF-36 can be self-administered in ten minutes by
the participants via written questionnaire, computer survey, or interview in person or by
telephone to persons aged 14 years and older.
Validity. The aggregate summary measures - physical component summary (PCS) and
mental component summary (MCS) -were constructed based on factor analyses of correlations
among the eight SF-36 scales in the MOS and the general U.S. population (Ware & Gandek,
1998; Ware & Sherbourne, 1992). Two principal components were extracted and rotated to a
simple orthogonal structure by the Varimax method. Physical and mental health factors
accounted for 82.4% of the variance in the eight scales (Ware et al., 1995).
The SF-36 is widely used and validated in studies including patients with MS (Jenkinson
et al., 1994; Szilasiova et al., 2011). Freeman, Hobart, Langdon, & Thompson (2000)
demonstrated in a cohort ( N = 149) of MS patients that the SF-36 was strongly correlated with
instruments measuring similar concepts. The PCS was strongly correlated with the functional
independence measure (r = 0.68) and the expanded disability status score (r = 0.82). The MCS
was also significantly correlated (r = 0.58) with the general health questionnaire, which measures
emotional status.
Reliability. The reliability of the eight scales and two summary measures have been
estimated using both internal consistency and test-retest methods across samples
(McHorney et al., 1993). Internal consistency reliability coefficients ranged from .78 to .93
on the eight scales (median = .85). Additionally, Szilasiova et al. (2011) reported in a cohort of
(N = 114) MS patients Cronbach’s alpha of 0.82 for the PCS and 0.84 for the MCS.
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Scoring. Scoring the SF-36 is a two-step process. Per the scoring key, precoded numeric
values are recoded and averaged according to a scoring algorithm (see Appendix C). Summed
scores range from 0 (poor health) to 100 (optimal health). Lower scores indicate the person
perceives worse possible health, and higher scores indicate better-perceived health. All
responses to questions are printed in a left-to-right format.
Multiple Sclerosis Treatment Adherence Questionnaire (MS-TAQ) V2
Because there are no adequate tools to quantify adherence to DMT in MS, Wicks et al.
(2011) developed an MS-specific assessment of adherence to DMT using an online community
sample (N = 431) of patients with relapsing and progressive MS. Qualitative analysis of the data
revealed vital themes relevant to the participants that were described in the literature as drivers of
adherence to DMT: perceived effectiveness of DMT, forgetting to take DMT, pain, needle
phobia/anxiety, adverse reactions, support and patient education, availability of help with
injecting, and stigma or reminders of disease. Additionally, three more themes emerged not
usually found in the literature as drivers of adherence: coping strategies, barriers, and experience
with DMT. The three additional themes were included in the final Multiple Sclerosis Treatment
Adherence Questionnaire (MS-TAQ) V2.
In the present study, only the DMT-Barriers subscale was used to measure Adherence to
DMT. The missed dose ratio (MDR) of the subscale quantifies adherence to DMT by
determining an MDR based on how many missed doses, in the last 28 days, of the prescribed
DMT the patients report. Patients who reported no missed doses were coded as a 0. The DMTBarriers subscale also quantifies the extent to which the patient rated 13 barriers to adherence as
important reasons for nonadherence and is asked only of patients who missed at least one dose in
the previous 28 days. Only the MDR of the DMT-Barriers subscale was used in this study.
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Validity. Pilot testing of the draft version of the questionnaire resulted in a reference
time change from the past 30 days to the last four weeks (28 days). Random selection of 1,209
participants from a list of 15,000 registered MS patients yielded a 41.9% response rate for the
final MS-TAQ. Due to patients who did not meet the inclusion criteria for the study, data were
analyzed for 37.5% of the respondents (Wicks et al., 2011). Data analysis revealed no significant
differences in response rate by gender (ꭓ2, 3 = 4.5, p = .02). Because older participants completed
the survey, there was a significant difference in age (F (3,1205) = 4.860, p = .002)
(mean difference 2.3 years, 95% CI 0.5-4 years, p = .004) compared to those who did not
respond. A common theme from the literature is that older patients with MS were more apt to be
adherent to DMT than younger patients. Therefore, it is probable that higher responses from
older patients are possible in adherence studies.
Compared to the first ongoing population-based longitudinal study of 2,000 MS patients
in the US (Minden et al., 2006), the MS-TAQ cohort was similar for gender (79.3% (MS-TAQ)
vs. 77% (Minden et al., 2006), age slightly younger (MS-TAQ mean age 47 years, SD 10 vs.
Minden et al.(2006): 51 years, SD 11), and asymptomatic for less time (MS-TAQ mean duration
since onset: 11 years, SD 9 vs. Minden et al., (2006) 18 years, SD 11). Because the study
selected patients who were using DMT, there was a higher proportion of patients with relapsing
MS compared to progressive MS (MS-TAQ 72.2% (311/431) vs. Minden et al. 58%). Data
analysis revealed similarities to other large-scale adherence studies in MS
(Devonshire et al., 2011a; Treadaway et al., 2009) for age, type of MS, and adherence outcomes.
There was a strong correlation between how often patients missed doses and the
DMT-Barriers subscale (r = .50, p < .001), suggesting that with more barriers, there may be more
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missed DMT doses. Based on data analysis, Wicks et al. (2011) suggest that the Barriers subscale
is a better predictor of missed doses (r = .5) than general satisfaction questions of DMT (r = .3).
The MS-TAQ Barriers Subscale can be self-administered in 10 minutes to adults with MS.
Reliability. Cronbach alpha of the MS-TAQ V2 was .82 for the DMT-Barriers subscale
(Wicks et al., 2011). Kołtuniuk and Rosińczuk (2018) computed Cronbach alpha of 0.89 for the
DMT-Barriers scale in a descriptive cross-sectional survey (N =226) of participants on adherence
to DMT in MS. Kołtuniuk and Rosińczuk (2018) found no differences in age between adherent
(37.59 ± 9.96) and nonadherent (36.43 ± 8.70) (p.0625) (p = 0.625) participants.
Scoring. Patients were asked how many of the previous 28 days they are to take the
DMT, if any doses were missed, and how many. A missed dose ratio (MDR) was then calculated
for all patients. The MDR is reported as the number of doses missed divided by the number of
prescribed doses over 28 days. Patients who did not report missing a dose were coded as having
an MDR of 0. Therefore, adherence rates can be calculated from 0% to 100%.
Brief RCOPE
The Brief Religious Coping Questionnaire (Brief RCOPE) (Pargament, Smith, Koenig, &
Perez, 1998), developed from Pargament’s (1997) Theory of Religious Coping, is a 14-item
measure of Positive and Negative Religious Coping with life stressors. Grounded in theories of
religion and coping, the Brief RCOPE, a short version of the Religious COPE (RCOPE), was
designed to provide researchers and practitioners with a practical and efficient measure of
Positive and Negative Religious Coping (Pargament et al., 2011). The RCOPE initially
developed for use with Christians was revised for use in religions such as Islam (Vizehfar &
Jaberi, 2017) and Judaism (Rosmarin et al., 2009).
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To form the Brief RCOPE, a principal component factor analysis with oblim rotation and
constraint to two factors was done on the 105 item RCOPE. This factor analysis resulted in two
factors: positive and negative religious coping. Item selection for the Brief RCOPE was based on
several criteria: RCOPE items with the largest factor loadings on their respective factors, items
that loaded on only one factor, items from a variety of RCOPE subscales, and items that were
used in a formerly shortened version of the RCOPE used with hospitalized elderly patients
(Pargament et al., 1998). Pargament et al. (2011) provided reliability and validity data from
various empirical studies with samples of patients with varying medical conditions.
Validity. Pargament and colleagues (1998) noted that confirmatory factor analysis
(CFA) of the 14 items from the two subscales demonstrated an acceptable fit
(2 = 210.77, df = 64, p < .001), given the large sample of 540 college students. They
acknowledged that the CFA needed additional measures of fit; therefore, the chi-square to degree

of freedom ratio was calculated and found to be 2.12. Values of less than 3.0 indicate a good fit.
Additionally, the root square error of approximation was calculated as 0.46, which is less
than .05, indicating a good fit (Browne et al., 2002).
A CFA was then done on RCOPE data from a large sample (N = 551) of hospitalized
elderly patients, and this CFA yielded similar results (Pargament et al., 1998). Notably, sample
sizes greater than 400 in CFA may yield high values of chi-square fit indices leading researchers
to conclude a poor model fit; therefore, additional measures of fit should be done (MacCallum et
al., 1996). Although the chi-square is significant and not the ideal result, the Brief RCOPE is the
most widely used measure of Religious Coping. This planned study can contribute to its further
exploration and development.
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Reliability. In studies across different samples of medically ill patients of various
religious faiths, Cronbach alpha for the Positive Religious Coping subscale ranged from 0.67 0.94. Cronbach alpha for the Negative Religious Coping subscale ranged from 0.60 - 0.90. In a
hospitalized sample (N = 551), Cronbach α was reported as .87 for the positive scale and .69 for
the negative scale. In a sample of (N = 213) patients with multiple myeloma, Cronbach α was .92
for the positive scale and .90 for the negative scale (Sherman et al., 2005). Additionally, in a
study of outpatients (N = 450) in various stages of HIV, Tsevat et al. (2009) reported Cronbach
α = .92 for the Positive Religious Coping scale and .82 for the Negative Religious Coping scale.
Scoring. The Positive and Negative Religious Coping scales are scored separately on
a Likert scale with response options of 1 = not at all, 2 = somewhat, 3 = quite a bit and, 4 = a
great deal. Responses are tallied across each scale item to produce a score. Scores for each scale
range from 7 (low) to 28 (high). High scores on the Positive Religious Coping subscale indicate
more positive Religious Coping. High scores on the Negative Religious Coping subscale indicate
more negative coping.
Personal Data
The investigator constructed a demographic data questionnaire to collect information
about personal characteristics and MS diagnosis. Some questions were taken from and modeled
after questions from the Behavioral Risk Factor Surveillance System (BRFSS), a tool in the
public domain (CDC, 2018). Demographic questions allow for the control of factors such as the
type of MS, marital status, income, education, and age.
Data Analysis
Bivariate correlation was used to examine the relations between Perceived Health Status
and Adherence to DMT, between Perceived Health Status and Positive Religious Coping, and
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between Perceived Health Status and Negative Religious Coping. Multiple regression analysis
was conducted to examine relations between the dependent variable Perceived Health Status and
the independent variables Adherence to DMT and Positive and Negative Religious Coping. Data
downloaded into SPSS version 25 (IBM SPSS Statistics for Windows, 2017) statistical software
was analyzed for relations among the variables.
Demographic data were used to describe the study participants and to make within and
between-group comparisons. The data were explored to determine if the data met the
assumptions for parametric tests. Measures of kurtosis, skewness and central tendency
determined the normality of the data. Chi-square analysis identified whether statistically
significant relationships exist between the participants and national data.
To account for participant survey data missing at random, the data was partitioned, and ttests were performed to check for mean differences. If significant differences existed between
missing and complete survey data, estimation and imputation of missing values were done.
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Chapter IV
Results
This study aimed to examine the relations between Perceived Health Status, the
dependent variable, and the independent variables Adherence to DMT and Religious Coping.
Based on the Neuman Systems Model (Neuman & Fawcett, 2011) and Pargament's Theory of
Religious Coping (1977), it is proposed that Adherence to DMT and Religious Coping are
respectively one's physiological and spiritual lines of resistance that would affect reconstitution
to the Normal Lines of Defense, Perceived Health Status.
These relations were tested using SPSS version 25 (IBM SPSS Statistics for Windows,
2017) with data collected via an online survey from a randomized sample of males and females,
18 years of age and older in the US, with a clinically definite MS diagnosis. Participants were
taking an FDA-approved DMT for at least six months at study enrollment.
Data Collection Results and Response Rates
Study recruitment was supported by NARCOMS, a project of the Consortium of MS
Centers. NARCOMS was solely responsible for sending an invitational email (see Appendix H)
and communicating with 600 potential participants randomly selected from their database
representing at least 10% (50,000) of the US MS population. The organization helps to facilitate
confidential ways for patients to participate in research about their disease course leading to
more effective treatments and care for people living with MS.
The study survey was made available for four weeks, from August 25, 2019, to
September 22, 2019. Weekly calls/emails between the researcher and NARCOMS involved
reviewing response rates and responding to participants' questions. Because of the survey's high
response rate, NARCOMS did not send reminders to complete the survey. Of the 600 invited
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participants, 277 responded, for an overall 46% response rate. Two respondents did not consent
to participate in the study, and two respondents noted that they did not have an MS diagnosis.
These four respondents were excluded leaving 273 respondents.
Missing data on the study variables for these 273 respondents were evaluated. Perceived
Health Status (SF-36), Adherence to DMT (MS-TAQ), and Religious Coping (Brief RCOPE),
6.5% (n = 18) had missing data. Of these 18 respondents, 2.56% (n = 7) did not answer any
questions and were excluded from further analyses leaving 266 respondents (see Table 1).
Of these 266 respondents, missing data rates for Perceived Health Status was 4.1%.
Positive Religious Coping, Negative Religious Coping, and Adherence to DMT each totaled
4.1%. Because the missing value rates were < 5% of the variables' data, mean substitution
replaced the missing values (Tabachnick and Fidell, 2018). Analysis of the dataset before and
after mean substitution did not significantly change the analytic outcomes.
Table 1
Cases Excluded Due to Study Variables
Criterion
Did not consent

Not met (n)
2

Missing data

Did not have MS

2

Perceived Health Status

7

18

Religious Coping

7

18

Adherence to DMT

7

18

Note: N=11. 7 respondents had overlapping criteria.
Sample Characteristics
Table 2 presents the characteristics of the participant population. In the study, 81.6%
(n = 217) of the participants were female, 88.7% (n = 236) were 45 years and older, 89.8% White
(n = 239) and 45.1% (n = 120) Christian. Most were separated 65% (n = 173), 65.6% (n = 175)
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reported having a bachelor’s degree or higher, with median household income of $50,000 $75,000. Most were not working 65% (n = 173): unable to work (23.7%), unemployed (7.5%)
and retired (33.8%). Of the 266 participants, 230 (86.5%) reported being diagnosed with
Relapsing MS versus 36 (13.5%) diagnosed with Progressive MS.
Table 2
Demographic Characteristics
Demographic characteristics

n

%

Female

217

81.6

Male

48

18

Non-Conforming

1

0.40

18-24

2

0.8

25-34

2

0.8

35-44

26

9.8

45-54

37

13.9

55-64

130

48.9

65-74

55

20.7

>= 75

3

1.1

Missing

11

4.1

45 years and older

236

88.7

Less than 45 years

30

11.3

Other

10

3.8

Christian

120

45.1

Jewish

15

5.6

Gender

Age (Years)

Age

Religion
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Demographic characteristics

n

%

Roman Catholic

39

14.7

Spiritual, not committed to a particular religion

32

12

Agnostic

25

9.4

Atheist

22

8.3

Latter-Day Saints or Mormon

2

0.80

Buddhist

1

0.40

239

89.8

Hispanic, Latino, or Spanish Origin

9

3.4

Black or African American

5

1.9

Mixed Race

6

2.3

Native American or American Indian

1

0.40

Asian/Pacific Islander

1

0.40

Other

5

1.9

Single

28

10.5

Separated

173

65

Widowed

14

5.3

Domestic partnership

32

12

Married

19

7.1

Some high school, no diploma

1

0.4

High school graduate, diploma or equivalent

17

6.4

Trade/technical/vocational training

10

3.8

Some college credit, no degree

36

13.5

Associate Degree

27

10.2

Bachelor's Degree

93

35

Master's Degree

54

20.3

Race
White

Marital Status

Education
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Demographic characteristics

n

%

Doctoral Degree

18

6.8

Professional Degree

10

3.8

Less than 20,000

25

9.4

20,000 - 34,000

27

10.2

35,000 - 49,000

33

12.4

50,000 - 74,000

37

13.9

75,000 - 99.000

54

20.3

Over 100.000

85

32

Missing

5

1.9

Unable to work

63

23.7

Unemployed

20

7.5

Retired

90

33.8

Employed part-time

20

7.5

Employed full time

73

27.4

Type of Multiple Sclerosis
Relapsing
Progressive
Note. N = 266.

230
36

86.5
13.5

Income (USD, Combine Household, 2018)

Employment

Psychometric Evaluation of the Instruments
RAND 36-Item Health Survey (SF-36) (Version 1.0)
The SF-36 (Ware, 2000; Ware & Sherbourne, 1992) measures medical and socially
relevant differences in health status and health changes over time. It is a suitable instrument for
measuring perceived general health, which is not specific for any age, disease, or treatment
group. The two summary scales measure physical (PCS) and mental (MCS) health. Summed
scores range from 0 (poor health) to 100 (optimal health). Higher scores indicate better-perceived
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health. This study’s scores ranged from 6.13 to 94.15 for PHS, 5.25 to 93.85 for PCS, and 7.00 to
93.25 for MCS. Cronbach's alpha (Nunnally & Bernstein, 1994) was .84 (Table 3) for PHS, PCS
was .95 and was .75 for MCS in this study.
Multiple Sclerosis Treatment Adherence Questionnaire (MS-TAQ) V2
Because there are no adequate tools to quantify DMT adherence in MS, Wicks et al.
(2011) developed an MS-specific assessment of DMT adherence using an online community
sample (N = 431) of patients with relapsing and progressive MS. Only the missed dose
ratio (MDR) of the DMT-Barriers subscale quantified adherence in the present study.
The MDR is the number of doses missed divided by the number of prescribed doses over
28 days. Patients reporting no missed doses were coded as having an MDR of 0. Adherence
ranged from 86% - 100%.
Brief RCOPE
The Brief Religious Coping Questionnaire (Brief RCOPE) (Pargament, Smith, Koenig, &
Perez, 1998) developed from Pargament's (1997) Theory of Religious Coping is a 14-item
measure of positive and negative Religious Coping with life stressors. Scores for each scale
range from 7 (low) to 28 (high). High scores on the positive (PRC) and negative (NRC)
Religious Coping subscales indicate higher positive or negative Religious Coping. In this study,
scores ranged from 7 to 24 for PRC and 7 to 21 for NRC. Cronbach's alpha for the Brief R COPE
scales: PRC was .96, and NRC was .84 (see Table 3).
A principal component factor analysis was done with this study's data to explore further
the Brief RCOPE's dimensionality as reported in the literature (Pargament et al., 2011).
Consistent with earlier findings, the 14 items from the two subscales in this study showed two
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distinct clusters (PRC and NRC) that explained 62.46% of the Brief RCOPE variance. See the
full factor analysis results in Appendix J.
Table 3
Psychometric Properties of Study Variables
Variable
PHS

M
56.32

SD
21.67

Variance
469.85

Cronbach's alpha
.84

PCS

50.81

24.71

610.85

.95

MCS

61.84

22.88

523.68

.75

PRC

12.36

6.02

52.71

.96

NRC

7.83

2.03

4.34

.84

Note. N = 266.
Main Analysis
This study examined relations between the dependent variable Perceived Health Status
(PHS) and the independent variables: Adherence to DMT and Positive and Negative Religious
Coping (PRC, and NRC). Data were received as an spss.sav file from SurveyMonkey. In the
first step, descriptive analyses were conducted, with an evaluation of normality.
Fisher's measures of skewness (skewness/SE skewness) (see Table 4) and kurtosis
(kurtosis/SE kurtosis) (see Table 5) an evaluation of symmetry of the distribution revealed that
PHS was not skewed (.046) but had a negative kurtosis (-3.52) that was statistically significant.
The PHS physical subscale (PCS) was not skewed (.928) but had negative kurtosis (- 4.16) that
was statistically significant. The PHS mental subscale (MCS) had a negative (-2.56) skew and a
negative kurtosis (-3.16) that were statistically significant. PRC was statistically significantly
positively skewed (3.69) and negatively kurtosed (-.3.34), and NRC had severe positive
skewness (23.15) and positive kurtosis (44.39) that was statistically significant. Likewise,
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Adherence to DMT had an extreme positive skew (40.33) and positive kurtosis (148.79) that was
statistically significant.
Table 4
Evaluation of Skewness for Study Variables
Variable

Skewness

PHS

.007

Standard Error
of Skewness
.149

Fisher's Measure
of Skewness
.046

PCS

.142

.153

.928

MCS

-.393

.153

-2.56*

PRC

.551

.149

3.69*

NRC

3.45

.149

23.15*

Adherence to DMT

6.010

.149

40.33*

Note. N = 266. *Indicates values statistically significant.
Table 5
Evaluation of Kurtosis for Study Variable
Variable

Kurtosis

PHS

-1.05

Standard Error
of Kurtosis
.298

Fisher's Measure of
Kurtosis
-3.52

PCS

-1.265

.304

-4.16*

MCS

-.961

.304

-3.16*

PRC

-.996

.298

-3.34

NRC

13.23

.298

44.39*

Adherence to DMT

44.34

.298

148.79*

Note. N = 266. *Indicates values statistically significant.
The normality of variance was measured using the Kolmogorov-Smirnov (K-S) test for
normality with a visual examination of histograms, Q-Q, and box plots. The K-S analyses
revealed that the dependent variable PHS (D (.072) df =266, p =.002) was statistically
significant, showing a non-normal distribution. The independent variables PRC (D (.152) df=
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266, p < .001), NRC (D (.376) df=266, p< .000) and Adherence to DMT (D (.394) df=266,
p<.000) were also statistically significant showing non-normal distributions.
To examine cases that may contribute to skewness and kurtosis, Tabachnick and Fidell
(2018) recommend screening for univariate outliers by analyzing boxplots and z-scores > 3.29
that indicate scores unattached from the rest of the distribution. The analysis showed that the
most extreme cases were participants 32, 69, and 164. Individual analysis of these cases revealed
z-scores for all variables < 2.0, which is below 3.29.
Next, a screening for multivariate outliers with analysis of residual scatterplots in SPSS
Regression using casewise diagnostics for standardized residuals (> 3.3) was done. Mahalanobis
distance (p < .001) and Cook's distance (> 1). Mahalanobis distance criterion is evaluated as 2
with degrees of freedom equal to the number of variables. Cook's distance estimates data points
that may exert undue influence and distort the regression's outcome and accuracy. Data points
that are extreme are then checked for validity to indicate how much leverage that record may be
influencing the regression. Leverage indicates values from records that may be so far from the
mean that they may have an undue influence on the regression. Only case 23 had values more
extreme from the other data points. There were no data entry errors. The data were analyzed with
and without the case. Results revealed no significant difference in analytic results; therefore, case
23 remained in the dataset.
When variable data have statistically significant positive or negatively skewed and
kurtotic distributions and violate parametric test assumptions, data transformation may be
employed to bring the data to a more normal distribution (Tabachnick & Fidell, 2018). The best
use of square root transformation is when variable data has no negative numbers or zeros;
however, Adherence to DMT has zeros; therefore, square root transformation is not an option to
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bring the DMT data to a more normal distribution. Regarding Religious Coping, square root
transformation did not affect outcomes and is not reported.
Tolerance values were examined for evidence of multicollinearity and singularity to
identify problems that may hinder further analyses. If two independent variables are highly
correlated, there will be uncertainty about how much variance each contributes to the dependent
variable. Tabachnick and Fidell (2018) note that perfect multicollinearity between two
independent variables has tolerance values of 0; therefore, high tolerance values are desired.
Tolerance values for Adherence to DMT are .99, for PRC is .97, and for NRC is .97, which
indicates non-multicollinearity.
Pearson product-moment correlations for the study variables indicate no multicollinearity
because all correlations are < .7 (see Table 6). An analysis of standardized residuals showed that
the data contained no outliers (Minimum = -2.068, Maximum = 2.034) with values between -3 to
3. The histogram of the standardized residuals indicated a non-normal data distribution with
points that were not completely on the line but close. Tabachnick and Fidell (2018) state that
multivariate outliers exert undue influence on a regression if Cook's distance is larger than 1.0.
Cooks distance for this sample showed no values > 1 (.000 - .239). Therefore, the next step was
to run the regression analysis.
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Table 6
Multicollinearity Correlation
Variable

Perceived
Health
Status
-

Adherence
to DMT
-.066

Positive
Religious
Coping
-.070

Negative
Religious
Coping
-.116

Adherence to DMT

-.066

-

-.042

.010

PRC

-.070

.042

-

.139

NRC

-.116

.010

.139

-

PHS

Research Question
Considered together, does Adherence to DMT and Religious Coping (PRC and NRC)
explain a statistically significant portion of the Perceived Health Status (PHS) variance in
patients diagnosed with MS?
Statistical regression analysis of PHS regressed on Adherence to DMT and PRC and
NRC were done to determine the model fit (see Table 7). Considered together; the independent
variables contribute no statistically significant variance to PHS (R2 = .02, p = .159). Examination
of the Beta scores showed that NRC contributed the most to PHS (Beta = -.108, p = .087) but
was not statistically significant. Likewise, PRC (Beta =.-.053, p = .404) and Adherence to DMT
(Beta= -.062, p = .320) contributed very little to explained variance in PHS. Due to the low effect
size (.02), the power to detect a statistically significant result at alpha .05 if it was present is only
.46 as calculated using G-Power (Faul et al., 2007).
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Table 7
Predictors of Perceived Health Status
Variable
Adherence to DMT

ß
-.935

SE ß
.939

Beta
-.062

T
-.996

Sig. T
.320

PRC

-.186

.222

-.053

-.836

.404

NRC

-1.127

.657

-.108

11.716

.087

F = 1.740
Sig. F =.159
Multiple R = .143
R Square = .020
Adjusted R Square = .009
Note. N = 266. Analysis: Kendall-tau correlation coefficient.
In conclusion, the present study proposed that Adherence to DMT, PRC, and NRC work
together to predict PHS. The study results showed that these independent variables did not
collectively contribute a statistically significant portion of PHS variance.
Ancillary Analyses
Perceived Health Status
The standardized mean scores for PHS, PCS and MCS reported by the SF-36 scale
developers (Hays et al., 1995) are (M = 50, SD = 10). This sample’s PHS (M = 56.32, SD = 21),
PCS (M = 50.81, SD = 24.71) and MCS (M = 61.84, SD = 22.88) means are higher than that of
the reported standardized population. Therefore, comparisons between the standardized scores
and this sample's data were made. One sample t-tests determined whether PHS, PCS, and MCS
scores for this study were significantly different than the standardized population means. The
results indicate a statistically significant higher (mean difference = 6.3) than the standardized
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population mean (t (4.6) = 6.32, p < .001) in PHS. Scores on PCS was not statistically
significantly different (mean difference = .81) in scores (t (.524) = .81, p = .60) than the
standardized population. However, MCS showed (mean difference = 8.26) statistically
significantly higher (t (8.26) = 11.84, p < .001) scores than the standardized population score.
Because this sample reported statistically significantly better PHS than the standardized
population, additional analyses were run to determine if this sample's self-rated health would
also be significantly different from that reported for the national US health survey.
The annual National Health Interview Survey (NHIS) is a multipurpose health survey
administered by the Centers for Disease Control (CDC) National Center of Health Statistics
(NCHS) to noninstitutionalized US adults 18 years and older (National Center for Health
Statistics, 2019). Data are collected face to face or via computer-assisted interviews. The survey
questionnaire, designed by NHIS, incorporates demographic, household, socioeconomic, and
health topics deemed essential to US population health and emerging topics deemed critical to
the NHIS. The questionnaire topics are based on public comments and expert opinions.
As part of the questionnaire, NHIS uses the first question (see Appendix B) from the SF36 (Ware & Sherbourne,1992) to determine the population's self-rated general health. This one
question is from a set of 21 questions that loads on the SF-36 PCS subscale to measure physical
self-rated health. This self-rated one-question measure has been widely used and is a significant
predictor of mortality and health care utilization (Idler & Benyamini, 1997; Imai et al., 2008)
even when controlling for disability and other health conditions.
Data from the NHIS indicate that 88.1% of the adult population 18 years and older in the
US rated their health as good to excellent based on this single question. Therefore, to determine
if the present study’s sample was statistically significantly different from the general US
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population using only the question used by the NHIS, one sample Chi-square analysis was
conducted. With alpha set at .05, 72.5% of this study's participants self-rated their health on
question one of the SF-36 as good to excellent. The rating was lower but not statistically
significantly lower than the general population's 88.1% rating (2 = 13.87, df =24, p =.94).
Further analysis of the self-rated health question with the independent variables PRC,
NRC, and Adherence to DMT (see Table 8) indicates people's self-rated health using the one
question is statistically significantly inversely correlated with NRC (r = -.12, p < .01). Therefore,
people reporting better self-rated health also report low NRC, and the reverse is true. As with the
full PHS measure, there were no significant correlations between self-rated health and PRC (r = .02) or Adherence to DMT (r = -.06).
Table 8

Coefficient Self-rated Health With Independent Variables
Variable

Self-rated
health
-

PRC

NRC

Adherence to DMT

-.029

-.120*

-.065

PRC

-.029

-

.171**

-.038

NRC

-.120*

.171**

-

.093

Adherence to DMT

-.065

-.038

.093

-

Self-rated health

Note. ** p < 0.01, two-tailed. *p < .05, two-tailed.
Analyses of Subscales. Analyses were then run to explore the effects of the independent
variables (PRC, NRC, and Adherence to DMT) on the PHS subscales: PCS and MCS.
Additionally, the relations between the components of the subscales (PCS/MCS and PRC/NRC)
were explored. Because of the exploratory nature of the analysis, bivariate correlations (alpha
.05) were first run.
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Table 9

Correlation Coefficient Perceived Health Status, PCS, MCS, Adherence, PRC, NRC
PRC

NRC

.658**

Adherence
to DMT
-.054

-.059

-.007

.658**

-

-.065

-.069

-.212**

Adherence to DMT

.054

-.065

-

.042

.010

PRC

-.059

-.069

.042

-

.139*

NRC

-.007

-.212**

.010

.139*

-

Variable

PCS

MCS

PCS

-

MCS

Note. ** p < 0.01, two-tailed. *p < .05, two-tailed.
The expected strong positive correlation (see Table 9) between mental (MCS) and
physical (PCS) health status perception was statistically significant (r = .65, p < .001).
As respondents' perception of their physical health status went up, their mental health status
also went up, and the opposite is true. Perception of Physical Health (PCS) did not
significantly correlate with any of this study’s three independent variables: Adherence to DMT
(r = -.05, p = .38), PRC (r = -.05, p =.34) nor NRC (r = -.00, p = .90). Also, perception of
Mental Health (MCS) did not correlate with either Adherence to DMT (r = -.06, p = .29) nor
PRC (r = -.06, p = .27). However, unlike the PCS, NRC was statistically significantly correlated
to the MCS (r = -.21, p < .001). Therefore, as one's mental health status increased, then negative
religious coping decreased. Finally, as previously reported by Pargament et al. (1998), in this
study, the two components of the independent variable RC (NRC and PRC) were also
statistically significantly positively correlated (r = .13, p = .001). Hence, as either form of
Religious Coping (NRC or PRC) increased, the other also increased. Because there are
statistically significant results in the above correlations, further analyses were run to determine if
significant differences existed among people reporting relapsing and progressive MS.
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Analyses of Type of MS on PHS. Independent samples t-test was conducted to compare
PHS, PCS and MCS in relapsing and progressive MS. The results showed there was not a
statistically significant difference in PHS scores for relapsing MS (M = 56.41, SD = 21.55) and
progressive MS (M = 53.98, SD =7.03); (t (264) = .336, p = .73). Likewise, there were no
statistically significant differences in scores for PCS in relapsing MS (M = 61.90, SD = 24.56),
progressive MS (M = 47.81, SD = 8.98); (t (264) = .377, p = .70) or MCS in relapsing MS
(M = 61.90, Sd = 22.77) and progressive MS (M= 60.15, SD = 5.07); (t (264) = .230, p =.81).
Thus, the type of MS, relapsing or progressive did not influence PHS, PCS or MCS.
Analyses Type of MS on Adherence to DMT and Religious Coping. Independent
samples t-test was conducted to determine if the type of MS, relapsing or progressive influenced
scores in Religious coping (PRC, NRC) or Adherence to DMT. There were no statistically
significant differences in scores for PRC in relapsing MS (M = 12.37, SD = 6.12) and
progressive MS (M = 11.87, SD = 1.45); (t (264) = .245, p =.80) or NRC in relapsing MS
(M = 7.83, SD = 2.07) and progressive MS (7.73, SD = .27); (t (264) = .137, p =.89). In
Adherence to DMT there was also no difference in scores with relapsing MS (M = .39, SD = 1.4)
or progressive MS (M = .46, SD = .20); (t (264) = -.145, p = .88). These results also suggest that
the type of MS reported by the participants has no effect on Adherence to DMT or Religious
Coping. Given these t test results and low sample size (n = 36) in the progressive group, further
analyses of the research question in the two groups using multiple regression was not done.
Patterns of Response on Independent Variables
When exploring the extreme positive skewness of both PRC and NRC, frequency data
(see Figure 1) show that 33.5% of respondents (n =89) had PRC scores of 7 (the lowest score),
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and (see Figure 2) 71.8% of respondents (n=191) had NRC scores of 7. Note, in Figure 3, that
the mean scores for PRC are less than 13, and the mean scores for NRC are less than 8.
Figure 1
Positive Religious Coping Frequencies
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Figure 2
Negative Religious Coping Frequencies
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Figure 3
Mean Positive Religious Coping and Negative Religious Coping Scores

Likewise, Figure 4 shows that Adherence to DMT has severe positive skewness.
Adherence to DMT also has very low variability, with approximately 78% (n = 208) participants
reporting 100% adherence.
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Figure 4
Adherence to DMT Scores and Frequencies

PHS And Demographic Variables
Demographic data were analyzed in an exploratory regression analysis to determine
which other independent variables may predict PHS variance. Studies on PHS in patients with
MS indicate gender (Mavaddat et al., 2011), age (Krokavcova et al., 2012), employment for pay
versus unemployed, income (Estrutti et al., 2019; Julian et al., 2008; Krokavcova et al., 2013),
and marital status (Ren, 1997) are associated with better PHS.
Because of the analysis' exploratory nature, bivariate correlations (alpha .05) were first
run to investigate the relations between demographic variables and the dependent variable (PHS)
as well as the components of PHS (PCS and MCS) (see Table 10). PHS was positively correlated
with employment status (r = .32, p <.001) and income (r = .29, p < .001). As well, both PHS sub
scores, PCS (r = .31, p < .001) and MCS (r =.27, p < .001) were statistically significantly
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positively correlated with employment status. Income was also statistically significantly
positively correlated with both sub scores: PCS (r = .29, p < .001) and MCS (r = .22, p < .001).
Finally, as one’s age increased perception of PCS decreased (r = -.19, p < .001). Concerning the
demographic variables’ intercorrelations, employment status was understandably positively
correlated with income (r = .23, p < .001) and negatively correlated with age (r = - .11, p = .03)
and income was negatively correlated with marital status (r = -.17, p < .001).
Table 10
Correlation Coefficient Perceived Health Status, MCS, PCS and Demographic Variables
PHS

MCS

PCS

Gender

Age

Employment
statusa

Incomea

Marital
statusa

PHS

-

.903**

.918**

.081

-.079

.327**

.291**

.011

MCS

.903**

-

.658**

.053

.058

.277**

.226**

.009

PCS

.918**

.658**

-

.093

-.191**

.315**

.292**

.005

Gender

.081

.053

.093

-

-.083

-.029

.030

-.010

-.079

.058

-.191**

-.064

-

-.112*

-.050

.055

.282**

.204**

.317**

.090

-

.237**

-.050

Income a

.291**

.226**

.292**

.019

-.047

.237**

-

-.174**

Marital
statusa

.011

.009

.005

.013

.064

-.050

-.174**

-

Variable

Age
Employment

.107*

statusa

Note. * p < .05, two-tailed. ** p < 0.01, two-tailed. a Kendall's Tau.
To account for shared variance, stepwise regression was then run due to the
intercorrelations between employment and income, employment and age, income, and marital
status. With alpha set at .05, PHS was regressed on employment, income, age, and marital status.
The results are in Table 11. In step 1, employment entered the regression equation and
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significantly predicted PHS ( = 6.29, p < .001) contributing 18% of the variance. In step 2,
income entered the equation and predicted a unique 6% PHS variance. Neither age nor marital
status entered the equation. Together, employment and income predicted 24% of PHS variance,
and employment is the primary predictor of overall PHS. Separate regressions were then run for
both subscales (PCS and MCS).
Table 11
Regression Coefficients Perceived Health Status on Demographic Variables
ß

SE ß

T

Sig T

R2

F

Employment

6.29**

.82

7.60

.000

.18

57.87

Sig
F
.000

Employment

4.99**

.84

5.9

.000

Income

3.45**

.76

4.5

.000

20.31

.000

Step

Variable

1
2

Total
Note. N = 266. ** p< .01.

.06
.24

With alpha (.05), PCS was regressed on employment, income, age, and marital status.
The results in Table 12 show three predictor models. In step 1, employment ( = 7.06, p < .001)
alone predicts 18% of the variance in PCS. When income enters the equation (step 2), it
contributes an additional 5% to the variance. Hence, employment and income considered
together contribute 24% of the variance to PCS. Age entered the regression (step 3) and added a
unique contribution of 1% to the variance for a total of 25%. Again, employment is the primary
predictor of PCS.
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Table 12
Regression Coefficient of PCS on Demographic Variables
Step

Variable

ß

SE ß

T

1

Employment

7.06**

.94

7.48

2

Employment

5.67**

.96

5.81

Income

3.81**

.87

4.37

Sig. T

R2

.000

.18

.000

.05

Total
3

.23
Employment

5.20

.97

5.32

Income

3.94

.87

4.53

Age

3.29

1.37

2.39

Total
Note. N = 266. ** p< .01. * p < .05.

.017

F

Sig.
F
56.02 .000

18.98 .000

.01
.25

5.73

.017

MCS was regressed on employment, income, age, and marital status. The results are
shown in Table 13. Employment’s unique contribution to MCS ( = 5.52, p < .001) variance in
step 1 of the regression is 13%. When income enters step 2, it contributes only an additional 4%
to the variance. In step 3, age did enter the regression with a p-value approaching significance
(.048) and only contributed another 1% to MCS variance. Again, employment emerges as the
primary predictor of MCS. Employment status is the best predictor of PHS, MCS, and PCS in
this sample. Although age and income had unique contributions to health status, they will not be
included in the final analysis.
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Table 13
Regression Coefficient of MCS on Demographic Variables
Model
1

Variable
Employment

β
5.51

SE ß
.90

T
6.07

Sig. T
.000

2

Employment

4.35

.94

4.62

.00

Income

3.08

.85

3.62

.000

Total
3

Employment

4.70

.95

4.94

.000

Income

2.98

.84

3.51

.001

2.66

1.34

1.98

.048

Age
Total
Note. N = 266. ** p< .01.

R2

F
36.93

Sig. F
.000

.16

13.10

.000

.01
.17

3.95

.04

.13

.04

With MS, older age (> 55 years old) is associated with a greater probability of disability
(Trojano et al., 2002) with worse PCS (Wilski & Tasiemski, 2016). Therefore, the longer one is
diagnosed with MS, the disability to some degree is more likely to occur. Additionally, in this
study, age's contribution to PHS, PCS, and MCS variance was minor. Therefore, age will not be
included in the final analysis.
Low socioeconomic status and income ranges at or near the poverty level can lead to
poor health (Stronks et al., 1997; Woolf et al., 2015). However, people with disabilities are more
likely to earn less and work fewer hours and often supplement income with disability benefits
(Walls & Dowler, 2015) and may not report poor PHS. Importantly, to adequately consider
income, a comprehensive household size analysis, all other revenue, how much is available for
the participant's use combined with employment status cannot be determined. Therefore, income
will not be included in the final analysis. Because employment status is the primary predictor of
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PHS, PCS, and MCS, one-way ANOVAs were done with follow-up post hoc tests to determine
employment group differences.
The ANOVA for PHS yielded overall statistically significant (F (4,250) = 19.07, p < .001)
variations among the groups. Pairwise comparisons among the employment conditions (unable to
work, unemployed, retired, work part-time, and work full time) were conducted using Tukey's
HSD. Based on Tukey's results (see Table 14), there are significant mean differences among the
groups. The mean difference in PHS scores for people who are unable to work (M = 40.09, SD
=14.79) compared to all employment groups is statistically significantly lower than: unemployed
(mean difference = -24.76, p < .001), retired (mean difference = -15.35, p < .001), employed
part-time (mean difference = -25.23, p < .001) and employed full time (mean difference =- 27.18,
p < .001). Most notably, PHS scores of those unable to work are statistically significantly lower
than all other groups. Regarding differences amongst the remaining work categories, retired
responders had lower PHS scores than those working full time (mean difference = -11.83, p =
.002). Interestingly, the PHS scores of those who reported that they were not working instead of
not able to work were most similar to both employed groups.
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Table 14
Between Subjects Comparisons for Employment and PHS
Employment

Employment

Mean difference

SE

Sig.

Unable to work

Unemployed

-24.76*

4.90

.000

Retired

-15.35*

3.18

.000

Work part time

-25.23*

4.90

.000

Work full time

-24.76*

4.90

.000

Unable to work

24.76*

4.90

.000

Retired

9.41

4.75

.279

Work part time

-.46

6.04

1.000

Work full time

-2.42

4.86

.988

Unable to work

15.35*

3.18

.000

Unemployed

-9.41

4.75

.279

Work part time

-9.88

4.75

.233

Work full time

-11.83*

3.11

.002

Unable to work

25.23*

4.90

.000

Unemployed

.46

6.04

1.000

Retired

9.88

4.75

.233

Work full time

-1.95

4.86

.995

Unable to work

27.18*

3.34

.000

2.42

4.86

.988

11.83*

3.11

.002

1.95

4.86

.995

Unemployed

Retired

Work part-time

Work full time

Unemployed
Retired
Work part time
Note. * The mean difference is significant at p < .05.

As in overall PHS, one-way ANOVA results for employment differences in PCS
sub scores (F (4,250) = 21.76, p < .001) show that there were overall group differences (see
Table 15). Again, pairwise results show that the mean scores for people who are unable to work
(M = 33.82, SD = 16.17) are statistically significantly lower than all other groups: unemployed
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(mean difference = - 31.13, p < .001), retired (mean difference = - 12.26, p < = .00), employed
part time (mean difference = - 28.63, p < .001), and employed full time (mean difference = 30.97, p < .001). As with overall PHS scores, people who report being unable to work have the
worst PCS of all employment conditions.
For retirees, whose overall PHS scores showed statistically significant lower scores only
than those of full-timers, their PCS sub scores were quite remarkably different. Retirees’ scores
on the physical component (PCS) showed statistically significantly lower scores than the
unemployed (mean difference = -18.86, p = .004), part-timers (mean difference = -16.36, p = .02)
and full-timers (mean diff = 18.70, p < .001). These findings show that people who are unable to
work are significantly worse in PCS than all other employment groups. Those who are retired
rate their PCS higher than only those reporting they are unable to work. Notably, again PCS
scores of those who are unemployed instead of being unable to work are quite comparable to
those working full and part-time.
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Table 15

Between Subjects Comparisons for Employment and PCS
Employment

Employment

Mean difference

Unable to work

Unemployed

-31.13*

5.50

.000

Retired

-12.26*

3.57

.006

Work part time

-28.63*

5.501

.000

Work full time

-30.97*

3.75

.000

Unable to work

31.13*

5.50

.000

Retired

18.86*

5.33

.004

Work part time

2.50

6.78

.996

Work full time

.16

5.45

1.000

Unable to work

12.26*

3.578

.006

Unemployed

-18.86*

5.33

.004

Work part time

-16.36*

5.33

.020

Work full time

-18.70*

3.50

.000

Unable to work

28.63*

5.50

.000

Unemployed

-2.50

6.78

.996

Retired

16.36*

5.33

.020

Work full time

-2.34

5.45

.993

Unable to work

30.97*

3.75

.000

-.16

5.45

1.000

18.70*

3.50

.000

2.34

5.45

.993

Unemployed

Retired

Work part-time

Work full time

Unemployed
Retired
Work part time

SE

Sig.

Note. * The mean difference is significant at p < .05.
The final ANOVA concerning employment differences was done with MCS scores.
Again, one way ANOVA yielded significant MCS differences (F (4,250) = 11.77, p < .001)
among the employment groups. Consistent with the above findings, a post hoc Tukey test (see
Table 16) showed that the mean MCS scores for people who are unable to work are statistically
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significantly lower (M = 46.37, SD = 19.87) than all other groups: unemployed (mean difference
= - 18.40, p = .00 ), retired (mean difference = - 18.43, p < .001), employed part-time (mean
difference = - 21.84, p = .00 ), and employed full time (mean difference = - 23.40, p < .001 ).
Interestingly, unlike with PCS, in MCS there were no significant differences between being
retired and unemployed (p = 1.0), employed part-time (p = .96) or employed full time (p = .60).
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Table 16
Between Subjects Comparisons for Employment and MCS
Employment

Employment

Unable to work

Unemployed

Unemployed

Retired

Work part-time

Work full time

Mean difference

SE

Sig.

-18.40*

5.43

.007

Retired

-18.43*

3.52

.000

Work part time

-21.84*

5.43

.001

Work full time

-23.40*

3.70

.000

Unable to work 18.40*

5.43

.007

Retired

-.03

5.26

1.000

Work part time

-3.44

6.69

.986

Work full time

-5.00

5.38

.885

Unable to work 18.43*

3.52

.000

Unemployed

.03

5.26

1.000

Work part time

-3.40

5.26

.967

Work full time

-4.96

3.45

.603

Unable to work 21.84*

5.43

.001

Unemployed

3.44

6.69

.986

Retired

3.40

5.26

.967

Work full time

-1.56

5.38

.998

Unable to work 23.40*

3.70

.000

Unemployed

5.00

5.38

.885

Retired

4.96

3.45

.603

Note. * The mean difference is significant at p < .05.
Interestingly, the mean scores of the unemployed align with the people who work.
Although a small (n =20) 7% of the sample, knowing who the unemployed are may indicate why
they align with the employed.
The unemployed (n = 20) are between 35 and 64 years (65%) and primarily female (n =
18). This is lower than the full 2018 US retirement age of 66 years (SSA.gov, n.d.). Most, 75%
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(n = 15), report their marital status as separated. With 85% (n = 17) reporting incomes greater
than $35,000, and 55% (n = 11) with incomes over $100,000. Additionally, 2 had some college
credit, with the majority (n = 18) having a college degree. This group is educated, primarily
female, below the US full retirement age with high reported income.
Concerning the subsample of people who are unable to work (n = 63), they are primarily
female (n = 55), with 93% (n = 59) in the 35 to 64 age range. A large 58.7% reported marital
status as separated. Most have a college education 68.3% (n = 43). This sample is educated, and
most participants are below the 2019 full US retirement age of 66 years (SSA.gov, n.d.). Reported
income for this group ranged from less than $20,000 to over $100,000. Furthermore, most
(n = 50) reported having relapsing rather than progressive MS. Progressive MS tends to have a
higher and more profound disability trajectory that can lead to the inability to work and job
loss (Julian et al., 2008). This group also reported lower MCS than all other employment groups.
The MCS has shown significant negative correlation (r = -.21, p < .001) to NRC for this study.
However, the unable to work group’s NRC scores (M = 7.9, SD = 1.9) are not
significantly different from the other study population scores (M = 7.8, SD = 2.12) on
NRC (t (190) = .007, p = .99).
Retirees (n = 90) are older than people who are unable to work, ranging in age from 45 to
over 75 years. Notably, most (n = 81) are older than 55 years with (n = 50) 79.4% reported
having relapsing MS. A considerable number have a college degree 74.4% (n = 60), with 66.7%
(n = 61) reported earnings greater than $35,000. Most of these retirees reported being separated
68.9% (n = 62). Compared to people unable to work, these retirees are older with higher reported
income. Both groups of people who are unable to work and retired are primarily separated with
relapsing MS, and most have a college education.
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People who are unable to work are significantly different from people in the other
employment conditions, with scores lying at the lower end of overall PHS and each component
score: PCS and MCS. Retirees have lower PCS scores than the unemployed, part-timers, and
full-timers but have similar MCS scores to these groups. Those who are unemployed (rather than
unable to work) have remarkably similar overall good PHS, PCS, and MCS to those working
part-time and full time and have higher PHS, PCS, and MCS scores than those who are unable to
work and retired.
Summary of Results
In this study of people with MS, three variables were examined: PHS, Adherence to
DMT, and Religious coping. Collectively, neither Adherence to DMT or Religious Coping was
significantly correlated with PHS. Participants showed little evidence of religious coping
measured in this study with uniformly low scores in both PRC and NRC. Likewise, most
participants reported 100% Adherence to DMT.
However, in ancillary analyses, significant findings were found that require continued
discussion. Employment status was the best predictor of overall PHS, Physical and Mental
health. People who were unable to work had lower overall PHS, Physical, and Mental health than
all other employment groups. Retirees had lower overall PHS and Physical health than other
employment groups with better Mental health than people unable to work, similar to all other
employment groups. Negative Religious Coping was significantly negatively correlated to age
and Mental Health. Additionally, this sample's PHS, Physical and Mental health was significantly
better than the standardized population's mean, and the study participants' self-rated health was
not statistically different from the general US population despite an MS diagnosis.
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Chapter V
Discussion
The purpose of this study was threefold: the first was to examine the relations among
Perceived Health Status (PHS), Adherence to DMT (Disease Modifying Therapy), and both
positive and negative Religious Coping (PRC and NRC) in adults with MS to further develop the
concept of reconstitution in the Neuman Systems Model (NSM) (Neuman and Fawcett, 2011).
In particular, the study examined the impact of the physiological and spiritual lines of resistance
on reconstitution to the normal line of defense. The second purpose was to examine these NSM
concepts at a theoretical level. A literature review suggested that problem-focused (Adherence to
DMT) and emotion-focused (Religious Coping) coping can heighten PHS. If successful
adaptation occurs, there is reconstitution to a new normal evidenced by high PHS. Lastly, the
study proposed to test these theoretical links empirically by measuring the dependent variable
PHS using the SF-36 (Ware & Sherbourne, 1992), the independent variables Adherence to DMT
with the MS-TAQ (Wicks et al., 2011), and Religious Coping with the Brief-RCOPE (Pargament
et al., 2011). Appendix A illustrates the conceptual, theoretical, and empirical (C-T-E) links.
As noted earlier, neither Adherence to DMT nor Religious Coping influenced PHS in this
sample. The only statistically significant findings surfaced in ancillary analyses concerning the
effects of work status on PHS. This discussion explores this study's findings at all three levels:
empirical, theoretical, and conceptual. The operationalization of the study variables is discussed
first in the empirical referent section. Discussion of the research question results, and ancillary
findings follow in the theoretical referent section. Finally, a discussion of the study’s findings on
the NSM's conceptual elements (Neuman & Fawcett, 2011) is provided.
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Empirical Indicators
RAND 36-Item Short Form Survey (SF-36)
The SF-36 (Ware & Sherbourne, 1992) measured PHS (see Appendix B). The SF-36 is a
36 item 100-point questionnaire comprised of two summary scales that measure Physical and
Mental Health. Scores on each scale range from 0 to 100. The scales are averaged to obtain an
overall PHS score. High scores indicate good to excellent PHS, Physical Health, and Mental
Health. The SF-36 is the most widely used measure of health-related quality of life in the US
(Jenkinson et al., 1994; Lins & Carvalho, 2016; McHorney et al., 1993; Pittock et al., 2004).
The standardization of the SF-36 as a self-report measure of functional health and well-being
used factor scoring coefficients from the general US (N = 3,445) population to arrive at
standardized population scores (M = 50, SD = 10) (Ware et al., 1995) for overall PHS, as well as
both Physical and Mental Health subscale scores. In this study, PHS scores ranged from 6.13 to
94.15 (M = 56.32, SD = 21.67). This sample's higher SD (21.67) compared with the population
SD (10) is likely indicative of the varying functional disability of this study's participants.
Notably, people with MS exhibit wide variations in disability.
Fisher's measures of normality showed that PHS scores were not skewed (.046) and had a
slight but statistically significant negative kurtosis (- 3.52). Thus, the non-normality of the
dependent variable did not account for this study's non statistically significant findings.
Regarding the PHS subscales: Physical scores (M = 50.81, SD =24.71) were not skewed (.928)
but had a statistically significant kurtosis (- 4.16) and Mental scores (M = 61.84, SD = 22.88)
had statistically significant negative skew (-2.56) and kurtosis (-3.16). These were notably mild
deviations from normality. Again, note the high SD’s for each subscale in comparison to the
population SD. Cronbach's alpha for PHS was .84, the Physical score was .95, and the Mental
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score was .75. All are comparable to reported reliability estimates in other MS studies using the
SF-36 (McHorney et al., 1993; Riazi et al., 2003; Szilasiova et al., 2011).
Compared to the standardized population means (M = 50, SD = 10) for overall PHS as
well as Physical and Mental Health, this study’s sample (M = 56.32, SD = 21.67) had statistically
significantly higher mean scores in PHS (mean difference = 6.3), (t (4.6) = 6.32, p < .001).
Mean Mental Health (M = 61.84, SD = 22.88) scores were also statistically significantly higher
than those of the population (mean difference = 8.26), (t (8.26) = 11.84, p < .001). However,
surprisingly, mean scores on Physical Health (M = 50.81, SD =24.71) were not statistically
significantly different (mean difference = .81) (t (.524) = .81, p = .60) than the standardized
population. This last finding concerning the Physical Health score is notable because the
standardized population mean reflects the general population and not solely people with
disability such as MS, who would be expected to have worse physical health.
One reason for this study's higher PHS and Mental Health means than the comparable
population means likely stems from the necessary averaging of scores and the wide score
dispersion. Physical Health scores ranged from 5.25 – 93.85, and Mental Health scores from
7 – 96.50. Mean scores are always sensitive to extreme values, but both subscales and the
summary PHS must be averaged. Therefore, information was undoubtedly lost in the averaging
process across such a large distribution of scores. The frequency distribution of Physical Health
scores revealed no clusters concentrated around one score with the median (48.95). Likewise,
Mental Health scores showed no clusters around one score with a median (65.37).
Consequently, the summary scales may overestimate Physical and Mental Health in this
study's sample leading to results higher than those typically seen in people with MS.
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Overestimation of the subscales would also lead to an overestimation of averaged PHS scores.
Such overestimation introduces error variance and decreases the power of the statistical tests.
MS-Treatment Adherence Questionnaire (MS-TAQ) V2 DMT-Barriers Subscale
The MS-TAQ DMT-Barriers Subscale was used to measure Adherence to DMT (see
Appendix D). This subscale independently quantifies Adherence to DMT and is reported to be a
good predictor of missed doses (Wicks et al., 2011) because providers can assess adherence and
patient-reported barriers to adherence. In this study adherence ranged from 86 % to 100%, with
78% of the participants reporting 100% adherence (non-adherence: M = .39, SD = 1.4). Unlike
PHS, Adherence to DMT was not normally distributed. The data exhibited a statistically
significant extreme positive skew (40.33) and kurtosis (148.79). No data entry errors were found
that could account for non-normality, and missing data accounted for only 4.1% of MS-TAQ
scores. Data transformation is sometimes recommended for failures of normality. However, the
assumptions of transformation indicate data must have no values of 0. There were (n = 208)
78.2% scores of zero; therefore, data transformation could not be used to bring the data to a more
normal distribution. Because good adherence was categorized as being ≥ 80% adherent, there
may be a loss of information leading to the decreased statistical power.
The MS-TAQ has zero values; therefore, transforming the data may lead to erroneous
results and underestimate adherence in this study. Such significant skewness and kurtosis of one
variable can decrease the power of the statistical tests. Interestingly, few adherence studies report
data distributions with skewness or kurtosis results. There may be a large percentage of values at
0 or 100% because adherence is a continuous variable. Therefore, the distribution may be highly
skewed to the right or left.
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In MS, estimates indicate that only 30% to 40% of people adhere to medications (DMT
Consensus MS Coalition, 2017), including all DMT's daily to once yearly dosing regimens. How
adherence was calculated was not reported by the DMT Coalition and may be a factor in the low
adherence rates. Additionally, the dosing reported by the DMT Coalition includes selfadministered and healthcare provider in center administered. Conversely, this study's inclusion
criteria required self-administration only, and participants reported prescribed regimens from
daily to monthly only.
The different regimens may factor in the notably different adherence rates in this study
than the DMT Coalition's report. Despite these differences, this study's adherence rates are
similar to Kołtuniuk and Rosińczuk's (2018) adherence study. In people with MS (N = 226), they
found a 76.5% adherence rate calculated from the MS-TAQ barriers subscale. Though the
authors did not report data skew or kurtosis results, they used the nonparametric Mann-Whitney
U test to compare continuous variables. This may indicate a non-normal distribution.
In a DMT adherence study, Devonshire et al. (2011) reported 75% of participants (N =
2640) with  80% adherence to similar DMT dosing reported in this study. Likewise, Treadaway
et al. (2009) reported 85% of participants (N = 708) were  80% adherent to DMT for
medication regimens prescribed daily to monthly. None of the mentioned studies reported data
distribution: skew or kurtosis.
Using patient self-reports for the past 28 days, Ožura, Kovac, and Sega's (2013) study
with (N = 299) patients with MS found an 81.5% DMT adherence rate. They reported nonnormal data distribution but no report of skewness or kurtosis results. Similarly, a multicenter
study of adherence to DMT (N = 234) found a 86% adherence rate (Zwibel et al., 2011). Zwibel
and colleagues reported highly skewed data. However, they reported neither skewness nor
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kurtosis results. Because near-perfect adherence is a goal, regardless of how adherence is
measured, there will be a risk of highly skewed data.
Brief RCOPE
The Brief Religious Coping (Brief RCOPE) scale (Pargament, Smith, Koenig, & Perez,
1998) developed from Pargament's (1997) Theory of Religious Coping is a 14-item measure of
positive (PRC) and negative (NRC) Religious Coping with life stressors. This study is the first
to use the Brief-RCOPE for patients with MS.
The Brief RCOPE’s PRC and NRC scores range from a possible 7 (low) to 28 (high). In
this study, scores ranged from 7 to 24 for PRC (M = 12.36, SD = 6.02) and 7 to 21 for NRC (M =
7.83. SD =2.03). Cronbach's alpha for the Brief RCOPE scales: PRC was .96, and NRC was .84.
Cronbach's alpha for NRC is generally lower (.60 - .90) than PRC, as Pargament et al. (2011)
reported. The PRC and NRC scales had a low positive correlation (r = .17, p = .001) which was
also found in Pargament’s (1998) (r = .18, p < .001) correlational studies.
Median scores were (median =12) for PRC and (median = 8) for NRC, indicating low
levels of either type of Religious Coping for the study's participants. Roughly one-third (33.5%)
(n = 89) of participants reported the lowest possible score (7) for PRC. For NRC, the
overwhelming majority (71.8%) (n = 191) reported the lowest possible score (7). These low
scores indicate a group that does not use Religious Coping methods or at least not Religious
Coping as measured by the Brief RCOPE.
Due to this preponderance of non-religious copers, Fisher's measures of skewness and
kurtosis revealed non-normal distributions. PRC was significantly positively skewed (3.69) and
significantly negatively kurtosed (- 3.4). NRC was significantly positively skewed (3.45) and
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severely positively kurtosed (23.15). Though analyses were conducted with and without data
transformations to correct non-normality, the results were the same.
The PRC and NRC scales had a low positive correlation (r = .17, p = .001), and the few
participants who did use Religious Coping reported using both positive and negative methods to
cope. However, participants reported greater use of PRC (M = 12.36 SD = 6.02) and less NRC
(M = 7.83, SD = 2.03). These results are similar to studies in medically ill patients (Freitas et al.,
2015; Tsevat et al., 2009; Vizehfar & Jaberi, 2017), who use more positive than negative
methods. However, this study's participants' mean, and median scores are low on both scales.
A full factor analysis of the 14 items from the two subscales explored the scale's
dimensionality (see full results in Appendix J), especially because this is the first use in
MS participants. The analysis showed two factors present with Eigenvalues greater than 1 that
explained 67.51% of the scale's variance. Additionally, like Pargament et al. (2011) results
(2 =2406.46, df = 1133, p < .05), this study found significant (2 =2883, df =91, p < .001)
Bartlett’s chi-square supporting the factorability of the matrix. Similar to this study, in
a predominantly Christian sample, PCA of the Brief RCOPE also showed (2 = 604.89, df = 168,
p < .001) significant Bartlett's chi-square, with a two-factor structure that together explained
48.9% of the variance (Ramirez et al., 2012b). Additionally, Mohammadzadeh and Najafi
(2016) explored the scale's factor structure with PCA on a Muslim sample and reported
Bartlett's (p = .0001, 1911.3). They also found two distinct factors explaining 52.2% of
observed variance, which is lower than the results obtained for this analysis. The evaluation of
the psychometric properties of the Brief RCOPE shows reliability and construct validity
replicating the results obtained in other studies. Therefore, the non significant study findings are
probably not related to the reliability and validity of the instrument.
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Other considerations were explored to explain the lower means and medians in this
sample compared to other studies using the Brief RCOPE. One reason could be the wording of
the questions in the scales. For example, on the PRC, one question asked for
agreement/disagreement with this statement:
"Looked for a stronger connection with God."
The response choices are: not at all (1), somewhat (2), a great deal (3), or quite a bit (4). If
participants are just not religious copers, they might rate that question and all the others (1),
leading to low scores on the positive scale. Consequently, a person will have only a minimum of
7 on the positive scale because they just do not use religion to cope.
Likewise, on the NRC, if the person is not questioning God's power or does not believe
Religion has anything to do with illness, they may have low NRC and be identified as a low
Negative religious coper. Noted below is an example of an NRC question:
"Wondered whether God had abandoned me."
One can see that if religion were not a coping means, then that statement would likely be
answered as not at all.
Theoretical Elements
Perceived Health Status In MS
It was noted above that mean scores in PHS (M = 56.32, SD = 21.67) and Mental Health
(M = 61.84, SD = 22.88) were higher in this sample than in the standardized (not exclusively
MS) population (M = 50, SD = 10). Physical health mean scores were similar to the standardized
population but had a higher SD (M = 50.81, SD = 24.71). The high dispersion of scores coupled
with the necessary averaging to achieve summary scales could be a reason for this difference

87
from an empirical standpoint. From a theoretical perspective, studies in the MS population using
the SF-36 were compared with the present study's data.
Pittock et al., (2004) found markedly lower PHS (M = 39.2, SD = 12.7), Physical Health
(M = 36.8, SD = 17.4) and Mental Health scores (M = 54.2, SD = 12.7) than those of the present
sample, using only the SF-36 questions from the MSQOL survey. The MSQOL survey consists
of the SF-36 with 18 additional items pertinent to MS. These 18 items were not used. Similarly,
Szilasiova et al., (2011) (N = 114) found markedly lower Physical Health (M = 39.9, SD = 10.5)
and Mental Health scores (M = 43.8, SD =11.1); overall PHS was not reported. Note also the
lower SD's in both of these studies compared with the present study's very high SD's. As in the
present study, Mental Health scores in these studies are higher than Physical Health scores,
indicating that people with MS report better mental than physical health.
Reasons for the present study's higher overall and subscale means were considered. One
noted empirical concern is the self-administration of the questionnaire in the present study.
Specifically, Pittock et al. (2004) and Szilasiova et al. (2011) gathered the SF-36 questionnaire
information from their study participants via interview and physical examination. Whereas, for
this study, the SF-36 was self-administered online without the researcher's participation.
Theoretical considerations may be related to the way people use cognitive appraisal
processes to rate perceived health subjectively. Rapkin and Schwartz (2004, 2016) posited that
any subjective appraisal process involves four appraisal aspects related to the person's frame of
reference, sampling experience, comparison standards, and a combinatory algorithm to arrive at
a summary judgment. These are necessary processes for people to understand and interpret the
disease experience and may allow them to rate their health higher than expected. Appraisal and
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reappraisal are continually changing, reflecting positive or negative appraisal of illness based on
its significance to personal well-being in the short or long term (Lazarus & Folkman, 1984).
This study measured PHS within the past four weeks, capturing a cross-sectional measure
of function and well-being. Perception could depend on the person rating themself against
someone with MS, a specific MS symptom, or the overall meaning of well-being despite the
illness. Thus, one’s perception involves subjective components and belief-laden variables.
Notably, MS patients report feeling boxed into a diagnosis that implies poor outcomes when
people with MS exhibit varied symptoms (Burtchell et al., 2019). Albrecht and Devlieger (1999)
proposed a "disability paradox" where people with significant disabilities are expected to
perceive low health but instead rate health more highly than do people without disability. This
paradox suggests that ratings are subject to personal appraisal and may differ from how people
without disabilities perceive health. Self-rated health may not match objective medical
assessments, and those assessments may give an incomplete picture of overall health (Drum et
al., 2008).
Life expectancy for people with MS is not significantly different from the general
population, and people can live with MS for 20 – 55 years, depending on when diagnosed.
Therefore, it is reasonable to expect people to cope and adapt to disability as they do with the
normal aging process (Finlayson, 2004). This sample's characteristics reflect an aging MS group.
The majority (n = 188), 70.7%, are over 55 years and likely were diagnosed more than 20 years
ago. Therefore, these participants are likely using highly individualized appraisal processes that
were not measured or accounted for in this study. Appraisal profiles may need to be a part of
perceived health studies because they may be influencing factors that can quantitatively measure
why individuals rate health, physical function, and mental health good despite significant health
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problems. These profiles may explain variance in perceived health because they may uncover the
factors people think are essential in how they rate their quality of life.
Another reason for the high means was clear in this study's ancillary analyses.
Correlation of demographic variables; employment, income, age, and marital status with
perceived health revealed employment status (r = .28, p < .001) and income (r = .29, p < .001)
were significantly correlated with PHS. Stepwise regression showed employment status and
income together explained 24% of the variance in PHS.
However, of the total 24% explained variance, employment contributed a unique 18 %.
Although income contributed 6% of variance to PHS, to include income as a predictor for this
study, a comprehensive income analysis is needed to determine the household size, total
revenues, and how much is available for the participant's use. Income, therefore, is not in the
final analyses. ANOVA results showed that there were statistically significant differences in PHS
(F (4,250) = 19.07, p < .001), Physical Health (F (4,250) = 21.76, p < .001) and Mental Health
(F (4,250) = 11.77, p < .001) based on work status. Post hoc t-tests indicated scores for PHS (t
(253) = 5.99, p < .001), Physical Health (t (253) = 6.8, p < .001), and Mental Health (t (253) =
3.98, p < .001) were significantly lower for people who are unable to work compared with all
other workgroups: unemployed, retired, or working part-time or full time.
Their means were markedly lower than all other employment groups: PHS (M = 40.09,
SD = 12.79), Physical Health (M = 33.82, SD = 16.17), and Mental Health (40.09, SD = 14.79).
Participants who were unable to work (n = 63) made up nearly a quarter (23.7%) of the study's
participants. This group was primarily female (n = 55), with 59 of the 63 participants being
below the 2019 full retirement age of 66. This group reported being unable to work rather than
unemployed or retired. Therefore, it is likely they are not working due to factors associated with
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MS. There are consistent associations between increasing disability, not working, and quality of
life in MS (Busche et al., 2003; Krokavcova et al., 2013).
The ability to keep employment is of concern to people with MS. Unemployment is more
likely to occur when people exhibit disease severity markers that affect physical and cognitive
function (Busche et al., 2003; Flensner et al., 2013; Julian et al., 2008). Miller and Dishon
(2006) found unemployment as a whole was associated with lower scores in overall PHS (Mean
= 51.6, SD not reported) than for employed people (Mean = 64.6, SD not reported, p  .005)
measured with the SF-36. These results align with this study’s results showing lower PHS in
people not working than those employed. Additionally, like in this study, unemployed people
rather than unable to work had scores not significantly different from the population (M = 50).
Other demographic data in this study, age, gender, and marital status, were not
significantly correlated with PHS. Age is notable because this sample is primarily (70.7%) older
than 55 years (n = 188). In MS, older age (> 55 years) confers a greater probability of disability
(Trojan et al., 2002) and worse physical health (Wilski & Tasiemski, 2016). This is because the
age of MS onset is typically mid-twenties to thirties (Milo & Miller, 2014), and it is a
progressive disease. The revised McDonald diagnostic criteria position paper (Etemadifar &
Sabeti, 2018) for MS specifies three disease course types; primary progressive, relapsing and
secondary progressive. The vast majority (85%) of people with MS are initially diagnosed with
relapsing MS characterized by increasing central nervous system inflammation resulting in
episodes of disability, with some symptom resolution after the inflammation subsides. Most
people in this diagnostic grouping will transition to a progressive course marked by a gradual yet
steady decline (secondary progressive MS) because of the disease's progressive nature.
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However, there are no definitive diagnostic markers for this transition from relapsing to
secondary progressive beyond the absence of relapses. Because of the psychological impact of a
secondary progressive diagnosis, health care providers are reluctant to make the actual change in
diagnosis, and patients are reluctant to accept it if made (Ciotti & Cross, 2018). Despite their age
and thus likely longer time since MS diagnosis, 83% of participants over 55 years report having
relapsing rather than secondary progressive (17%) MS and the Physical Health scores
(M = 47.28, SD = 24.75) of those over 55 years of age are not significantly different
(mean difference = - 2.71, p = .135) than standardized population scores (M = 50, SD = 10). This
finding points to a differential appraisal process concerning health perception in this sample.
Perceived Health Status And Adherence To DMT
Good Adherence to DMT was proposed to be related to better PHS because of better
reported clinical outcomes (Devonshire et al., 2011a; Treadaway et al., 2009). Participants in this
study had to be on a DMT for a minimum of six months. Stopping DMT is more likely to occur
in the first six months. Patients who continue therapy in the long term are more likely to have
developed coping mechanisms to manage factors that might decrease adherence (Bruce et al.,
2010; Devonshire et al., 2011). In this study, over 78% of participants reported not missing a
DMT dose in the past four weeks (100% adherence). The past four weeks appeared reasonable to
be remembered by the participants about their drug regimen. Missing a single dose was a
stringent criterion, but pre-defined criteria were necessary as a benchmark because of the varied
dosing regimens and reports in the literature. Adherence was measured as a binary static
construct. Either one is adherent or is not.
Though participants were adherent, they were within the reported adherence studies rates,
and though improved PHS is linked to good Adherence to DMT's (Coyle et al., 2014; Devonshire
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et al., 2011), there was no statistically significant relationship between Adherence to DMT and
PHS in this sample. The empirical measure of adherence with highly skewed data discussed
previously may have contributed to the non-significant findings. Also, the questionnaire elicits a
self-report of adherence. Self-reports are controversial, but there is support due to theoretical and
empirically sound adherence measures (DiMatteo et al., 2002; Nguyen et al., 2014; Svarstad et
al., 1999). This study did not gather adherence data from chart review, pharmacy refill data, or
pill counts due to the anonymous design.
Participant demographics could account for the adherence rates and highly skewed data.
There are inconsistent reports of which demographic influence (gender or age) is of primary
importance in adherence. Being female and older than 34 years (Devonshire et al., 2011a;
Treadaway et al., 2009) confers greater odds of better adherence than males or younger than 34
years. This sample was primarily female (n = 217) 81.6% and 94.4% were older than 34 years of
age. Zhornitsky et al. (2015) reported people younger than 18 – 30 years were 7.8 times more
likely to stop DMT and be less adherent than people who were 31 and older. In the present
study, only two participants were younger than 24 years, and two participants were 25 – 34
years. Since most, 93.2% (n = 251) of the participants were older than 34; this may also
contribute to the high adherence rates noted in this study.
Additionally, the knowledge that DMTs could decrease relapse rate, decrease CNS
damage, and slow disease progression may influence adherence (Bruce et al., 2010; Coyle et al.,
2014). Therefore, MS type may influence adherence, particularly because DMTs for relapsing
MS have shown effectiveness. People who believe they have relapsing MS may be more
hopeful of DMT benefits and may be more adherent. A patient-centered goal for healthcare
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providers who prescribe DMTs is to help patients see the benefit of their long-term use in
slowing disease progression.
The first DMT was FDA approved in 1993 for relapsing MS, and they have become
increasingly efficacious in recent years. Until 2017, DMTs were primarily effective in relapsing
MS with limited secondary progressive MS efficacy (Maskaly, 2018). Since that time, one DMT
has shown effectiveness in primary progressive MS, and others are in development. Thus DMTs
have a long history of treating relapsing forms of MS and limited availability and efficacy in
secondary progressive MS. Most participants (n = 230) 86.5% in this study reported having
relapsing MS and may be more hopeful of DMT benefits and be more adherent.
It is reasonable to think that participants who believe medications are helping may rate
PHS better—giving support to the value of appraisal profiles. Treadaway et al. (2009) reported
similar results to the present study. Adherent people recruited from 17 neurology clinics had
significantly higher scores on both Physical Health (M = 59.7, SD = 20.7) p = .0020 and Mental
health (M = 69.5, SD =20.5) p = .0001(t not reported) health, than non adherent people. The high
adherence rates coupled with high Physical (M = 50.81, SD =24.71) and Mental (M = 61.84, SD
= 22.88) scores reported for the present study may indicate a highly adherent sample that is
representative of participants enrolled in NARCOMS. These people may be more apt to enroll in
studies that measure adherence. Turner et al. (2007) also reported better than 80% adherence in
people who perceive beneficial DMT outcomes. Adherence may be related to personal appraisal,
attitudes, beliefs, and self-care and may not function singularly as a coping mechanism. If so,
then perceived health ratings might be independent of how adherent people are.
Finally, it is important to consider that there may be no correlation between Adherence to
DMT's and PHS because the DMTs are not effective in this sample. Thus, adhering or not
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adhering does not influence perceived health. Specifically, as detailed above, given the typical
age at onset of MS, higher age is associated with a longer duration of having MS. A longer
duration of having MS is associated with the transition to secondary progressive MS (Burtchell
et al., 2019). Thus there are two effectiveness-related explanations for the lack of association
between Adherence to DMT and PHS. The first explanation centers on the fact that DMT's are
effective when used early in the disease and regularly throughout the disease (Ben-Zacharia,
2011). Given recent advances in the effectiveness of MS DMTs, the older age of this sample, and
their probable age at diagnosis, it is highly likely that most of them did not have access to
effective DMTs for an extended period after being first diagnosed. Thus, their MS was left
untreated for many years, and prompt treatment with DMTs shows the best results. Thus no
correlation between current DMT adherence and PHS.
The second explanation is somewhat related. Previously noted, there is hesitancy on both
providers and patients to transition to the secondary progressive diagnosis. This hesitancy has
psychological and practical roots. Most of the DMTs in use today have limited efficacy in
secondary progressive MS (Maskaly, 2018). So those with secondary progressive MS but
identifying as relapsing are likely taking a DMT that is not effective. It follows then that
Adherence to DMT and PHS are working independently. It would be beneficial to restrict the age
to younger participants or specify disease duration less than ten years in future studies to account
for advances in DMT science and disease progression.
Perceived Health Status And Religious Coping
Positive and Negative Religious Coping was theorized to work with DMT adherence to
help people manage MS's stress and improve PHS. In this study, with the lowest level being 7,
participants had overall very low levels of both PRC (M = 12.36 SD = 6.02) and NRC (M = 7.83,
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SD = 2.03). To manage stressful situations, religion can be a source of strength. Pargament et al.
(2000) reported that PRC and NRC are differentially related to physical and mental health, and
higher NRC is associated with worse physical and mental health.
This study's main findings indicate that, considered together with Adherence to DMT's,
neither PRC (Beta =.-.053, p = .404) nor NRC (Beta = -.108, p = .087) contributed to explained
variance in PHS. In ancillary analyses, it was found that PRC was not associated with Physical
Health (r = .05, p = 34) nor Mental Health (r = -.06, p = .29). Additionally, no associations
between NRC and Physical Health (r = .00, p = .90) were found. However, high use of NRC was
associated with worse Mental Health (r = -.21, p < .001), indicating the differing impact on
mental health as proposed by Pargament and colleagues (2000).
These ancillary findings concerning PRC are contrary to reports from Sherman et al.
(2005) indicating significant correlations between PRC and both Physical Health (r = -.18, p <
.01) and Mental Health (r = - .29, p < .01). Sherman et al. measured PHS using the SF-12, a
similar but shorter version of the SF-36 in participants (N = 213) with multiple myeloma.
However, similar to this study, Sherman and colleagues report that people who reported high
Mental Health scores also reported low NRC (r = -.29, p < .0001), showing that low NRC is an
indicator of psychological well-being.
Similarly, in a sample (N = 170) of dialysis patients, Ramirez et al. (2012) used the Brief
RCOPE and the WHO HRQoL (WHO, n.d.) to measure quality of life and found Mental Health
(r = -.26, p < .01) negatively correlated with NRC. Conversely, PRC was correlated to better
quality of life (r = .17, p = .02) and Mental Health (r = .26, p < .01). However, there were no
associations between PRC and Mental health in the present study. High NRC appeared as an
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overall indicator of poor mental health for the present study's participants. Analysis of the nonsignificant main findings for PRC and NRC and overall PHS in this study were then investigated.
Consideration was given to the question wording on the scales. Participants' answers to
the scale's questions, coupled with 17.7% (n = 47) of the participants identifying as
agnostic/atheist, may have contributed to low Religious Coping scores and non-significant
findings in this study. Possibly, low Religious Coping may not be disadvantageous for people
with low religiosity, hence the high (M = 56.32, SD = 21.67) PHS scores despite low Religious
Coping scores. If people do not view religion as essential to their lives, Religious Coping
methods will not factor into how they cope with stressors.
However, further analysis of the scales' dimensionality was necessary to determine if
ambiguous factor loadings explained why most participants had low PRC and NRC scores.
Because the Brief RCOPE is the most widely used measure of Religious Coping, PCA provided
additional information on the scale’s dimensionality. As reported above, the psychometric
properties are satisfactory for use in people with MS, replicating results obtained by Pargament
et al. (2011) and other authors. Therefore, the reliability and construct validity of the instrument
was not a factor in the non-significant findings.
Theoretically, there may have been some confusion about Religious Coping and how
people use it based on a personal appraisal of its significance in their lives. The literature defines
spirituality broadly and includes personal experience, public expressions, and religion (Wirth &
Büssing, 2016; Zwingmann et al., 2011). Additionally, there are definitional incongruences
among the authors.
Religion/religiosity could be a formalized set of principles practiced by an individual
publicly (Reutter & Bigatti, 2014). Words that are used interchangeably with religion are
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religiosity and religiousness. In contrast, other authors consider spirituality and religion as
overlapping dimensionally related constructs (Hill & Pargament, 2003). It is acknowledged that
measuring spiritual coping in a religious context resulted from the researcher's personal and
cultural bias and the varied definition noted in the literature.
Participants' interpretation of Religious Coping may be related to religious attendance or
congregational support, and they did not view religion as a primary coping mechanism.
Conversely, people probably do not use Religious Coping to cope with all medical situations,
particularly in a chronic disease where they may be more concerned with finding coping
resources to manage other life-affecting disease changes. Because there were no studies in
people with MS in the US, religious coping data from other chronic conditions such as
inflammatory bowel disease (Freitas et al., 2015) and HIV (Lee et al., 2014) provided insight into
how Religious Coping may be essential to cope with chronicity.
Freitas et al. (2015) used the Brief RCOPE with the WHO Quality of life instrument with
(N = 147) participants. They found more depression in study participants (β = 0.307, p < .001)
with more significant NRC use. Thus, the link between NRC and Mental health surfaces again.
Lee et al. utilized the more extended (63 items) version of the Brief RCOPE with the HIV/AIDStargeted quality of life instrument with (N = 198) participants. The results indicated that as NRC
increased, there was a corresponding decrease in quality of life (r = -.39, p < .001). In these two
chronic conditions, low NRC was important in psychological adjustment and supported the
correlation with NRC and Mental health found in this study.
If religion and spirituality are impactful in a person's life, they may be more apt to use
religion to cope. Therefore, two explanations for the low levels of Religious Coping in this study
are possible. If individuals have better PHS reported for this study, there may be no need to look
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to a higher power to cope with a disability. There may be an intrinsic reverence for religion that
permeates throughout their lives but is not used as a primary coping mechanism. These
participants may be secure in their chosen coping methods to manage MS, and those methods are
working shown by the high scores in PHS.
Additionally, people may use religion to cope when initially diagnosed. Mainly because
there is no cure for MS; it is neurologically profound and is progressive over time. However,
over time, people appraise the impact disability and chronicity of MS have on their lives and
may need to solve MS's practical problems. Therefore, alternate coping mechanisms become
primary to manage the consequences of MS, employment, and disability, that religion does not
help solve.
However, NRC was impactful in this study, and there are reports of the associations with
mental health in the literature (Pargament, 1997, 2013; Pargament, 2002). Spiritual and religious
well-being may be predictive of psychological adjustment to MS (Bussing et al., 2005; McNulty
et al., 2004; Torskenæs et al., 2015). People may experience religious and spiritual struggles in
life, and the struggles may lead to emotional distress and poor physical health (Exline et al.,
2014). Therefore, Religious Coping may show significant correlations with health in those
people. Notably, the PRC subscale assesses the supportive aspects of religion in times of
adversity. However, if this sample did not connect with God or does not have religious or
spiritual struggles, no insight would emerge from Religious Coping scores. Furthermore, no
single measure has emerged as the gold standard (Hill & Pargament, 2003; Szaflarski et al.,
2012) for measurement of Religious Coping.
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Conceptual Elements
The study's conceptual foundation based on the Neuman Systems Model (NSM)
(Neuman & Fawcett, 2011) proposes that a person is an open and multidimensional system
interacting with the environment. The individual's five-person variables: physiological,
psychological, sociocultural, developmental, and spiritual, are inherent in all lines of defense and
resistance and therefore affect the degree of protection against stressors. Pargament (1997)
explicitly describes coping behaviors closely related to Neuman's spiritual variable in the lines of
resistance. Spirituality is all-encompassing, affects all the other person variables, and offers
protection against stressors.
Neuman's (Neuman & Fawcett, 2011) and Pargament's (1997) propositions about the
importance of the physiological and spiritual variables, and their effects on health outcomes,
guided this study to examine their combined ability to return a person to system stability. MS is a
stressor that invaded the normal line of defense and activated the lines of resistance. The person
with MS would optimally adhere to DMTs and use Religious Coping to adjust and reconstitute.
Reconstitution, a new normal, is rebuilding the normal defense line (Gehrling, 2011; Gehrling &
Memmott, 2008). The normal defense line represented the state of wellness and adaptation of the
individual to stressors over time. It was operationalized as PHS, which are health concepts that
are real for and relevant to the patient. Two components make up PHS: Physical and Mental
Health. The Normal Line of Defense, PHS, was measured with the SF-36 and represented a
quantitative measure of Reconstitution.
Perceived Health Status
Analysis of PHS (M = 56.32, SD = 21) and Mental health (M =61.84, SD = 22.88)
indicates scores higher than the standardized US non-MS population (M = 50, SD = 10),
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showing a high level of perceived wellness for the study participants. However, the differential
stress of MS is clear in the large standard deviations of the participants' PHS (SD = 21), Physical
Health (SD = 24.71), and Mental Health (SD = 22.88) compared to the general population
(SD = 10). The large SDs indicate that MS is widely variable (wide dispersion of scores) in its
physical and mental effects on the system and can significantly influence Reconstitution.
Consistent with the NSM's holistic view, the two summary scales of PHS were significantly
positively correlated (r = .65, p < .001). Therefore, as one's perception of Physical Health went
up, Mental Health perception also went up. This correlation indicates Neuman's proposed
interrelated effect of the lines of resistance in adapting to the stress of MS. The high PHS scores
in this study provide evidence that Reconstitution is possible for people with MS. Additionally,
the findings help expand knowledge of a quantitative measure of Reconstitution.
Perceived Health Status And Adherence To DMT
The physiological variable in the lines of resistance was proposed to be Adherence to
DMT, a coping method used by the individual to help mitigate disease damage to the system.
Adherence was quantified and measured with the MS-TAQ Barriers subscale. It was reasoned
that as one is diagnosed with MS causing invasion of the normal lines of defense, the person
appraises the situation and takes steps to minimize damage to the system by adhering to the
medical regimen and taking the prescribed DMT. Adherence supports system stability by
functioning as a defense mechanism to move the person back to a stable new normal
(reconstitution). The majority, 78%, of participants reported high adherence at (86 % - 100%).
Though there was a high level of adherence coupled with good mean PHS (M = 56.32),
Physical Health (M = 50.81), and Mental Health (M = 61.84) scores, Adherence did not explain
the variance in PHS. As noted, people older than 55 years (n = 188) who comprised most of the
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sample are more likely to have progressive disease, with greater physical and mental deficits.
Therefore, adherence may not change the trajectory of the disease and thus not influence their
perception of their physical or mental health.
Perceived Health Status And Religious Coping
In the NSM, the spiritual variable is an essential aspect of the system, and it permeates
and interacts with all person variables. It was proposed to be Religious Coping because
spirituality is a part of the human dimension; this aspect would assist in Reconstitution. The
spiritual variable could help manage, provide comfort, and improve chronic health issues.
Hughes et al. (2017) report that addressing religious and spiritual issues with patients will help
with collaboration adjustment and coping. The spiritual variable can positively or negatively
affect the interactions of the other variables. Coping strategies within the realm of spirituality are
dynamic and help people manage environmental stressors that exceed personal resources
(Lazarus & Folkman, 1984).
A person’s spiritual energy may not become evident until a life event or crisis tests one’s
belief in a higher power (Neuman & Fawcett, 2011). The person then incorporates spirituality
into their lives. Spiritual energy helps one to achieve and sustain positive mental and physical
outcomes. In a qualitative study, Bussing et al. (2013) report (N = 213) MS participants who
identified being religious/spiritual did not find faith as a resource to cope but as a lifestyle to find
gratitude and awe in living. Bussing et al.’s report is in line with the tenets of the NSM that the
spirit controls the mind, which in turn is interconnected with the body.
Study findings showed high use of NRC was significantly negatively (r = -.21, p < .001)
correlated with Mental Health. Thus, high NRC inhibited Reconstitution. If the religious
orientation is intrinsic, deeply rooted in religious beliefs, then this association between NRC and
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Mental Health reflects religion's negative effects in coping with MS. In people with HIV, positive
religious copers had better odds (OR 1.07, 95% CI: 1.02 1.12, p = .008) of higher PHS and
health outcomes after the HIV diagnosis (Lee et al., 2014) than did negative religious copers.
Intrinsic use of positive Religious Coping helped manage the stress of HIV leading to better
coping and adaptation. Like this study’s results, Freitas et al. (2015) found greater use of
negative Religious Coping was associated (ß = 0.196, p = .02) with worse Mental Health.
Ancillary Findings
Employment status was significantly correlated with PHS (r = .32, p < .001); Physical
Health (r = .32, p < .001) and Mental Health (r = .27, p < .001). Regression analysis indicated
employment status was the primary predictor (18% of variance) of PHS. In particular, being
unable to work was significantly associated with worse PHS (M = 40.09, SD = 14.79), Physical
Health (M = 33.82, SD = 16.17) and Mental Health (M = 46.37, SD = 19.87) than all other work
groups in this study.
Regrettably, disability status was not requested as demographic data, but unable to work
is a good "stand-in" variable for disability. MS affects all dimensions of a person, and thus all
person variables are affected. MS disability status is a good indicator of the strength of the Lines
of Resistance to recover and Reconstitute. The physiological, psychological, sociocultural,
developmental, and spiritual variables have a part to play in the ability of the Lines of Resistance
to support Reconstitution (Neuman & Fawcett, 2011). Therefore, all five-person variables are
considered when discussing the impact being unable to work has on the participants'
reconstitution effect. Gaining and keeping employment when diagnosed with MS depends on the
disease progression and personal factors (Busche et al., 2003; Krokavcova et al., 2013;
Krokavcova et al., 2012; Mattina, 2019; Miller & Dishon, 2006).
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Physiological Variable
The physiological variable refers to the body’s physical and physiological functions
(Neuman & Fawcett, 2011). There is a disruption in the physiological line of resistance with an
MS diagnosis. The inability to work breached the line of resistance. This breach is evident
because the Physical Health (M = 33.82, SD = 16.17) of the group was significantly lower than
all other employment groups. Motl (2010) reports the neurodegenerative processes of MS will
have a global effect on physical functioning due to increasing impairment, inactivity, and
disability over time. Accumulating disability results in loss of employment, and the person
cannot work due to the inability to perform role functions.
Julian et al. (2008) report worsening of physical MS symptoms over a six-month
timeframe confers greater odds (OR 1.41, CI 1.11 – 1.79, p < .01) of employment loss. An
involuntary reduction in income occurs, creating stress and consequently the lower PHS scores in
people with MS who are unable to work in the present study. The effects of not working have
been associated with greater psychosomatic symptoms and higher physiological stress reactions
such as higher stress cortisol levels (Wong & Shobo, 2016). McKee-Ryan et al. (2005) notes that
negative physiological effects on the person who cannot work will also negatively affect
psychological outcomes. This is congruent with Neuman’s proposed interrelated effects of the
physical and psychological variables.
Psychological Variable
The psychological variable refers to internal and external mental processes and
relationships (Neuman & Fawcett, 2011). In this study, people who are unable to work report
statistically significantly lower Mental Health (M = 46, SD = 19.87) than all other employment
groups. Self-perception of Mental Health is a good indicator of the participants' ability to manage
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the psychological consequences of MS, so with low Mental Health, Reconstitution is negatively
affected. The low Mental Health scores show evidence of destabilization in the psychological
lines of resistance. Unemployment, in particular an inability to work, produces high levels of
psychological stress (Busche et al., 2003).
The severity of depression with MS increases with more disabilities and has a negative
effect on employment status (Forbes et al., 2006). The majority of participants, 93%, in the
unable to workgroup were between 35 to 64 years old. Long term physical disease such as MS
also contributes to more severe psychological distress in people younger than 65 compared to
people > 65 years (χ2 = 8.15, df = 2, p = .017) (Goulia et al., 2012). Most participants (58.7%)
who are unable to work reported their marital status as separated, possibly leading to low social
support and help from a partner to manage psychologically.
Sociocultural Variable
Neuman (2011) posits that the condition of the flexible lines of defense determines if
stress can cause a stress reaction. The socio-cultural variable in the line of resistance relates to
societal, cultural expectations and activities. People can live with MS for over 40 years, and
many will not be economically able to support themselves because they are unable to work. The
result is decreased earning power and economic productivity loss (Roessler et al., 2011). Loss of
income can negatively impact family relationships due to the loss of earning power and
economic standing.
Stronks et al. (1997) reported that financial loss from not working could mean losing
hopes and dreams because it negatively impacts one's socioeconomic status. From a sociocultural aspect, it is evident that being unable to work is a stressor that plays an integral part in
reduced PHS. However, to cope with the loss and Reconstitute, some participants in Stronks et
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al.'s study reported they had more time to do things they have always wanted to do and found
family relations were improved. The participants in that study showed there could be a state of
balance and a path to Reconstitution based on appraisal and coping with the stress of not
working.
In a qualitative study on MS's economic impact, De Judicibus and McCabe (2007)
reported that participants discussed a trade-off between unable to work and spending more time
with the family. Therefore, the lines of resistance helped in the coping process to view the loss of
employment as a way to reconnect with the essential people in their lives, appraising and
changing the factors used to rate perceived health. Being unable to work due to MS may not
change over a person's lifetime. Therefore, coping mechanisms are needed to adapt and to
accommodate the new normal.
Developmental Variable
Many people are diagnosed with MS in early adulthood (Milo & Miller, 2014) when
people typically consider plans to set up a career, confirm life paths, or have a family. The
developmental impact of being unable to work on the individual can be profound. Most of the
people who are unable to work in this study are separated (58.7%). Participants (N = 100) in a
pilot study with young adults (aged 18 – 31 years) from NARCOMS reported feeling
embarrassed and worried about MS's personal effects on their lives and relationships (Buchanan
et al., 2010). The worry was evident in their concerns for their future and how they would
manage as the disease progresses. Due to the uncertainty of what the future brings, participants
reported deferring life plans which affected personal relationships. Though most (68.3%)
participants in this study who were unable to work had a college degree, being unable to work is
a significant stressor leading to instability in the line of resistance.
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Spiritual Variable
Neuman (2011) indicates the spiritual variable must be considered when discussing the
person. The spiritual variable permeates all system variables and is a search for life’s meaning.
Neuman (2011) refers to spirituality as necessary for the functioning of the system. Measures of
spirituality in this study were from a Religious Coping perspective. The people who were unable
to work did not significantly differ from the other groups in Religious Coping.
The NSM (2011) refers to the spiritual variable as “positive use of spiritual energy
empowerment” (p17), not Religious Coping. Therefore, measuring spiritually quantitatively
requires assessing the person’s awareness of spiritual energy, the definition of that energy force,
and how the participants used spirituality to cope with changes in their condition. Stressors on
the system catalyze positive spiritual thoughts and behaviors to affect the system through
interactions with all variables. Only one aspect of the spiritual variable measured in this study
correlated to Mental Health. People who reported low Mental Health had high NRC, but as
noted, those who were unable to work did not use NRC more than other groups. Thus, it is clear
that Religious Coping (PRC and NRC) was not used by the participants to cope with MS.
Summary
Participants were not able to work due to reduced physical and psychological health, as
noted above. Working generally confers higher income than disability payments and,
importantly, enables people to view themselves as independent rather than limited and dependent
on others. Because of the disease's progressive nature, an involuntary reduction in income creates
stress and negatively impacts people with MS. Being unable to work weakened all the lines of
resistance. Conversely, those in all other work status groups gave evidence through high PHS
scores that they had reconstituted to a new normal. These results confirm Neuman's argument
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that the system's reconstitution depends on the efficacy of the resistance lines (Neuman &
Fawcett, 2011) in all five-person variables.
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Chapter VI
Summary, Implications, Conclusion, and Limitations
Overview
The aim of this cross-sectional randomized study of 266 people with MS was to examine
the relations among the dependent variable, Perceived Health Status, and independent variables
Adherence to DMT and Religious Coping. The Neuman Systems Model's (Neuman & Fawcett,
2011) conceptual underpinnings and Pargament's Theory of Religious Coping (Pargament, 1997)
linked the variables. The research question aimed to determine if, considered together, does
Adherence to DMT and Religious Coping explain statistically significant variance in Perceived
Health Status? A self-administered web-based survey used the SF-36 (Ware & Sherbourne,
1992), the MS-TAQ (Wicks et al., 2011), and the Brief RCOPE (Pargament et al., 2000).
Questions from the BRFSS (CDC, 2018) described the participants' demographics.
Summary Of The Findings
It was posited that Adherence to DMT and both Positive and Negative Religious Coping
worked together to predict Perceived Health Status in people with MS. However, neither
Adherence to DMT nor Religious Coping contributed statistically significant variance to
Perceived Health Status. Participants' mean scores in Perceived Health Status were statistically
significantly higher than the standardized population mean. Scores on the Mental Health
subscale were also statistically significantly higher than the standardized population scores, and
Physical Health scores were the same as the standardized population scores. Thus, participants
perceived their health to be good despite having MS. Perceived Health Status' subscales (Mental
and Physical Health) showed a statistically significant large positive correlation.
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Regarding the independent variables, there was very little variability in the scores.
Participants were overwhelmingly Adherent to DMTs, and they had uniformly low Positive and
Negative Religious Coping scores. It appears they did not use religion as a significant coping
strategy. Additionally, Positive and Negative Religious Coping showed a small but statistically
significant negative correlation. Finally, the only independent variable to correlate with any
aspect of Perceived Health was Negative Religious Coping. Participants who used Negative
Religious Coping had lower perceived Mental Health scores.
In ancillary analyses, Employment Status contributed a statistically significant 18% of
variance to Perceived Health Status. Participants who reported being unable to work had
statistically significantly lower mean scores in overall Perceived Health, Physical Health, and
Mental Health than all other employment groups. The unable to work group represented
approximately 25% of the sample, and their scores were at the lower end of Perceived Health,
Physical Health, and Mental Health. This group was primarily over 55 years old and likely had
secondary progressive MS though most reported having relapsing-remitting MS.
Implications
Implications For Model Development
Fawcett and Gigliotti (2001) recommended researchers select a conceptual model to
provide context and guide research. Therefore, this study was an essential first step into
exploring Perceived Health Status as an indicator of Reconstitution to the normal line of defense
in the NSM. The role of the Lines of Resistance in preventing a stress response is essential to
help the system Reconstitute. The SF-36 (Ware & Sherbourne, 1992) quantified Reconstitution.
However, valid, and reliable instruments that measure concepts can be challenging. Additionally,
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quantitative measures of Reconstitution can vary depending on the aspect that is important to the
researcher.
The pros of viewing Reconstitution as a self-reported measure align with the system's
multidimensionality discussed in the NSM. Items on the SF-36 aggregated Physical and Mental
Health measures and the instrument's multidimensionality are evident in the sub-scores. Physical
functioning, role limitations due to physical and emotional health, energy/fatigue, social
functioning, pain, and general health comprise Perceived Health's aggregate score. However,
measures of the spiritual and physiological lines of resistance were lacking. Therefore, the study
analyses did not explain possible interrelations physiologically and spiritually. Regrettably,
Religious Coping did not measure spirituality within the context of the NSM adequately.
Although the study's results gleaned no key variable that positively affected
Reconstitution, Employment Status, particularly being unable to work, taxed the system and
contributed to the invasion of all resistance lines. All parts of the system are interrelated
(Neuman & Fawcett, 2011); hence, examining any aspect of the NSM concepts requires the
researcher to measure all interrelated variables in the Lines of Resistance. Conceptualizing and
measuring Reconstitution requires consideration of disease factors with an account of their goals
and expectations of their health.
Implications For Nursing Practice
Knowledge about how the Lines of Resistance work to defend the core can inform
practicing nurses about the importance of nursing measures to support Reconstitution. Stressors
affect all dimensions of a person's life with an MS diagnosis. Rehabilitation nurses are important
to help patients rehabilitate successfully. The nurses are positioned to assess the physical and
psychosocial impact of MS on the person. Assessment should also include those MS-related
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factors that influence the person's abilities to perform work-related tasks. Finally, collaborative
interventions need to be planned to account for the patient's rehabilitative preferences.
Rehabilitation services are important to intervene in physical and mental health issues
affecting employment (Motl, 2010). Considering the consequences of Employment Status on a
person's quality of life, timely interventions at diagnosis for vocational rehabilitation may
forestall eventual employment loss. Multi-professional interventions focused on improving and
managing MS impairments are critical. Referrals for financial, rehabilitation and other support
can facilitate Reconstitution for people with MS who are significantly affected by the disease
(Gerhard et al., 2020). Other psychological intervention methods may be necessary for people
with MS who cannot work and try to cope with the profound physical, psychological,
sociocultural, developmental, and spiritual impact of being unable to work.
Implications For People With MS
People with MS face many uncertainties regarding disease course. The physical and
psychological impact of MS can result in life-altering loss and lifestyle changes that affect the
person and their loved ones. Employment challenges due to MS-related symptoms affect all
aspects of a person's life. Work provides meaning in peoples' lives (Saunders & Nedelec, 2014),
which can provide financial independence. However, more importantly, people with physical and
cognitive disabilities identified that working is natural, a source of identity, and contributes to
improved self-esteem and personal worth (Strong, 1998).
Working can positively influence self-concept, self-efficacy, and self-reported health,
empowering patients to communicate their concerns regarding when and if a return to work is
possible. Outdated skills may impact a successful return to work. Therefore, people with MS
may need rehabilitation interventions that prioritize patients' goals for employment. Using valid
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and reliable multidimensional self-reported measures can help identify patient condition changes
and communicate what is important to the individual to healthcare providers. Better
communication can lead to more focused interventions.
Implications For Healthcare Disparities
Recent studies indicate that MS has a higher incidence in African Americans (10.2%)
than Caucasians (6.9 %), Latinx Americans (2.9%), or Asian Americans (1.4%) (Khan et al.,
2015). Also, African Americans are at a 47% higher risk of developing MS than Caucasian
Americans (Khan et al., 2015). This study's racial demographic is skewed towards Caucasians.
Caucasians made up 89.8% of the study participants; therefore, generalizability is limited to
other groups.
One recommendation for future research is to include more non-Caucasian participants to
provide new MS insights (Institute of Medicine, 2001). Unemployment in African Americans is
multifactorial and is compounded by MS. Older minority individuals with MS are less likely to
be employed (Rumrill et al., 2015) than Caucasians. Potential barriers to study enrollment for
racial and ethnic minorities are multifactorial; therefore, multilevel interventions to boost
enrollment are needed (Hamel et al., 2016).
The U. S. Department of Health and Human Services gives recommendations for age,
racial, and ethnic diversity for clinical trial enrollment (FDA/CDER/Fox, 2019). Some of the
recommendations can be adopted for social and behavioral science research. Underserved
populations need better representation in research; therefore, targeted information and education
may help them participate (Amorrortu et al., 2018). In this study, there was no consideration to
capture information on nationality; therefore, sociocultural correlations of Perceived Health
Status, Adherence to DMT, and Religious Coping were not analyzed.
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Conclusions
There is no debate on the fact that MS causes substantial physical and cognitive hardships
to people, especially during the prime years of adulthood. Physical and cognitive disability
affects all aspects of the person, and this was made evident by the fact that MS poses significant
challenges to employment and its subsequent effect on Perceived Health Status. These challenges
can affect how the person adapts to MS. Thus, Reconstitution is affected. The results of this
study, though descriptive, call attention to the need to consider physical and cognitive disability
to better understand Perceived Health Status in MS. However, the relationship between
Perceived Health and disability is not straightforward.
There is some support for the conceptual and theoretical link between Neuman's System
Model (Neuman & Fawcett, 2011) and Pargament's Theory of Religious Coping (1997).
Specifically, the effect of the spiritual line of resistance on Reconstitution to a new normal.
The spiritual variable worked to weakly influence Reconstitution via negative Religious Coping.
Participants who used less or no Negative Religious Coping reported better Mental Health.
Perceived Health Status
Analyzing Perceived Health against demographic data showed Employment Status and,
particularly, people who were unable to work had significantly worse Physical and Mental
Health than all other employment groups. Perceived Health Status is an important measure of
patients' condition and treatment outcomes and can help with collaborative care. MS can affect a
person's daily life with disruption in social, family, and work functioning leading to diminished
Perceived Health (Aronson, 1997; Busche et al., 2003).
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Examining the role of Employment Status in Perceived Health provided insight into the
physical and mental effects MS has on those participants who were unable to work. The SF-36
was a good measure of the participants' Physical and Mental Health and was a gauge of the
disability status in the employment groups. Not expected were the overall high scores in
Perceived Health for the study participants. More than 70% were older than 55 years, implying
they lived with MS for years. People with MS typically have worse scores in Perceived Health
than the general US non-MS population (Wilski & Tasiemski, 2016).
The high scores in Perceived Health could indicate unique appraisal, and adaptational
processes participants used to rate their PHS, particularly because of the long and progressive
nature of MS. Because of the heterogeneous nature and variable presentations of the disease,
how the patient views disease and its effects on their life are important. Therefore, addressing
Perceived Health clinically involves a view of the total disease experience and not just a focus on
disability. Perceived Health and disability may not be truly linear (Miller & Dishon, 2006),
especially since one must adapt and learn to live with progressive disease.
All aspects of one's life with MS are affected over time. To engage in adaptive coping,
people are more likely over time to view their condition more favorably, resulting in decreased
stress, adaptation, and higher Perceived Health Status (McCabe & McKern, 2002). Perceived
Health's findings in this study show that many participants could adapt and reconstitute to a new
normal living with MS. However, this Reconstitution was not related to Adherence to DMT nor
Religious Coping in this study.
Adherence to DMT
Adherence to DMT did not contribute significant variance to Reconstitution. Participants
were largely (78%) highly adherent (86% - 100%). This high adherence may be because the
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sample was participants from NARCOMS who enroll in studies that measure adherence. Mowry
et al. (2009) reported better Adherence to DMT among older patients, and people who have good
adherence may be more apt to enroll in studies that assess adherence. Studies have shown that,
when approached, older adults are often willing to participate in research (Mody et al., 2008).
Therefore, this study's data may favor the older MS population who probably have been adapting
their lives to cope with MS for decades and truly arrive at a new normal, Neuman's normal line
of defense.
Adherence by itself was not an indicator of better or worse Perceived Health. There are
most likely other potential mediators or moderators between Perceived Health and Adherence to
DMT at play in the lives of this study's participants. Hofer, Choi, and Mase (2017) report
satisfaction with information and knowledge about prescribed drugs led to better medication
adherence. This study's participants sampled from NARCOMS may likely be more
knowledgeable about the types of DMTs, and the role DMTs can play in disability progression.
These patients may be more similar in their beliefs about DMTs. Therefore, they had less
variability in responses.
There is value to research in using an organization to obtain an adequately powered
representative sample size. With NARCOMS, many participants are willing to enroll in studies
that benefit the MS community. Therefore, attracting respondents, decreasing time to data
collection, and decreased recruitment cost for a sample is minimized. However, the respondents
who are more willing to enroll may be more similar in beliefs and more adherent than
participants recruited from a wide variety of settings. Future studies should employ systematic,
stratified, or cluster sampling in a wider variety of participants from different clinical and
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community settings. Other groups of patients may have less experience with research and bring
a new perspective to the study, yielding significant findings generalizable to people with MS.
How people with MS appraise the effect of DMTs on disease progression and beliefs
about DMTs could have provided further insight on the role adherence plays in Perceived Health.
People with MS are likely Adherent to DMTs with such serious side effects because of some
inherent belief that disease trajectory will improve. The role of treatment belief as a predictor of
Perceived Health Status requires further research.
Religious Coping
The participants in this study were not religious copers, thus no explained variance in
Perceived Health. Religious copers use religion to decrease stress and assist with problemsolving techniques (Kossiwa et al., 2020). Measuring Religious Coping as an independent
variable did not provide insight into religiosity or spirituality in this study's sample. Though
religiosity and spirituality can provide context to behavior, offer social support, a sense of
meaning in life, and living a healthy lifestyle (VanderWeele et al., 2017), this cross-sectional
design only showed weak associations between Negative Religious Coping and Mental Health.
Religiosity/Spirituality measures may need to contain questions about the role religion
plays in individuals' lives. How the person defines religion/spirituality, the importance it plays in
their life, and not just how they use it to cope with illness requires further examination.
Additional work is needed to conceptualize and operationalize the differences between religiosity
and spirituality. The socio-cultural aspect is also important because the meaning of spirituality is
diverse among different religious denominations, ethnic and cultural groups (Sessanna et al.,
2011). According to Neuman (2011), all people are spiritual beings. Spirituality permeates all
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variables, and people need to express their meaning of spirituality and define how it contributes
to illness and health.
Coping requires evaluating one's ability to manage stressful situations (Susan Folkman et
al., 1986). Psychological factors are inherently important to people and influence coping with
MS. Therefore, we need to understand the psychological variables that may determine MSrelated Perceived Health. Possibly, people with MS who appraise situations more positively
show less emotion-focused coping. Adopting a more problem-focused task-oriented coping style
to manage health problems may help solve practical issues living with MS. Quality of life and
Perceived Health Status are more than just the sum of physical, mental, or disease diagnosis. All
sources of life satisfaction, social support, self-efficacy, coping style, mood, and perceived
support (Benito-León et al., 2003; Mitchell et al., 2005), as well as disease factors, may have
been better predictors of Perceived Health Status in this study.
Employment Status
Being unable to work significantly affected all five-person variables. People with MS
often cannot work because they typically are symptomatic with a progressive disease course
(Bisht et al., 2014; Busche et al., 2003). After diagnosis and the onset of symptoms, up to 80%
of people with MS can become unemployed (Johnson et al., 2004). However, work status in MS
may be a dynamic process. People enter and exit the workforce for different reasons that may or
may not be disease related. MS exacerbations that include mobility impairment, hand weakness
or sensory loss, fatigue, and cognitive difficulties over six months were predictive of work loss
in MS (Julian et al., 2008).
One strength of this study is that Employment status was not defined as a dichotomous
variable: employed versus unemployed. The work categories, unable to work, unemployed,
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retired, working part-time or full-time, enabled more granular analyses of the participants in each
group. What was lacking in this study was investigating the reasons why the person was not
working. For example, being unable to work or unemployed may be due to having a permanent
disability with no plans to re-enter the workforce. Conversely, a person may not be working due
to temporary changes in life situations, possibly recovering from a relapse with plans to return to
work, or reasons that are unrelated to MS. Women who are predominantly affected by MS are
more likely to leave the workforce because of responsibilities not related to MS (Gerhard et al.,
2020).
Furthermore, the Coronavirus (COVID) pandemic has changed the way Americans work
(Parker et al., 2020). Remote work may usher in a new paradigm for the workforce. People with
MS-related disabilities may, if given a choice, keep working remotely. According to a new Pew
Research Center Survey (2020), about 49% of workers felt they had more flexibility to choose
the time of day to work leading to better role function. Of interest, the workplace COVID-related
changes may allow people with MS to gain and keep their employment. Future studies should
include qualitative descriptions of reasons for unemployment among patients with MS.
Information about Employment Status before MS and current unemployment reasons are needed
because non-MS factors also influence Employment status.
Limitations
Several limitations of the current study require attention. Most notable was categorizing
the type of MS as only Relapsing or Progressive. Although there is no way to predict how a
person's disease will progress, MS's subtypes have some differences in the disease trajectory.
Identifying if participants had relapsing-remitting, secondary progressive, or primary progressive
MS may have identified differences in Perceived Health and coping among the MS types.
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There are several considerations to discuss in light of this study's methodological
limitations. This study was cross-sectional. Thus, it did not evaluate Perceived Health Status,
Adherence to DMT, and Religious Coping (PRC and NRC) at different times along the
continuum of MS and the patients' lives. MS is a progressive disease with accumulating physical
and cognitive disability. Therefore, the adaptational processes that occur over a person's life
contributing to Reconstitution were not captured in this study. There may have also been
selection bias by using only participants from NARCOMS.
The study variables Adherence to DMT and Religious Coping were key measures in the
study. However, their importance in Reconstitution may have been hindered by not measuring
current disability, specific types of MS, years since MS diagnosis, or appraisal methods used to
arrive at Perceived Health Status. Despite these limitations, this is the first study to quantify
Reconstitution and use the Brief RCOPE in people with MS. Research on Employment Status at
all levels and its role in causing a stress reaction in all Lines of Resistance should focus on
unraveling the pathways between employment and health outcomes.
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Appendices
Appendix A
Conceptual-Theoretical-Empirical Structure
Neuman’s
Concept

Environmental Normal Line
Stressors
of Defense

║
Coping
Theory

Environmental Primary and
Antecedents:
Secondary
Situational
Appraisal
Demands

Diagnosed
with MS

│
Health
Perception

¦
Empirical
Indicators

Sample
Delimitations

Psychological
Lines of
resistance

║

│
Theoretical
Linkages

Physiological
Lines of
Resistance

¦
SF-36

Reconstitution

║
Problemfocused
Coping

Emotionfocused
Coping

│

│

Adhering to
DMT

Religious
Coping

¦
MS-TAQ

║
Adaptational
Outcomes

│
Health
Perception

¦
Brief R-Cope

Legend*:
║= denotes moving from model concept to grand theory concept
│= denotes moving from grand theory concept to theoretical linkages
¦ = denotes moving from theoretical linkages to empirical indicators
Gigliotti, E., & Minister, N. N. (2012) A Beginner’s Guide to Writing the Nursing Conceptual
Model-Based Theoretical Rationale. Nursing Science Quarterly, 25(4), 301–306.

¦
SF-36
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Appendix B
Terms and Conditions for Using the RAND 36-Item Short Form Survey (SF-36)
RAND hereby grants permission to use RAND 36-Item Short-Form Health Survey in
accordance with the following conditions, which shall be assumed by all to have been agreed to
as a consequence of accepting and using this document:
1. Changes to the Health Survey may be made without the written permission of RAND.
However, all such changes shall be clearly identified as having been made by the
recipient.
2. The user of this Health Survey accepts full responsibility, and agrees to indemnify and
hold RAND harmless, for the accuracy of any translations of the Health Survey into
another language and for any errors, omissions, misinterpretations, or consequences
thereof.
3. The user of this Health Survey accepts full responsibility, and agrees to indemnify and
hold RAND harmless, for any consequences resulting from the use of the Health Survey.
4. The user of the 36-Item Health Survey will provide a credit line when printing and
distributing this document acknowledging that it was developed at RAND as part of the
Medical Outcomes Study.
5. No further written permission is needed for use of this Health Survey.
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SF36 Health Survey. INSTRUCTIONS: This set of questions asks for your views
about your health. This information will help keep track of how you feel and how well
you are able to do your usual activities. Answer every question by marking the answer as
indicated. If you are unsure about to answer a question, please give the best answer you
can.
1.
In general, would you say your health is: (Please tick one box.)
Excellent –
Very Good –
Good –
Fair –
Poor –
2.
Compared to one year ago, how would you rate your health in general now? (Please
tick one box.)
Much better than one year ago –
Somewhat better now than one year ago –
About the same as one year ago –
Somewhat worse now than one year ago –
Much worse now than one year ago –
3.
The following questions are about activities you might do during a typical day. Does
your health now limit you in these activities? If so, how much? (Please circle one
number on each line.)
Yes, limited a
Yes, limited
Not
Activities
lot
little
limited
at all
3(i)
Vigorous activities, such as running,
1
2
3
lifting heavy objects, participating in
strenuous sports
3(ii)
Moderate activities, such as moving a
1
2
3
table, pushing a vacuum cleaner,
bowling, or playing golf
3(iii)
Lifting or carrying groceries
1
2
3
3(iv)
Climbing several flights of stairs
1
2
3
3(v)
Climbing one flight of stairs
1
2
3
3(vi)
Bending, kneeling, or stooping
1
2
3
3(vii)
Walking more than a mile
1
2
3
3(viii)
Walking several blocks
1
2
3
3(ix)
Walking one block
1
2
3
3(x)
Bathing or dressing yourself
1
2
3
4.
During the past 4 weeks, have you had any of the following problems with your
work or other regular daily activities as a result of your physical health? (Please
circle one number on each line.)
YES

NO
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4(i)
4(ii)
4(iii)
4(iv)
5.

5(i)
5(ii)
5(iii)
6.

7.

8.

9.

Cut down on the amount of time you spent on work or
1
2
other activities
Accomplished less than you would like
1
2
Were limited in the kind of work or other activities
1
2
Had difficulty performing the work or other activities
1
2
(for example, it took extra effort)
During the past 4 weeks, have you had any of the following problems with your
work or other regular daily activities as a result of any emotional problems (such as
feeling depressed or anxious)?
(Please circle one number on each line.)
Yes
No
Cut down on the amount of time you spent on work or
1
2
other activities
Accomplished less than you would like
1
2
Didn’t do work or other activities as carefully as usual
1
2
During the past 4 weeks, to what extent has your physical health or emotional
problems interfered with your normal social activities with family, friends,
neighbors, or groups? (Please tick one box.)
Not at all –
Slightly –
Moderately –
Quite a bit –
Extremely –
How much physical pain have you had during the past 4 weeks? (Please tick one
box.)
None –
Very mild –
Mild –
Moderate –
Severe –
Very Severe –
During the past 4 weeks, how much did pain interfere with your normal work
(including both work outside the home and housework)? (Please tick one box.)
Not at all –
A little bit –
Moderately –
Quite a bit –
Extremely –
These questions are about how you feel and how things have been with you during
the past 4 weeks. Please give the one answer that is closest to the way you have
been feeling for each item.
(Please circle
one number
on each line.)

9(i)

Did you feel
full of life?

All of
the time

Most of
the time

A good
bit of the
time

Some of
the time

A little of the time

None
of the
time

1

2

3

4

5

6
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9(ii)

9(iii)

9(iv)

9(v)
9(vi)

9(vii)
9(viii)

9(ix)
10.

11.

Have you
been a very
1
2
3
4
5
6
nervous
person?
Have you
felt so down
in the dumps
1
2
3
4
5
6
that nothing
could cheer
you up?
Have you
felt calm
1
2
3
4
5
6
and
peaceful?
Did you
have a lot of
1
2
3
4
5
6
energy?
Have you
felt
1
2
3
4
5
6
downhearted
and blue?
Did you feel
1
2
3
4
5
6
worn out?
Have you
been a
1
2
3
4
5
6
happy
person?
Did you feel
1
2
3
4
5
6
tired?
During the past 4 weeks, how much of the time has your physical health or
emotional problems interfered with your social activities (like visiting with friends,
relatives etc.) (Please tick one box.)
All of the time –
Most of the time –
Some of the time –
A little of the time –
None of the time –
How TRUE or FALSE is each of the following statements for you? Please circle one
number on each line
Definitely false
Definitely true
Mostly
Don’t know
Mostly

true
11(i)

I seem
to get
sick a

1

false
2

3

4

5
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11(ii)

11(iii)

11(iv)

little
easier
than
other
people
I am as
healthy
as
anybody
I know
I expect
my
health to
get
worse
My
health is
excellent

1

2

3

4

5

1

2

3

4

5

1

2

3

4

5
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Appendix B1
Scoring SF-36 Step 1: Recoding Items
Item numbers
1, 2, 20, 22, 34, 36

3, 4, 5, 6, 7, 8, 9, 10, 11, 12
13, 14, 15, 16, 17, 18, 19
21, 23, 26, 27, 30

24, 25, 28, 29, 31

32, 33, 35

Change original
response category *
1→
2→
3→
4→
5→
1→
2→
3→
1→
2→
1→
2→
3→
4→
5→
6→
1→
2→
3→
4→
5→
6→
1→
2→
3→
4→
5→

To recoded
value of:
100
75
50
25
0
0
50
100
0
100
100
80
60
40
20
0
0
20
40
60
80
100
0
25
50
75
100
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Step 2: Averaging Items to Form Scales
Scale

Number of items

Physical functioning
Role limitations due to
physical health
Role limitations due to
emotional problems
Energy/fatigue
Emotional well-being
Social functioning
Pain
General health

10

After recoding per Table 1,
average the following items
3 4 5 6 7 8 9 10 11 12

4

13 14 15 16

3

17 18 19

4
5
2
2
5

23 27 29 31
24 25 26 28 30
20 32
21 22
1 33 34 35 36
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Appendix C
MS-TAQ Permission
From: Eleanor Byrne
Sent: Friday, February 23, 2018 11:14 AM
To: Marcia Jones George
Subject: Re: Permission to Use the MS-TAQ for my Research
Thank you for your interest in the MS-TAQ. It is licensed under Creative Commons Sharealike
3.0 and is therefore free of charge. You can see all available translations here:
https://www.openresearchexchange.com/public/library/instruments/26/overview
I enclose the relevant publication. Please note that the MS-TAQ was developed at a time
when only injectable drugs were available, so it may require modification to cover newer drugs.
Please ensure you detail any modifications in your published work.
If there is anything more I can help you with, please let me know.

Eleanor Byrne
PatientsLikeMe Research Support
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Appendix C1 (cont’d)
Multiple Sclerosis Treatment Adherence Questionnaire (MSTAQ)
Name: _________________________________________________________________
Today’s date (mm/dd/yyyy): ____________________________________________
It is important that you take your medication as prescribed by your physician. However,
from time to time you may find it difficult or impossible to take your DMT as prescribed. This
instrument is designed to help you and your physician understand what these barriers are and to
come up with ways to make it easier to take your treatment. It is very important that you are
honest when completing this instrument so that your MS team can help to look after you better.

1) Which of the following are you currently taking to treat Multiple Sclerosis (MS)? (Check
one)
Copaxone (Glatiramer Acetate)
Avonex or Avonex pre- ‐filled syringe
(Interferon Beta 1a intramuscular)
Rebif (Interferon Beta 1a subcutaneous)
Betaseron or Betaferon (Interferon Beta 1b
subcutaneous)
Tysabri (Natalizumab)
Novantrone (Mitoxantrone)
Other, please specify:
I do not know
Does not apply
I prefer to skip
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2) On how many days during the last 4 weeks (28) days were you supposed to take this
medication. (Check one)
Every day (28 times)
Every other day (14 times)
Three times a week (12 Times
Once a week (4 times)
Once a month (1 time)
Other, please specify
3) During the past 4 weeks (28 days) did you manually inject, use an auto-injection device, or
do both? (Check one)
Manual injection only
Auto-injection only
Both manual and auto-injection
Not applicable / I take a pill

4) During the past 4 weeks (28 days), how often was your injection done by someone else?
(Check one)
Never
A few times
About half the time
Most of the time
All or nearly all of the time
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5) Did you miss or forget to take any doses of this medication during the last 4 weeks (28 days)?
(Check one)
Yes
No

6) How many doses did you miss or forget? __________________

Complete this section only if you missed a dose in the past 28 days
7) How important were the following factors in missing or forgetting to take a dose? (Please
check one answer for each).
Not important
at all

A little
important

Moderately
important

Extremely
important

Memory problems

0

1

2

3

Too busy

0

1

2

3

Side effects of injection

0

1

2

3

Side effects of medication

0

1

2

3

Fear of needles

0

1

2

3

Needing someone to help me
take my medication

0

1

2

3

Ran out of medication or
could not refill my
prescription
Away from home and could
not access my medication

0

1

2

3

0

1

2

3
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Feeling anxious, depressed, or 0
nervous about taking my
medication

1

2

3

Dissatisfaction with my
medication

0

1

2

3

Did not want my medication
to interfere with activities

0

1

2

3

Tired of taking my
medication

0

1

2

3

Did not feel like taking my
medication

0

1

2

3

For completion by examiner only; DMT-Barr Score:
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Appendix D
The Brief Religious COPE
The following items deal with ways you coped with the negative event in your life. There are
many ways to try to deal with problems. These items ask what you did to cope with this negative
event. Obviously different people deal with things in different ways‚ but we are interested in how
you tried to deal with it. Each item says something about a particular way of coping. We want to
know to what extent you did what the item says. How much or how frequently. Don’t answer on
the basis of what worked or not - just whether or not you did it. Use these response choices. Try
to rate each item separately in your mind from the others. Make your answers as true FOR YOU
as you can. Circle the answer that best applies to you.
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The Brief RCOPE
Not
at all
1

Looked for a stronger connection with God

2

Sought God’s love and care

3

Sought help from God in letting go of my anger

4

Tried to put my plans into action together with God

5

Tried to see how God might be trying to strengthen
me in this situation

6

Asked forgiveness for my sins

7

Focused on religion to stop worrying about my
problems

8

Wondered whether God had abandoned me

9

Felt punished by God for my lack of devotion

10

Wondered what I did for God to punish me

11

Questioned God’s love for me

12

Wondered whether my church had abandoned me

13

Decided the devil made this happen

14

Questioned the power of God

Somewhat Quite A
a bit great
deal

Legend: 1 = Not at all, 2 = Somewhat, 3 = Quite a Bit, 4 = A Great Deal
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Appendix E
Demographic Data Questionnaire
Have you
1. been diagnosed with multiple sclerosis by a health care provider?
Yes _____
No_____
What 2.
type of multiple sclerosis do you have?
Relapsing Multiple Sclerosis ________
Progressive Multiple Sclerosis _____
What 3.
is your gender identity?
Male _____
Female _____
Other _____
Which4.of the following do you consider yourself?
Christian
Muslim
Jewish
Roman Catholic
Latter Day Saints or Mormon
Buddhist
Hindu
Agnostic (you are not sure if there is a God.)
Atheist (you believe there is no God.)
Spiritual, but not committed to a particular faith
Other _______
Which5.category below includes your age?
18-24 years-old _____
25-34 years-old _____
35-44 years-old _____
45-54 years-old _____
55 to 64 years-old _____
65 to 74 years-old _____
75 years or older ______
What 6.
is your CURRENT marital status? (CHOOSE ONLY ONE)
Single _____
Married ______
Domestic partnership _____
Separated _____
Divorced _____
Widowed _____
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What 7.
is the highest level of education you have completed or the highest degree
you have received?
Some high school, no diploma _____
High School graduate, diploma or equivalent _____
Some college credit, no degree _____
Trade/technical/vocational training _____
Associate degree _____
Bachelor’s degree _____
Master’s degree _____
Professional degree _____
Doctoral degree _____
Which8.of the following categories best describe your employment status?
(CHOOSE ONLY ONE)
Employed fulltime _____
Employed part-time _____
Retired ______
Not employed _____
Unable to work ______
How much
9.
total combined income did ALL members of you household earn in
2018?
Less than $20,000 _____
$20,000 to $34,000 _____
$35,000 to $49,000_____
$50,000 to $74,000_____
$75,000 to $99,000 _____
Over $100,000 _____
How would
10. you describe yourself?
White _____
Hispanic, Latino or Spanish origin _____
Black or African American _____
Native American or American Indian _____
Asian/Pacific Islander _____
Other _____
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Appendix F
CUNY IRB Approval
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Appendix G
NARCOMS Approval
From: Tyry, Tuula - SJHMC
Sent: Monday, April 17, 2017 2:36 PM
To: Marcia Jones George
Subject: RE: Researcher Information Form submission

Hi Marcia – the EC approved your proposal but would like to get further information on
the basis of the power calculation once you have figured out the methodology in more detail. In
other words, we would like to make sure that you get enough responses for a meaningful
analysis. Please keep us in the loop in terms of the instruments you will be using, and we will
discuss the sample size requirement again at that time.
Tuula

On Feb 22, 2019, at 6:35 PM, Tyry, Tuula - SJHMC <Tuula.Tyry@dignityhealth.org>
Your proposal resubmission has been approved : ) Let me know when you are ready to discuss
the logistics involved. Tuula
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Appendix H
Introductory E-mail to Study Participants Sent by NARCOMS
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Appendix I
Protection of Survey Participants
This survey was designed to be completely anonymous to protect the participants.
No identifying information, such as state or zip code, will be asked in this survey. Use of the
blind “cc” feature when sending emails to participants and the procedure for gaining consent
further protects the participant anonymity.
Procedure for consent: The participant may only access the survey by clicking on the survey link,
and then the participant may read the consent and then click on the continue button, as tacit
consent (with no signature) protects the anonymity of the participant. Additionally,
SurveyMonkey provides for the protection of survey participants and data in the following
safeguards and procedures:
Physical Security:
SurveyMonkey’s information systems and technical infrastructure are hosted within SOC 2
accredited data centers. Physical security controls at our data centers include 24x7 monitoring,
cameras, visitor logs, entry requirements, and dedicated cages for SurveyMonkey hardware.
Access Control
Access to SurveyMonkey’s technology resources is only permitted through secure connectivity
(e.g., VPN, SSH) and requires multi-factor authentication. Password policy requires complexity,
expiration, and lockout and disallows reuse. SurveyMonkey grants access on a need to know
based on least privilege rules, reviews permissions quarterly, and revokes access immediately
after employee termination.
Security Policies:
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SurveyMonkey maintains and regularly reviews and updates its information security policies, at
least on an annual basis. Employees must acknowledge policies on an annual basis and undergo
additional training such as HIPAA training, Secure Coding, PCI, and job-specific security and
skills development and privacy law training for crucial job functions. The training schedule is
designed to adhere to all specifications and regulations applicable to SurveyMonkey.
Personnel:
SurveyMonkey conducts background screening at the time of hire (to the extent permitted or
facilitated by applicable laws and countries). SurveyMonkey also communicates its information
security policies to all personnel (who must acknowledge this) and requires new employees to
sign non-disclosure agreements and provides ongoing privacy and security training.
Dedicated Security Personnel:
SurveyMonkey also has a dedicated Trust & Security organization, which focuses on application,
network, and system security. This team is also responsible for security compliance, education,
and incident response.
Vulnerability Management and Penetration Tests:
SurveyMonkey maintains a documented vulnerability management program which includes
periodic scans, identification, and remediation of security vulnerabilities on servers,
workstations, network equipment, and applications. All networks, including test and production
environments, are regularly scanned using trusted third-party vendors. Critical patches are
applied to servers on a priority basis and as appropriate for all other patches. Regular internal
and external penetration tests and remediates according to severity for any results found are also
conducted.
Encryption:
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Data in transit is encrypted using secure TLS cryptographic protocols. SurveyMonkey data is
also encrypted at rest.
Development:
SurveyMonkey employs secure coding techniques and best practices, focused around the
OWASP Top Ten. Developers are formally trained in secure web application development
practices upon hire and annually. Development, testing, and production environments are
separated. All changes are peer-reviewed and logged for performance, audit, and forensic
purposes before deployment into the production environment.
Asset Management:
SurveyMonkey maintains an asset management policy which includes identification,
classification, retention, and disposal of information and assets. Company-issued devices are
equipped with full hard disk encryption and up-to-date antivirus software. Only company-issued
devices are permitted to access corporate and production networks.
Information Security Incident Management:
SurveyMonkey maintains security incident response policies and procedures covering the initial
response, investigation, customer notification (no less than as required by applicable law), public
communication, and remediation. These policies are reviewed regularly and tested bi-annually.
Breach Notification:
Despite best efforts, no method of transmission over the Internet and no method of electronic
storage is entirely secure. If SurveyMonkey learns of a security breach, affected users are
notified so that they can take appropriate protective steps. Breach notification procedures are
consistent with applicable country level, state and federal laws and regulations, as well as any
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applicable industry rules or standards. Customers are provided with all information necessary for
them to meet regulatory reporting obligations.
Information Security Aspects of Business Continuity Management:
SurveyMonkey’s databases are backed up on a rotating basis of full and incremental backups and
verified regularly. Backups are encrypted and stored within the production environment to
preserve their confidentiality and integrity and are tested regularly to ensure availability.
Logging and Monitoring
Application and infrastructure systems log information to a centrally managed log repository for
troubleshooting, security reviews, and analysis by authorized SurveyMonkey personnel. Logs are
preserved by regulatory requirements. Customers are provided with reasonable assistance and
access to logs in the event of a security incident impacting their account.
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Appendix J
Factor Analysis of the Brief RCOPE in People With Multiple Sclerosis
This analysis aimed to explore the factors of the Brief RCOPE in a cross-sectional survey
among people with MS (N = 277) to test Pargament's (1997) Theory of Religious Coping. The
study aimed to examine the relations between Perceived health status, Adherence to Disease
Modifying Treatment, and Religious Coping. Coping refers to the way people manage stressors
in their lives. Religious Coping is one way people use religion to deal with difficulties in their
lives. The Brief-RCOPE scale was formed based on Pargament's (1997) theory and measures
religious coping (see Appendix E).
The scale's items were developed through interviews with people experiencing negative
events in their lives. Pargament’s sample was primarily white (93%) and female (69%), similar
to this study's sample (see Table 2). However, unlike this study's sample, Pargament's sample
were college freshmen (70%) with an average age of 19 years (range: 18 – 38 years). Criteria
for selecting the items were based on factor-loading, the need to represent various coping
methods, and the need for a brief measure of religious coping (Pargament et al., 2000).
Confirmatory factor analysis (CFA) of the 14 items from the two subscales demonstrated
significant results (

2

= 210.77, df = 64, p < .001) among the 540 college students (K. I.

Pargament et al., 2000). When chi-squares are statistically significant, additional fit indices can
provide a better indication of fit (Tabachnick & Fidell, 2018). Pargament et al. (2000)
acknowledged needing additional fit measures due to the significant chi-square results.
Subsequently, two other fit indices were calculated. Chi-square to the degree of freedom ratio
was found to be 2.12. Values of less than 3.0 indicate a good fit. Additionally, the root square
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error of approximation was calculated as 0.46, which is less than .05 indicating an acceptable fit
(Browne et al., 2002).
The current analysis aims to evaluate the two-factor structure outlined by Pargament et al.
(2000). The Brief RCOPE consists of 14 items that measure positive and negative religious
coping. The data were analyzed using PCA with oblimin rotation to determine validity. Oblimin
rotation is best used for dimensions that are correlated, as found in this study. For this study, PRC
and NRC were correlated (r = .17), with Cronbach's alpha PRC (.96) and NRC (.84).
The adequacy of FA was examined through Kaiser-Meyer-Olkin (KMO) and Bartlett's
test of sphericity. Kaiser-Meyer-Olkin's (KMO) measure of sampling adequacy denotes an
adequate sample size, indicating partial correlations are small and robust factors may emerge
(Tabachnick & Fidell, 2018). Sample sizes above 200 are desired with recommended KMO
values above .6 (Tabachnick & Fidell, 2018). The rotated KMO factor extracted is higher (.875)
than 0.6 signifying sufficient items for each. The variables chosen are related to each other:
Bartlett's test of sphericity was significant (2 =2883, df =91, p <. 001), indicating they are
adequately related for factor analysis. To determine the relationship between variables and
achieve definitions of the factors, items with factor loadings correlations equal to or above .30
are desired (see Table 17). Factor loadings lower than .30 are considered random factors.
The analyses to estimate the number of factors, multicollinearity, and correlation matrices
suggest a two-factor solution (Eigenvalue over 1) as shown on the scree plot (see Figure 5)
(Tabachnick & Fidell, 2018).
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Figure 5
Brief RCOPE Eigenvalues

There are high correlations among the first seven variables, PRC, with the lowest (r = .6)
and the highest (r = .8) indicating the items are sufficiently related. Variables 8 – 14, NRC,
correlations were (r = .28) the lowest and the highest (r = .72) (see Table AJ1).

Looked for a stronger connection
with God
Sought Gods love and care
Sought help from God in letting go
of my anger
Tried to put my plans into action
together with God
Tried to see how God might be
trying to strengthen me in this
situation
Asked forgiveness for my sins
Focused on religion to stop worrying
about my problems
Wondered whether God has
abandoned me
Felt punished by God for my lack of
devotion
Wondered what I did for God to
punish me
Questioned Gods love for me
Wondered whether my church has
abandoned me
Decided the devil made this happen
Questioned the power of God

Table 17

Brief RCOPE Correlation Factor Matrix

Looked for a
stronger
connection
with God
.89
.76
.83
.81
.76
.77
.19
.18
.04
.05
.22
.17
-.04

Sought Gods
love and care
.89
.73
.86
.86
.75
.74
.11
.15
.05
.04
.18
.15
-.07

Sought help
from God in
letting go of
my anger
.76
.73
.75
.76
.67
.74
.18
.16
.12
.12
.27
.16
-.00
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Sought Gods love and care
Sought help from God in letting go
of my anger
Tried to put my plans into action
together with God
Tried to see how God might be
trying to strengthen me in this
situation
Asked forgiveness for my sins
Focused on religion to stop worrying
about my problems
Wondered whether God has
abandoned me
Felt punished by God for my lack of
devotion
Wondered what I did for God to
punish me
Questioned Gods love for me
Wondered whether my church has
abandoned me
Decided the devil made this happen
Questioned the power of God

Looked for a stronger connection
with God
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Tried to put
.83
my plans into
action
together with
God
Tried to see
.81
how God
might be
trying to
strengthen
me in this
situation
.86
.75
.87
.75
.76
.08
.12
-.00
.04
.22
.17
-.04

.86
.76
.87
.71
.77
.08
.12
-.00
.04
.22
.17
-.04

Asked
forgiveness
for my sins
.75
.67
.75
.71
.72
.11
.21
.12
.02
.25
.13
-.06

.76

Looked for a stronger connection
with God
Sought Gods love and care
Sought help from God in letting go
of my anger
Tried to put my plans into action
together with God
Tried to see how God might be
trying to strengthen me in this
situation
Asked forgiveness for my sins
Focused on religion to stop worrying
about my problems
Wondered whether God has
abandoned me
Felt punished by God for my lack of
devotion
Wondered what I did for God to
punish me
Questioned Gods love for me
Wondered whether my church has
abandoned me
Decided the devil made this happen
Questioned the power of God

151
Focused on
religion to
stop
worrying
about my
problems
.77
.74
.74
.76
.77
.72
.07
.13
.02
.04
.23
.19
-.05

Wondered
whether God
has
abandoned
me
.11
.11
.18
.08
.08
.11
.07
.54
.45
.52
.41
.36
.39

Felt punished .18
by God for
my lack of
devotion
.15
.16
.15
.12
.21
.13
.54
.73
.55
.44
.58
.31

Looked for a stronger connection
with God
Sought Gods love and care
Sought help from God in letting go
of my anger
Tried to put my plans into action
together with God
Tried to see how God might be
trying to strengthen me in this
situation
Asked forgiveness for my sins
Focused on religion to stop worrying
about my problems
Wondered whether God has
abandoned me
Felt punished by God for my lack of
devotion
Wondered what I did for God to
punish me
Questioned Gods love for me
Wondered whether my church has
abandoned me
Decided the devil made this happen
Questioned the power of God
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Wondered
what I did
for God to
punish me
.04
.05
.12
.00
-.00
.12
.02
.45
.73
.64
.28
.32
.31

Questioned
God's love
for me
.05
.04
.12
-.00
.04
.02
.04
.52
.55
.64
.39
.30
.64

Wondered
whether my
church has
abandoned
me
.22
.18
.27
.24
.22
.25
.23
.41
.44
.28
.39
.
.42
.32

Looked for a stronger connection
with God
Sought Gods love and care
Sought help from God in letting go
of my anger
Tried to put my plans into action
together with God
Tried to see how God might be
trying to strengthen me in this
situation
Asked forgiveness for my sins
Focused on religion to stop worrying
about my problems
Wondered whether God has
abandoned me
Felt punished by God for my lack of
devotion
Wondered what I did for God to
punish me
Questioned Gods love for me
Wondered whether my church has
abandoned me
Decided the devil made this happen
Questioned the power of God
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Decided the
devil made
this happen
.17
.15
.16
.17
.17
.13
.19
.36
.58
.32
.30
.42
.27

Questioned
the power of
God
-.04
-.07
-.00
-.05
-.04
-.06
-.05
.39
.31
.31
.64
.32
.22
-
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The analysis yielded two factors explaining 67.40% of the variance for the entire set of
14 variables (see Table 18). The first factor explained 42.72%, and the second factor explained
24.78% of the variance. Pargament labeled the first factor Positive Religious Coping and
included questions numbered 1 - 7. The second factor labeled Negative Religious Coping
includes questions 8 – 14. There is a correlation (r = .14) between PRC and NRC (see Table 19)
to make them sufficiently related (determinant = 8.72) but identifies each as a separate construct.
Table 18

Principal component Analysis for 14-items Brief-RCOPE
Factor

Eigenvalue

Percent of Variance

Cumulative Percent

1

5.98

42.73

42.73

2

3.46

24.78

67.51

3

.927

6.62

74.13

4

.825

5.89

80.02

5

.569

4.06

84.09

6

.530

3.78

87.87

7

.356

2.54

90.42

8

.316

2.25

92.68

9

.247

1.76

94.44

10

.225

1.60

96.04

11

.190

1.35

97.40

12

.167

1.19

98.59

13

.119

.84

99.44

14

.077

.55

100

Note. N = 266.
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Table 19

Between Factor Correlation Matrix Brief-RCOPE
Component

PRC

NRC

PRC

1.000

.14

NRC

.14

1.000

The pattern matrix (see Table 20) shows two distinct components. The first seven
variables load tightly together in the first component. This component is a measure of PRC. The
second component, variables 8 – 14, is also tightly loaded together and is an NRC measure.
Communality scores for each variable indicate the scale is better at measuring PRC. Values close
to 1 are preferable (Tabachnick & Fidell, 2018). Notably, variables 1 thru 7 account for 72% to
86% of the Religious Coping variance. However, variables loaded lower on factor 2 and
variables 8 thru 14 explain 39% to 70% of the Religious Coping variance.
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Table 20

Communalities Brief RCOPE
Variable

Component

Communalities

1

2

1

Looked for a stronger
connection with God.

.92

.00

.86

2

Sought Gods love and
care
Sought help from God in
letting go of my anger.

.93

-.02

.86

.84

.07

.74

4

Tried to put my plans
into action together with
God.

.93

-.03

.86

5

Tried to see how God
might be trying to
strengthen me in this
situation.

.92

-.03

.84

6

Asked forgiveness for
my sins.

.84

.03

.72

7

Focused on religion to
stop worrying about my
problems.

.87

-.01

.77

8

Wondered whether God
has abandoned me.

.01

.73

.54

9

Felt punished by God for
my lack of devotion.

.06

.82

.70

10 Wondered what I did for
God to punish me.

-.06

.78

.60

11 Questioned God's love
for me.

-.08

.83

.68

3
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Variable

Component

Communalities

12 Wondered whether my
church has abandoned
me.

.19

.59

.42

13 Decided the devil made
this happen.

.12

.59

.39

.64

.42

14 Questioned the power of
-.17
God
Note. Extraction Method: Principal Component Analysis

Three variables: wondered whether my church has abandoned me (.42), decided the devil
made this happen (.39), and questioned the power of God (.42) in component two, each
contributed less than 50% to the model. Subsequently, those three variables could be a separate
indicator of Religious Coping. Paika et al. (2017) also found low scores on the mentioned
variables in their analysis of the Brief-RCOPE.
For this study, participants reported using both PRC and NRC to cope with life
stressors similarly. Scores ranged from 6 to 24 for PRC and 7 to 21 for NRC. Pargament agrees
that study participants used more PRC than NRC (Pargament et al., 2000); however, NRC was
more predictive of adjustment and mental health. Studies using the Brief-RCOPE
(Mohammadzadeh & Najafi, 2016; Paika et al., 2017) report Cronbach's alpha > .80.
Mohammadzadeh and Najafi (2016) explored the scale's factor structure with PCA on an
Iranian sample.They found two distinct factors explaining 52.2% of observed variance, which
is lower than the results obtained for this analysis.
This study was the first to use Brief RCOPE for patients with MS. It was reasoned that
people would generally turn to religion to cope with chronic disease as a stressor. The MCS was
significantly correlated with NRC (r = -.21, p < .001). No significant correlations were observed
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with PRC and the study variables. What is unclear is the degree of religious coping people use
for non-life-threatening conditions and how it helps manage acute and chronic stress in MS.
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